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ABSTRACT 
The thoracic aortic wall can degenerate over time with catastrophic consequences.  
Vascular smooth muscle cells (SMCs) can resist and repair artery damage but their 
capacities decline with age and stress. Recently, cellular production of NAD+ via 
nicotinamide phosphoribosyltransferase (Nampt) has emerged as a mediator of cell vitality.  
However, a role for Nampt in aortic SMCs in vivo is unknown.  The purpose of this thesis 
was to determine if a Nampt-NAD+ control system exists within the aortic media and to 
investigate the biological and clinical importance of such a system. An additional aim was 
to determine if there was a requisite necessity for Nampt for adult mouse survival.  
To study the role of Nampt in SMCs, mice with Nampt-deficient SMCs were 
generated.  SMC-Nampt knockout mice were viable but had mildly dilated aortas.  Infusion 
of angiotensin II led to aortic medial hemorrhage and dissection.  SMCs were not apoptotic 
but had indicators of premature senescence.  Furthermore, there was evidence for oxidized 
DNA lesions and DNA breaks.  This was linked to suppressed poly(ADP-ribose) 
polymerase-1 activity and was reversible upon re-supplying NAD+ with nicotinamide 
riboside (NR).  Evaluating ascending aortas from patients with dilated aortopathy revealed 
an inverse relationship between SMC NAMPT content and aortic diameter. Remarkably, I 
discovered unrepaired DNA strand breaks in SMCs within the human ascending aorta, 
which were specifically enriched in SMCs with low NAMPT.  NAMPT promoter analysis 
revealed CpG hypermethylation within the dilated human aorta and in SMCs cultured from 
these tissues, which inversely correlated with NAMPT expression. 
Global transcriptome analysis of Nampt knockout SMCs revealed a shift in gene 
transcription. Transcripts associated with the production and assembly of collagens were 
decreased, and transcripts associated with selected proteoglycans were increased. This was 
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associated with corresponding changes in extracellular matrix content in SMC-Nampt 
knockout mouse aortas, which may be an additional reason for aortic wall vulnerability.  
Finally, by generating a global inducible Nampt knockout mouse, I determined that 
ablation of Nampt in the adult was lethal within 20 days.  Interestingly, this early death was 
not due to vascular SMC abnormalities but was associated with rapid degeneration of the 
exocrine pancreas, gut epithelial abnormalities, and halted gastrointestinal transit of 
undigested food. Remarkably, supplementing Nampt knockout mice with NR was able to 
double their lifespan.  
Collectively, my findings reveal new processes by which SMCs stay healthy and 
functional, with important implications for mitigating the consequences of the 
accumulation of the stresses that push blood vessels, and other organs, to catastrophic 
failure. 
Keywords: 
Vascular smooth muscle cells, Aortic disease, Nampt, DNA damage, Cell senescence, 
Extracellular matrix, Nicotinamide riboside 
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 CHAPTER 1 - GENERAL INTRODUCTION 
Vascular smooth muscle cells (SMCs) are vital for regulating arterial tone and are 
also major reparative cells of the artery wall. However, the ability of adult SMCs to 
function with high fidelity declines with age and with environmental stress. This can lead 
to vascular disease, including a predisposition to aortic aneurysms and dissections. 
Accordingly, it is important to understand pathways that regulate the ability of human 
SMCs to maintain a stress- and aging-resistant state in vivo.  
The broad goal of my research was to elucidate the in vivo role of nicotinamide 
phosphoribosyltransferase (Nampt), an NAD+ regenerating enzyme that increases 
intracellular NAD+, with a particular emphasis on the aorta. In order to address this goal I 
undertook four main aims: 
1) To determine if Nampt-mediated NAD+ biosynthesis in smooth muscle cells was 
required to maintain vascular stability in the mouse.  
2) To determine if there is an association in humans between NAMPT expression and 
aortopathy.  
3) To determine the role of Nampt-mediated NAD+ regeneration in smooth muscle 
cells in the context of the integrity of extracellular components of the aorta. 
4) To determine the consequences of global loss of Nampt in the adult mouse and the 
ability of nicotinamide riboside (NR) supplementation to mitigate the 
consequences. 
1.1 Vascular system in health and disease 
1.1.1 Importance of vascular health 
At the core of the human body is a system of blood-flowing conduits. It is through 
this system that the heart pumps blood rich with oxygen and nutrients to every tissue in the 
		 2	
body. Arteries transport blood away from the heart. Veins capture and return the blood to 
the heart once oxygen and other nutrients have been delivered to the tissues and waste 
products have been collected. The entirety of this network is the vascular system – 
“vascular” being from the Latin meaning hollow container.  
Diseases of the vascular system are a major factor contributing to global population 
morbidity and mortality (Lloyd-Jones, D et al. 2010). The term “vascular disease” broadly 
encompasses a great number of pathologies, and examples include: diseases relating to the 
narrowing of cardiac or peripheral vessels (i.e. by the build-up of plaque in atherosclerotic 
lesions or spontaneous spasm); the formation of blood clots; the disordered function of 
veins or the valves therein (e.g. chronic venous insufficiency); and aortic aneurysms, either 
thoracic or abdominal. Aneurysms can form in any blood vessel, but they occur most 
commonly in the aorta which is the main blood vessel leaving the heart. The importance of 
maintaining the integrity and proper functioning of the vascular system is underscored by 
the reality that every tissue and organ is dependent on this network for delivery of oxygen 
and nutrients and the removal of waste products generated by the normal function of each 
terminal cell (Topol and Califf 2007). 
1.1.2 Vessel morphology  
The arterial side of the vascular system is a dynamic network that is able to control 
the systemic delivery of blood oxygen and nutrients, and to respond to changes, even 
sudden changes, in hemodynamic stresses. The healthy artery is comprised of 3 layers: the 
outer tunica adventitia, the middle tunica media, and the inner (lumen-facing) tunica 
intima. These layers are discrete, and are identifiable by their cellular components and 
morphology. The outermost layer, the adventitia, is a loosely formed layer comprised of 
fibroblasts, progenitor cells, and connective tissue, including collagen. The medial layer is 
comprised mainly of layers of SMCs arranged in a mostly end-to-end fashion, interleaved 
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with layers of elastin. SMCs regulate vessel tone through contraction. They also provide 
structural integrity to the vessel wall through the synthesis and assembly of elastin and 
collagen.  The innermost layer, the intima, is a thin layer of endothelial cells, on top of a 
specialized basement membrane composed of laminin, type IV collagen, and nidogen. The 
intima is separated from the media by the internal elastic lamina, providing elasticity to the 
arteries and allowing them to accommodate changes in blood pressure and flow. The media 
is separated from the adventitia by the external elastic lamina (Fig. 1.1). 
Vessels on the venous side of the vascular system function mainly as a collection 
system for de-oxygenated blood and the waste products of cellular metabolism. The 
cellular layers that make up a vein are similar to those that form an artery, however the 
medial layer of SMCs is much thinner with fewer layers. As such, veins are less muscular, 
contain less elastin, and have relatively larger lumen sizes.  
Between the arterial system and venous system is an extensive bed of tiny vessels, 
the thickness of one-to-two cell layers. This is where the delivery of oxygen and nutrients 
to the tissues and organs occurs.  
1.1.3 The aorta 
The aorta is the largest blood vessel of the body, emerging directly from the heart 
and serving as a conduit the rest of the vascular tree. The aorta begins at the aortic valve, 
the most commonly replaced heart valve (Nishimura et al. 2014). The reasons for this 
include congenital malformations (bicuspid) or age-related degeneration. The capacity of 
the aorta to withstand a large and dynamic volume and pressure of blood that is pulsatile by 
nature is upheld by the stretch-resistant capacity of SMCs and the elasticity of the internal 
elastic lamina. 
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Figure 1.1 Architecture of the vessel wall 
Cross-sectional views of the arterial vessel (Top) and venous vessel (Bottom) walls. Vessel walls are 
organized into three concentric layers, named: tunica externa (adventitia), tunica media, and tunica intima. 
The tunica externa is mainly comprised of collagen fibres, fibroblasts, and the occasional small blood vessel 
(vaso vasorum). The tunica media is comprised of smooth muscle cells, elastic fibres, and interstitial matrix – 
predominantly collagen. The tunica intima is a thin layer of endothelial cells lining the lumen of the blood 
vessel. Image adapted from “Types of Arteries and Arterioles” by Phil Schatz, Anatomy & Physiology. 
OpenStax CNX. 2016 http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@8.24 
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1.1.4 Aortic diseases 
The term “aortic disease” comprises a group of different pathologies of high 
prevalence. Acute aortic dissection typically occurs when a small tear in the intimal layer 
allows blood to enter into the medial space, which itself is often diseased and contains 
degraded elastin and reduced SMC content. The pulsatile hemodynamic pressure forces 
blood to travel along the medial layers, separating them to create a “false” lumen. Acute 
aortic dissections are relatively uncommon in the broad population (approximately 3.5-6.0 
per 100,000 patient-years) but have a high mortality rate (Mussa et al. 2016). Moreover, 
dissections are much more prevalent in predisposed subpopulations with thoracic aortic 
disease. Thoracic aortic disease comprises rare syndromic forms and common 
nonsyndromic forms of thoracic aortic aneurysms (TAAs) and dissections (TAADs). 
Mechanisms of TAA formation overlap those of aortic dissection and largely involve the 
process that has historically been termed “cystic medial necrosis”, with focal degeneration 
of the elastic and muscle tissue within the medial layer of the aortic wall. The aortic wall 
subsequently weakens and dilates as a result of the high pressure of intraluminal blood 
flow. Acquired and hereditary conditions can exacerbate the process of degeneration. 
Chronic arterial hypertension is widely accepted as the most common acquired 
condition that leads to aneurysm and dissection of the aorta. Nearly 75% of patients with 
acute aortic dissection have a history of hypertension (Meszaros et al. 2000, Ramanath et 
al. 2009). In a large series from the Mayo Clinic, hypertension was present in ~ 60% of 
patients with a surgically resected thoracic aneurysm due to noninflammatory aortic 
disease (Homme et al. 2006). 
  Heritable thoracic aortic disease (HTAD) refers to thoracic aortic disease caused by 
mutation of a gene that confers a high risk for thoracic aortic disease. The most common 
genetically inherited conditions that are associated HTAD include Marfan syndrome, 
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vascular Ehlers-Danlos syndrome (or Ehlers-Danlos syndrome type IV), and Loeys-Dietz 
syndrome (Ramanath et al. 2009). Moreover, up to 20% of individuals with thoracic aortic 
disease who do not have features of Marfan syndrome, vEDS or Loeys-Dietz syndrome 
have a family history, thus indicating that their disease is heritable (Biddinger et al. 1997). 
Approximately 30% families with HTAD who do not have a clinical diagnosis of Marfan 
syndrome or another syndrome have a causative pathogenic variant in one of the known 
HTAD-related genes (Milewicz and Regalado 1993) (see Table 1). 
  Marfan syndrome may be the most prevalent amongst the etiologies, with an 
incidence of approximately 1 in 10,000. The most common form of Marfan syndrome is 
caused by a sequence variation of the fibrillin gene. The aortic pathology is characterized at 
the histologic level by medial degeneration, abnormal extracellular matrix accumulation, 
SMC loss, and elastin fragmentation (Halushka et al. 2016). Vascular Ehlers-Danlos 
syndrome is a connective tissue disorder associated with a defect of either the expression or 
assembly of type III procollagen, one of the collagen moieties present in high amounts in 
the aortic media (Eagleton 2016). This syndrome is characterized by thin, translucent skin, 
easy bruising, characteristic facial appearance, and arterial, intestinal, and/or uterine 
fragility, and affected individuals are at risk for arterial rupture, aneurysm, and/or 
dissection (Pepin et al. 1993). Loeys-Dietz syndrome, is associated with pathogenic genetic 
variants of transforming growth factor beta receptors 1 and 2, Smad3, and the ligand 
TGFβ-2 (Loeys and Dietz 1993). Patients with Loeys-Dietz syndrome manifest TAAs and 
dissections in an autosomal dominant pattern of inheritance and at an early age of onset 
(Loeys et al. 2006).  
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Table 1-1 HTAD-related genes and syndromes 
Syndrome/Disorder Associated genes 
Marfan  FBN-1; fibrillin-1 
Loeys-Dietz TGFBR1; TGF-β receptor 1 
TGFBR2; TGF-β receptor 2 
SMAD3; SMAD family member 3 
TGFB2; TGF-β 2 ligand 
TGFB3; TGF-β 3 ligand 
Vascular Ehlers-Danlos COL3A1; type III procollagen 
Other  ACTA2; smooth muscle alpha-2-actin 
MYH11; smooth muscle myosin heavy chain 
MYLK; myosin light chain kinase 
PRKG1; type I cGMP-dependent protein kinase regulating 
smooth muscle cell relaxation 
MFAP5; microfibril associated protein 5 
 
 
 
(Milewicz and Regalado 1993, Goyal et al. 2017). 
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Other congenital disorders can also result in susceptibility to aortic aneurysms 
(Halushka et al. 2016). This includes: bicuspid aortic valve (BAV) disease (Edwards et al. 
1978), coarctation of the aorta (Rosenthal 2005), tetralogy of Fallot (Rosenthal 2005), and 
diverticulum of Kommerell (Kim et al. 2014). BAVs are among the most common 
congenital heart abnormalities, occurring in approximately 2% of the population. It has 
been established that there is an association between congenital BAVs, and proximal aortic 
dilatation and aortic aneurysm/dissection (Ramanath et al. 2009). Patients with BAVs may 
inherit a predisposition to medial degeneration of the aorta (McKusick 1972). Some studies 
report that as many as half of all patients with a congenital BAV have or will develop 
dilatation of the ascending aorta (Nistri et al. 1999, Kim et al. 2014). 
Recent classification of degenerative pathology of the aorta by the Society for 
Cardiovascular Pathology and the Association For European Cardiovascular Pathology has 
also identified age as a risk factor for aortic disease (Halushka et al. 2016). In the aging 
aorta the elastin, SMCs, and extracellular matrix are all altered in progressive and negative 
ways. These changes can be exacerbated by the associated risk factors of smoking, 
hypertension, and hypercholesterolemia.  
1.2 Smooth muscle cell biology, dysfunction, and aging 
1.2.1 SMC embryological origins 
Vascular smooth muscle cells (SMCs) arise from multiple origins during the 
development of the vascular system and constitutes an early event during embryogenesis. 
The organization of endothelial cells into the primary vascular plexus is initiated shortly 
after gastrulation (the period of formation of the three germ layers; ectoderm, mesoderm, 
and endoderm) and marks the onset of vascular development. The endothelial vasculature 
is subsequently remodeled by recruitment of SMCs and pericytes to form a complex 
vascular system (Carmeliet 2000, Jain 2003). The origin of aortic SMCs is complex with 
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contributions from several independent cell lineages (Gittenberger-de Groot et al. 1999, 
Majesky 2007). SMCs of the basal aortic root is derived from the secondary heart field 
(Waldo et al. 2005), whereas SMCs of the ascending aorta and the arch are neural crest 
derived (Jiang et al. 2000). Descending aortic SMCs originate from paraxial (somitic) 
mesoderm (Wasteson et al. 2008).  
Recruitment of aortic SMCs to the primordial endothelial structure occurs in a 
ventral to dorsal manner as well as in a radial pattern emanating from the layer of cells 
most adjacent to the endothelium (Hungerford et al. 1996). Embryonic differentiating 
SMCs exhibit high rates of cell proliferation and migration. They also produce a large 
amount of extracellular matrix molecules, including collagens, elastin, and proteoglycans 
that comprise a major portion of the blood vessel mass (Hungerford and Little 1999).   
A major challenge in understanding differentiation of the SMC is that it can exhibit 
a wide range of phenotypes at different stages of development. Even in adult organisms 
SMCs are not terminally differentiated and are capable of major changes in their 
phenotype, in response to changes in its local environment. This phenotypic plasticity is 
often considered in terms of two functional phenotypes: “contractile” and “synthetic” (Fig. 
1.2). Adult, differentiated SMCs are generally thought to be contractile SMCs; expressing a 
repertoire of appropriate receptors, ion channels, signal transduction molecules, calcium 
regulatory proteins, and contractile proteins necessary for the unique contractile properties 
of the SMC (Owens 1995). A number of these genes are often used as signifiers of SMC 
differentiation. Upon vascular injury these contractile SMCs have the ability to undergo a 
phenotypic switch to a synthetic phenotype that plays a role in repair. This switch is 
associated with a downregulation of many of the genes associated with a contractile 
phenotype, and an upregulation of many of the factors that were being produced during  
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Figure 1.2 Smooth muscle phenotypes 
SMCs have been considered to have two distinct phenotypes: synthetic (Top) and contractile (Bottom). The 
synthetic state is characterized by spread, flattened morphology in culture, where the cells are non-contractile. 
These synthetic SMCs are proliferative and migratory. As well, they actively secrete ECM proteins, including 
collagen and elastin, as well as MMPs and growth factors. The contractile state is characterized by an 
elongated morphology in culture, owing to the accumulation of contractile-proteins. Contractile SMCs are 
relatively non-proliferative and migratory, and they have low secretory activity. SMCs can readily switch 
between synthetic and contractile phenotypes.  
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development that led to the formation of the vessel wall. Whether the synthetic SMCs 
active in the repair process are local contractile SMCs that have de-differentiated, or are 
derived from infiltrating precursors to SMCs, is not always clear. In either case however 
the production of various components that make up the artery wall is a necessity. The 
ability to withstand the dynamic hemodynamic stress to which an artery is exposed is 
conferred not only by the contractile apparatus of a differentiated vascular SMC, but also 
by the components of the extracellular milieu that the synthetic SMC has produced (and 
continues to produce even in the differentiated state, albeit at a lower level) (Humphrey et 
al. 2015). 
1.2.2 Extracellular components of the aorta 
1.2.2.1 Elastic fibres  
Elastin is the primary ECM molecule in large conduit vessels. In humans, the aortic 
media is composed of over 50 alternating layers of elastic fibres and SMCs. The elastic 
fibres are organized in concentric laminae. The core of elastin (Eln) is surrounded by 
microfibrils. These microfibrils are 10 – 15 nm filaments composed primarily of a large 
glycoprotein called fibrillin (Fbn1, Fbn2 and Fbn3). There are additional microfibril-
associated glycoproteins (Magps), including Magp-1 and Magp -2 (Mfap2 and Mfap5), and 
elastin microfibril interfacer protein 1 (Emilin1). These microfibril extensions are 
organized in an oblique orientation to the elastic fibres, and are attached to dense plaques in 
the SMC cell membrane (Karimi and Milewicz 2016). 
1.2.2.2 Collagen 
Other than elastin, collagen is the most abundant matrix protein in the aorta. There 
are 17 different collagen types expressed in the mouse aorta, with α chains for collagens I, 
III, IV, V, and VI having the highest expression levels (Kelleher et al. 2004, Wagenseil and 
Mecham 2009). Present in lesser amounts are collagens VII, VIII, IX, X, XI, XIV, XV, 
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XVIII, and XIX. Collagens II, XII, XIII, and XVII have little to no expression. Collagen 
types I, III, and V are fibril-forming collagens, with types I and III being mainly 
responsible for imparting strength to the vessel wall (Wagenseil and Mecham 2009). Type 
V collagen plays a critical role in collagen fibril nucleation (Wenstrup et al. 2004). 
Expression of type VI collagen chains in the mouse aorta is similar in abundance to elastin 
and collagen type I, but while it is a fibril-forming collagen, it does not colocalize in large 
collagen bundles with collagens I and III. Instead, collagen VI is frequently associated with 
fibrillin-1 and may serve to connect elastic lamellae to the basement membrane of SMCs, 
or connect SMCs to other ECM structures (Dingemans et al. 2000). Collagens IV, VIII, and 
X are members of the network-forming collagen family and create basket weave-like 
structures through associations between their helical and non-helical domains. Type IV 
collagen is the major structural protein of basement membranes. Collagens IX, XIV, and 
XIX are FACIT (fibril associated collagens with interrupted triple helices) collagens that 
attach to the surface of fibril-forming collagens but do not form fibers themselves. 
Collagen XIII is a collagen with a transmembrane domain that resides in adhesive 
structures of cells and has been implicated in cell adhesion. Collagens XV and XVIII are 
closely related non-fibrillar collagens that are associated with basement membranes.  
1.2.2.3 Proteoglycans 
The proteoglycans constitute a number of genetically unrelated families of 
multidomain proteins that have covalently attached glycosaminoglycan (GAG) chains. 
Proteoglycans are categorized based on the type of attached GAGs: 1) chondroitin sulfate 
and dermatan sulfate, 2) heparin and heparan sulfate, and 3) keratan sulphate. The 
proteoglycans found in greatest abundance in the vessel wall can be categorized into two 
classes: large proteoglycans that form large aggregates by interaction with hyaluronan, and 
small leucine-rich proteoglycans (Wagenseil and Mecham 2009). The large proteoglycans 
interact with hyaluronic acid to form an extensive, interconnected polymeric network in the 
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extracellular space. Hyaluronan is a linear polymer composed of repeating disaccharides of 
glucuronic acid and N-acetylglucosamine. It is synthesized at the plasma membrane by 
three different but related hyaluronan synthases: Has1, Has2, and Has3 (Weigel et al. 
1997). Versican is the largest proteoglycan in the vessel wall and has been localized to the 
aortic media and endothelial layers (Yao et al. 1994). Interestingly, in vascular injury 
models, high versican levels correlate with low elastin content, most likely due to 
inhibition of elastic fibre assembly by the chondroitin sulfate GAGs on versican (Huang et 
al. 2006, Wagenseil and Mecham 2009).  
The small leucine-rich proteoglycans (SLRPs) are a family of secreted 
proteoglycans that do not interact with hyaluronic acid but, instead, bind ECM molecules 
such as collagen, tropoelastin, fibronectin, and fibrillin-containing microfibrils, among 
others (Reinboth et al. 2002). The SLRP family includes decorin, biglycan, fibromodulin, 
osteoglycin, and lumican (Wagenseil and Mecham 2009). Both biglycan and decorin bind 
to and regulate collagen fibrillogenesis (Hocking et al. 1998). Biglycan localizes to all 
layers of the human aorta, whereas decorin is found only in the adventitia (Theocharis and 
Karamanos 2002). 
1.2.2.4 MMPs/TIMPs 
ECM proteins, including collagens and elastin, can be cleaved by 
matrix metalloproteinases	  (MMPs), a family of endopeptidases. MMPs are usually 
grouped according to substrate specificity as collagenases (Mmp-1, Mmp-8, Mmp-13 and 
Mmp-18), gelatinases (Mmp-2 and Mmp-9), stromelysins (Mmp-3, Mmp-10 and Mmp-
11), matrilysins (Mmp-7 and Mmp-26), membrane type (Mmp-14-17, Mmp-24 and Mmp-
25), and others (Mmp-12, Mmp-19-21, Mmp-23, Mmp-27 and Mmp-28) (Visse and 
Nagase 2003). In the arterial wall, contractile medial SMCs express Mmp-2 and minor 
amounts of Mmp-14, a membrane-type Mmp-1 (Wang and Keiser 1998). However, 
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activated SMCs, such as cells in atherosclerotic plaque, express large amounts of Mmp-1, -
3, -9, and -14, and activated Mmp-2 (Galis et al. 1994, Wang and Keiser 1998). MMPs are 
normally inhibited by endogenous inhibitors called TIMPs (tissue inhibitor of 
metalloproteinases), of which there four isoforms (Timp1-4).  Alterations in the balance 
between ECM MMPs and TIMPs may contribute to the profibrotic phenotype in aging and 
hypertension (Wang et al. 2006, Giannandrea and Parks 2014, Harvey et al. 2016). 
1.2.3 SMC senescence  
As outlined above, aortic SMCs are the main cellular mediators that give the aorta 
its resilience against hemodynamic forces and other environmental stress. As such, a 
dysfunctional SMC can lead to a vulnerable aortic wall. SMC dysfunction may be caused 
by a mutation or a polymorphism that affects the expression of a gene associated with the 
contractile or synthetic functions of the cell. Additionally, one process that has emerged as 
a potential contributor to cellular dysfunction in the vasculature is cellular senescence.  
Cellular senescence is a process typically induced by severe insult, whereby the 
affected cell enters a state of essentially permanent cell cycle arrest (Childs et al. 2015). 
This process is often explored in the context of tumor protection, where proliferative arrest 
occurs in response to severe or unrepairable DNA damage, typically a double strand DNA 
break, that could otherwise lead to oncogenic transformation. Thus, serves a vital 
protective mechanism to safeguard against cancer (Campisi 2013). However, the first 
description of cellular senescence was the observed proliferative arrest that occurs after 
long-term culture of human fibroblasts (Hayflick and Moorhead 1961). This form of 
senescence is termed replicative senescence and has been linked to progressive shortening 
of telomeres. This concept can be congruent with what happens in replicating tumor cells, 
but is also applied to aging cells both in culture and in vivo (van Deursen 2014).  
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Senescence can also occur independent of continuous cell replication and critically 
short telomeres. Some stresses such as oxidative stress and DNA damage elicit quite 
similar cell growth arrest within just a few days (Collado et al. 2007). This circumstance 
has been referred to as stress-induced premature senescence. Regardless of the cause, 
senescent cells of all tissue types (including those undergoing replicative and stress-
induced premature senescence) look alike and show similar characteristics (Bernadotte et 
al. 2016). Senescent cells are defined not only by proliferative arrest but also by the 
secretion of a set of proteins - a host of inflammatory cytokines and chemokines, growth 
factors, and proteases, that can affect the senescent cell and also the local tissue (Coppe et 
al. 2008, Tchkonia et al. 2013). This phenomenon is referred to as the senescence-
associated secretory phenotype (SASP) (Yin and Pickering 2016).  
1.2.3.1 Mechanisms of cellular senescence 
As noted, progressive shortening of telomeres upon repeated cell replication is an 
established route to cellular senescence (Hayflick and Moorhead 1961). However, stress-
induced senescence can be mediated by different stimuli that are beginning to be 
understood more fully (Yin and Pickering 2016). These stimuli are signalled through 
various pathways, many of which activate p53 (encoded by TP53 in humans and 
by Trp53 in mice), and essentially all of them converge in the activation of the cyclin-
dependent kinase (CDK) inhibitors p16 (also known as Ink4a; encoded by Cdkn2a), p15 
(also known as Ink4b; encoded by Cdkn2b), p21 (also known as Waf1; encoded 
by Cdkn1a) and p27 (encoded by Cdkn1b). The inhibition of CDK–cyclin complexes 
results in proliferative arrest, and the crucial component responsible for the implementation 
of senescence is the hypo-phosphorylated form of Rb (Chicas et al. 2010). (Fig. 1.3) 
DNA damage is a potent driver of cellular senescence. The main mediators of the 
DNA damage response are the DNA damage kinases ATM, ATR, CHK1 and CHK2,  
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Figure 1.3 Molecular mechanisms leading to cell senescence 
A range of stressors can trigger cell senescence. These include DNA damage, including critical telomere 
shortening, as well as oncogene activation, oxidative stresses, and TGF-β produced either during normal 
developmental remodeling or from senescent cells themselves. These stressors engage different signaling 
cascades that induce expression of p16 and/or p21. The resulting inhibition of cyclin-dependent kinase 
activity prevents Rb inactivation, leading to cellular senescence. ARF, alternative reading frame; ATM, ataxia 
telangiectasia mutated kinase; ATR, ataxia telangiectasia and Rad3- related kinase; CDK, cyclin-dependent 
kinase; ECM, extracellular matrix; Rb, retinoblastoma protein; SASP, senescence-associated secretory 
phenotype; TGF, transforming growth factor.  
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which phosphorylate and activate several cell cycle proteins, including p53 (Campisi and 
d'Adda di Fagagna 2007).. In turn, phosphorylated p53 protein activates the expression of 
p21, which binds to and inhibits certain CDK–cyclin complexes (Munoz-Espin and Serrano 
2014). 
Reactive oxygen species (ROS) also play an important role in the senescence of 
vascular cells (Chen et al. 1995). Levels of ROS increase after many different types of 
stresses, including chemotherapeutic drugs, loss of telomeric protective functions (Lee et 
al. 2009), and oncogene activation. Additionally, angiotensin II (Ang II), which has been 
widely implicated in the pathogenesis of cardiovascular disease, induces ROS production 
in SMCs (Herbert et al. 2008).   A persistent ROS burden has been associated with an 
increase of oxidized DNA lesions (Chen et al. 1995) as well as an increase in senescence 
through several mechanisms, including lipid oxidation and interference with cellular 
metabolism (Yin and Pickering 2016). In addition, oxidized DNA lesions themselves have 
been found to be pathological and their continuous clearance is required to prevent the cell 
from entering a senescent cascade (Rai et al. 2009). ROS also introduces DNA base or 
sugar damage leading to single-strand break (SSB) formation (Lindahl 1993).  Single-
strand DNA breaks are linked to cellular senescence, either directly or by predisposing to 
double-strand DNA breakage (Kuzminov 2001, Nassour et al. 2016). As noted above, 
double-strand DNA breakage in turn is a well established driver of cellular senescence 
(d'Adda di Fagagna 2008). ROS can also induce senescence in a DNA damage-independent 
fashion by activating p38 mitogen-activated protein kinase (MAPK). This stress-activated 
kinase drives p21 transcription and also that of another cyclin- dependent kinase inhibitor, 
p16Ink4a (Munoz-Espin and Serrano 2014). 
Normal cells can respond to the activation of many oncogenes by undergoing 
cellular senescence. A general feature of oncogene-induced senescence is the derepression 
of the Cdkn2a locus. This type of senescence may also induce a robust DNA damage 
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response owing to the DNA damage that is caused by aberrant DNA replication and/or 
ROS (Munoz-Espin and Serrano 2014). 
There is also a role that senescent cells themselves play in potentiating the spread of 
senescence to other cells. The secretion of SASP factors, including pro-inflammatory 
cytokines (interleukin-6 (IL-6) and IL-8), chemokines (monocyte chemoattractant proteins 
(MCPs) and macrophage inflammatory proteins (MIPs)), growth factors (transforming 
growth factor-β (TGF-β) and granulocyte–macrophage colony-stimulating factor (GM-
CSF)), and proteases causes inflammation. In some cases this response may be important 
for the clearance of senescent cells by phagocytosis (Hoenicke and Zender 2012, Munoz-
Espin and Serrano 2014). However, SASP components, most notably TGF-β, can also 
trigger senescence in neighbouring cells in a paracrine manner, through a mechanism that 
generates ROS and DNA damage (Nelson et al. 2012, Acosta et al. 2013).  
1.2.3.2 Markers of senescence 
There is no one marker that can identify a senescent cell. However, it is possible to 
identify a senescent cell using a set of indicators taken together. Identifying cells in culture 
that have ceased to replicate even under mitogenic conditions is a good indication that 
senescence is occurring. These cells often become more flattened and spread in appearance. 
Also, a powerful biomarker is the presence of senescence-associated β-galactosidase (SA-β 
Gal) activity. In senescent cells, lysosomal β galactosidase activity can be detected at an 
otherwise sub-optimal pH (pH 6), (Dimri et al. 1995) as a result of marked expansion of the 
lysosomal compartment (Lee et al. 2006). Other molecular markers are on the basis of the 
signaling hallmarks of cellular senescence, including high levels of p16Ink4a, p21, 
phosphorylated p38, and the presence of double-stranded DNA breaks as denoted by the 
modified histone, γ-H2AX (Yin and Pickering 2016).  
		 19	
1.2.3.3 Vascular cell senescence 
Senescent endothelial cells and SMCs have been identified in culture, and 
senescence of these cells is mainly driven by culture conditions (van der Veer et al. 2007, 
Borradaile and Pickering 2009). Senescent vascular cells have also been identified in vivo, 
although at a low prevalence. This may be because senescence develops at a very low rate, 
or because immune cells clear the senescent cells (Hoenicke and Zender 2012, Munoz-
Espin and Serrano 2014). Regardless, there is good evidence that senescent cells are 
associated with vascular disease and dysfunction. Senescent SMCs and endothelial cells 
have been identified in human atherosclerotic samples (Minamino et al. 2002, Minamino et 
al. 2003, Matthews et al. 2006). Senescent aortic SMCs have also been identified in mouse 
models of hypertension (Boe et al. 2013, Vafaie et al. 2014) and aging (Yepuri et al. 2012, 
Wang and Shah 2015).  
1.2.3.4 Benefits of cellular senescence 
Cellular senescence can be beneficial and, in fact, proceeds as part of normal 
embryonic development. For example: the mesonephric tubules during mesonephros 
involution; the endolymphatic sac of the inner ear, the apical ectodermal ridge of the limbs; 
the regressing interdigital webs and the closing neural tube (Munoz-Espin et al. 2013, 
Storer et al. 2013). In addition to embryonic development, senescence also occurs in a 
physiologically programmed manner in adult organisms. Normal megakaryocytes and 
placental syncytiotrophoblasts undergo senescence as part of their natural maturation 
programmes (Besancenot et al. 2010, Chuprin et al. 2013). Senescence can also protect 
against a damaging fibrotic response to injury. For example, senescent fibroblasts display a 
collagen suppressive phenotype, with upregulation of matrix metalloproteinases and 
downregulation of fibrillar collagen (Yin and Pickering 2016). The development of 
senescent fibroblasts has been reported to be a mechanism for limiting fibrosis in the heart, 
as well as in other organs (Krizhanovsky et al. 2008, Jun and Lau 2010, Zhu et al. 2013). 
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However, as extensively reviewed in Munoz-Espin and Serrano (Munoz-Espin and Serrano 
2014), there are a number of pathologies associated with cell senescence that illustrate the 
detrimental effect senescence can have, including the aggravation of pulmonary fibrosis 
and sarcopenia, and contributing to type II diabetes, cataracts, obesity, and radiation-
induced oral mucositis. Senescence has been associated with human aneurysms in the brain 
and the heart.  
1.3 NAD+ 
Nicotinamide adenine dinucleotide (NAD+) is an essential dinucleotide that has 
emerged as a multi-role determinant of cell health. NAD+ has classically been known as a 
cofactor for the oxidation-reduction events of cellular nutrient metabolism. Importantly, 
recent studies have established that, in addition to its redox carrier role, NAD+ can serve as 
a signalling nucleotide that regulates gene expression, genome integrity, and mitochondrial 
function. 
1.3.1 NAD+ in redox reactions 
NAD+ and its phosphorylated derivative, nicotinamide adenine dinucleotide 
phosphate (NADP), serve as essential coenzymes for hydride-transfer enzymes. They 
participate in redox reactions as hydride acceptors (NAD+ and NADP+) or donors [NADH 
or NADPH (reduced forms)]. These two redox pairs are kept in chemical opposition: 
NAD+ is mostly maintained in its oxidized form; NADP is mostly in its reduced form, 
NADPH. As a cosubstrate, NAD+ is essential for energy generation by transferring 
reducing equivalents from glycolysis (from the activity of glyceraldehyde-3-phosphate 
dehydrogenase) and from the TCA cycle under the form of NADH. When oxygen is 
limiting, NADH is converted to NAD+ by reduction of pyruvate into lactate. With oxygen, 
cytoplasmic NADH transfers its reducing equivalent through the malate-aspartate shuttle or 
the glycerol-3-3-phosphate shuttle to the mitochondrial matrix. These reducing equivalents 
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are oxidized by complex I of the electron-transport chain, thereby coupling glycolysis and 
the TCA cycle to ATP synthesis via oxidative phosphorylation. NADP is critical in several 
pathways, including fatty acid oxidation and cholesterol synthesis, as well as in redox 
protection. In these reactions, NAD+ and NADH (or NADP and NADPH) interconvert but 
are not consumed. (Fig 1.4) 
1.3.2 NAD+ in signaling. 
Beyond its role as a coenzyme in redox reactions, NAD+ is an important cosubstrate 
for three classes of enzymes: (i) the sirtuins (Sirts), (ii) the adenosine diphosphate (ADP)–
ribose transferases (ARTs) and poly(ADP-ribose) polymerases (Parps), and (iii) the cyclic 
ADP-ribose (cADPR) synthases (CD38 and CD157). NAD+ is consumed by these enzymes 
and continuously degraded.  
1.3.2.1 Sirtuins 
Silent information regulator 2 (Sir2) proteins, or sirtuins (Sirts), are NAD+-
dependent protein deacetylases/mono-ADP-ribosyltransferases found in organisms ranging 
from bacteria to humans (Schwer and Verdin 2008, Soppa 2010). In mammals the sirtuin 
family comprises seven proteins (Sirt1–Sirt7), which vary in tissue specificity, subcellular 
localization, enzymatic activity and targets. Sirt1 is mainly localized in the nucleus but is 
also present in the cytosol (Tanno et al. 2007). Sirt2 is considered to be cytosolic but is also 
present in the nucleus in the G2 phase to M phase transition of the cell cycle (Vaquero et 
al. 2006). Sirt3, Sirt4 and Sirt5 have a mitochondrial targeting sequence, and their 
localization to this organelle has been confirmed experimentally (Huang et al. 2010). Sirt6 
is predominantly nuclear (Mostoslavsky et al. 2006) and Sirt7 was reported to reside in the 
nucleolus, (Ford et al. 2006) although recent reports identify a cytosolic pool and a 
presence in the nucleus (Kiran et al. 2013). Sequence-based phylogenetic analysis revealed 
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that mammalian sirtuins can be divided into four classes: Sirt1–Sirt3 belong to class I, Sirt4 
to class II, Sirt5 to class III, and Sirt6 and Sirt7 to class IV (Frye 2000).  
Sirtuins were originally described as NAD+-dependent type III HDACs, as the 
founding member, Sir2 in yeast, silenced specific genomic loci by deacetylating histones 
H3 and H4 (Braunstein et al. 1996). Not only do Sirts deacetylate histones, but they also 
deacetylate a wide range of proteins in different subcellular compartments (Houtkooper et 
al. 2010).  In addition, Sirt4 and Sirt6 were reported to function as ADP-
ribosyltransferases,(Liszt et al. 2005, Haigis et al. 2006) even though Sirt6 also can act as a 
deacetylase (Zhong et al. 2010). Sirt5 was initially reported to be a deacetylase, but has 
been shown to primarily demalonylate and desuccinylate proteins(Du et al. 2011).  
Of the sirtuin family, Sirt1 has been studied the most extensively. The protein 
deacetylase of Sirt1 functions as an epigenetic regulator by targeting specific histone-
acetylated residues (e.g., H3K9, H3K14, and H4K16) but also regulates transcription by 
deacetylating transcription factors (such as TP53, NF-κB, PGC-1α, and FOXO3a) (Verdin 
2015). Sirtuin 3 is the major mitochondrial protein deacetylase, and several of its targets 
have been identified, many of which have important roles in metabolic homeostasis 
(Verdin 2015). Additionally, Sirt3 also affects oxidative stress defence by protecting cells 
from ROS (Qiu et al. 2010). 
The enzymatic reaction catalysed by sirtuins requires NAD+ as a substrate, the 
concentration of which is determined by the nutritional state of the cell. Consequently, 
NAD+ controls adaptive responses to energy stress by modulating the activity of sirtuins 
and their downstream effectors. Sirtuins convert NAD+ to nicotinamide, which at higher 
concentrations can non-competitively bind and thereby feedback-inhibit sirtuin activity 
(Bitterman et al. 2002). 
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1.3.2.2 Parps 
The most potent NAD+-consuming reaction is believed to be one catalyzed by 
poly(ADP-ribose) polymerase (Parp). Poly(ADP-ribosyl)ation (PARylation) is a 
posttranslational protein modification catalyzed by members of the Parp enzyme 
family. The best-characterized Parp is Parp-1. Parp-1 is a 116 kDa protein that contains a 
“Parp signature” sequence required for the catalysis of PAR synthesis (Luo and Kraus 
2012). Parp-1 belongs to a family of 17 proteins with confirmed or putative mono(ADP-
ribosyl) and poly(ADP-ribosyl) transferase activity, which share the “Parp signature motif” 
in the homologous catalytic domain (Kraus 2015). Some of the family members (e.g., Parp-
1 and Parp-2) catalyze the synthesis of PAR on target proteins using NAD + as a donor of 
ADP-ribose units.  However, other family members—the mono(ADP-ribosyl) transferases 
(e.g., Parp-3 and Parp-16), which comprise most of the family—use NAD + to catalyze the 
covalent attachment of mono-ADP-ribose (MAR) on target proteins. Finally, three 
remaining family members lack any apparent catalytic activity (Hottiger et al. 2010, 
Hottiger 2015). 
Parp-1 catalyzes the covalent attachment of PAR polymers on itself and other 
acceptor proteins, including histones, DNA repair proteins, transcription factors, and 
chromatin modulators, using NAD+ as a donor of ADP-ribose units (D'Amours et al. 1999, 
Hassa and Hottiger 2008). Parps are best characterized for their role in DNA damage 
pathways, but more generally Parps regulate adaptive stress responses, including 
inflammatory, oxidative, proteotoxic, and genotoxic stresses (Luo and Kraus 2012). 
1.3.2.2.1 Parp-1 and DNA damage response 
Parp1 is the most abundant Parp and is expressed ubiquitously. Parp1 is strongly 
activated by DNA damage, leading to consumption of a large amount of cellular NAD+. In 
fact, DNA damage leads to a decrease (up to 80% in acute situations) in cellular 
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NAD+ concentrations. Parp1 has been reported to bind to a variety of aberrant DNA 
structures, including cyclobutane pyrimidine dimers, 6,4-photoproducts, apurinic and 
apyrimidinic sites, SSBs and double-strand breaks (DSBs) (Lonskaya et al. 2005, 
Khodyreva et al. 2010). In fact, Parp1 is one of the first proteins to recognize damaged 
DNA and its interaction with DNA lesions triggers the PARylation of a variety of proteins, 
with Parp1 itself being the main PAR acceptor (Haince et al. 2007). Parp1 activation 
immediately creates long negatively charged PAR polymers attached to Parp1 at DNA 
lesion sites (D'Amours et al. 1999). Although none of the Parp family members have any 
known DNA repair enzymatic activity, Parp activity has been linked to DNA repair 
(Woodhouse et al. 2008). The evidence for this relationship: (i) DNA damage is the main 
activator of PAR synthesis, (ii) the depletion or inhibition of Parps 1–3 sensitizes cells to 
DNA-damaging agents and (iii) Parps 1–3 have been reported to interact physically and/or 
functionally with diverse DNA repair proteins (Sousa et al. 2012). Parp1 has been reported 
to be involved in different DNA repair systems, including BER, single-strand break repair 
and double-strand break repair (Yelamos et al. 2011). Parp1 plays an important role in the 
early steps of DNA repair targeting and in modulating the DNA repair proteins at the sites 
of DNA lesions, with the formation of long PAR chains that possibly act as scaffolds on 
which DNA damage repair proteins can assemble. Furthermore, Parp1-dependent 
chromatin remodeling was shown to facilitate the access of DNA repair proteins to DNA 
damage (Escargueil et al. 2008).  
1.3.2.2.2 PAR-dependent cell death induction—parthanatos 
When the levels of DNA damage are beyond the cellular repair capacity, 
programmed cell death is activated to prevent cells from accumulating mutations that may 
lead to carcinogenesis (Sousa et al. 2012). Because PARylation is a DNA damage-
dependent enzymatic activity, extensive DNA damage is accompanied by large-scale PAR 
polymer synthesis (Herceg and Wang 2001). However, excessive PAR production may 
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leads to a unique form of caspase-independent cell death, termed parthanatos (Andrabi et 
al. 2008). This type of cell death is associated with rapid Parp1 activation, early PAR 
accumulation, mitochondrial depolarization, early AIF translocation, loss of cellular NAD+ 
and ATP and late caspase activation (Yu et al. 2002, Andrabi et al. 2006, Yu et al. 2006). 
1.3.2.3 cyclic ADP-ribose synthases 
NAD(P)+-derived molecules are key elements of intracellular calcium signaling 
(Verdin 2015). Several of these derivatives, namely, nicotinic acid adenine dinucleotide 
phosphate (NAADP), cyclic ADP-ribose (cADPR) and ADPR have been characterized as 
potent calcium-mobilizing agents. All three molecules, ADPR, cADPR and NAADP are 
synthesized by multifunctional NAD+ glycohydrolases, in humans represented by the ADP-
ribosyl cyclase CD38 and its structural and functional homolog, CD157 (Malavasi et al. 
2008). CD38 and CD157 are membrane-bound ectoenzymes. Mice deficient in CD38 show 
significantly elevated levels of NAD+ (10- to 30-fold) in tissues such as liver, muscle, 
brain, and heart, (Aksoy et al. 2006, Barbosa et al. 2007) confirming the role of CD38 as a 
major NAD+ consumer. Conversely, cells overexpressing CD38 showed reductions in 
NAD+ levels and in the expression of proteins related to energy metabolism and antioxidant 
defense (Hu et al. 2014).  
An additional ectoenzyme has recently been shown to have NAD+ degrading 
activity. CD73, mostly known as the ectoenzyme dephosphorylating extracellular AMP to 
adenosine, is in fact also capable of degrading both NAD+ and NMN: specifically, CD73 
degrades NAD+ to NMN, which is subsequently dephosphorylated by the same enzyme to 
nicotinamide riboside (NR) (Garavaglia et al. 2012, Grozio et al. 2013). 
1.3.3 NAD+ as a neurotransmitter 
NAD+ is most widely considered in the paradigms outlined above: either as a 
coenzyme in redox reactions or a cosubstrate for the activities of Sirts, Parps, and cADPR-
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synthases. However, there is evidence that NAD+ may also be an inhibitory 
neurotransmitter candidate. NAD+ (referred to as ß-NAD in this field) is a purine substance 
released by nerve stimulation in vascular and visceral smooth muscles and neuro-secretory 
cells (Smyth et al. 2004, Smyth et al. 2006, Mutafova-Yambolieva et al. 2007). Purines can 
be released from intrinsic enteric nerves, sympathetic nerves or sensory motor nerves 
during axon reflexes, to act directly on smooth muscle purinoceptors mediating relaxation 
or contraction or on epithelial cell receptors. They act on prejunctional nerve terminals to 
modify transmitter release from motor and inhibitory neural control pathways (Burnstock 
2014). They participate in synaptic transmission in myenteric and submucosal ganglia that 
are involved in the control of gastrointestinal motility, mucosal secretion and absorption. 
They act on blood vessels or interstitial cells of Cajal (ICC) thereby indirectly modulating 
motility patterns. Purines also can act on sensory nerve endings in the gut wall after release 
from epithelial cells to initiate local and/or central reflex activity that alters gastrointestinal 
motility and secretory patterns and initiate nociception (Burnstock 2008, Burnstock 2014). 
To date the role of NAD+ as an enteric neurotransmitter is controversial as ATP has 
been assumed to be the known purine neurotransmitter (Xue et al. 1999), however 
experiments on mouse (Mutafova-Yambolieva et al. 2007) and primate colons (Hwang et 
al. 2011) showed that NAD+ and its bioactive metabolite, ADP-ribose (Durnin et al. 2013), 
mimic the endogenous purine neurotransmitter better than ATP. To date, experiments have 
shown both ATP and NAD+ and their metabolites, ADP and ADP-ribose, produced 
relaxation of murine colonic smooth muscle, and it was suggested that they might be 
involved in motility disorders (Durnin et al. 2012, Gallego et al. 2016). 
1.3.4 NAD+ biosynthetic pathways 
NAD+ can be synthesized from diverse dietary sources, including nicotinic acid 
(NA) and nicotinamide (NAM), tryptophan, and nicotinamide riboside (NR). (Fig. 1.4) 
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Figure 1.4 NAD+ metabolism 
The different precursors to intracellular NAD metabolism—tryptophan, nicotinic acid (NA), nicotinamide, 
NR, and NMN—are shown. The cytoplasmic and nuclear NAD+ pools probably equilibrate by diffusion 
through the nuclear pore. However, the mitochondrial membrane is impermeable to both NAD+ and NADH. 
Reducing equivalents generated by glycolysis are transferred to the mitochondrial matrix via the 
malate/aspartate shuttle and the glyceraldehyde-3-phosphate shuttle. The resulting mitochondrial NADH 
(malate/aspartate shuttle) is oxidized by complex I in the respiratory chain (ETC), whereas the resulting 
FADH2 (glyceraldehyde-3-phosphate shuttle) is oxidized by complex II. In each of the three compartments, 
different NAD+-consuming enzymes lead to the generation of nicotinamide, which is recycled via the 
NAD+ salvage pathway. Different forms of the NMNAT enzyme and sirtuins are localized in different 
compartments.	
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The primary biosynthesis of NAD+ starts with the essential amino acid L-
tryptophan, which is taken up from the diet (Bender 1983), and serves as the precursor for 
NAD+ through the multi-step de novo kynurenine pathway. The first step in this pathway is 
the rate-limiting conversion of tryptophan to N-formylkinurenine by either IDO or TDO. 
Formylkinurenine is transformed into L-kinurenine, 3-hydroxykinurenine, and 3-
hydroxyanthranilic acid and finally to ACMS. This compound can spontaneously condense 
and rearrange into quinolinic acid, which is transformed into NAMN, at which point it 
converges with the Preiss-Handler pathway.  
NAD + synthesis from NA, also known as the Preiss-Handler pathway, is initiated 
by the NA phosphoribosyltransferase (Naprt) which forms NA mononucleotide (NAMN) 
from NA. Together with ATP, NAMN is then converted into NA adenine dinucleotide 
(NAAD) by the nicotinamide mononucleotide adenylyltransferase (Nmnat1–3) enzymes. 
Finally, NAAD is transformed to NAD + through an amidation reaction catalyzed by the 
NAD+ synthetase (Nadsyn) enzyme. 
The synthesis of NAD+ from NAM or NR is more direct and relies on only two 
steps each. NAM is converted by the rate-limiting Nampt to form nicotinamide 
mononucleotide (NMN). NMN is also the product of phosphorylation of NR by the NR 
kinases (Nrk1 and Nrk2). The subsequent conversion of NMN to NAD + is catalyzed by the 
Nmnat1-3 enzymes.  
The formation of NAD+ from NR can be considered a de novo pathway in some 
respects as there have been nutritional sources of NR identified, i.e. milk (Bieganowski and 
Brenner 2004). The salvage pathway uses NAM or NA (together called niacin or B3) to 
make NAD+ (Bogan and Brenner 2008). While dietary maintenance may meet baseline 
requirements for NAD+, the local salvage pathways that supply or regenerate NAD+ are 
critical determinants of cell health and survival (Sauve 2008). 
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1.4 Nampt 
1.4.1 Biochemical function of Nampt 
Nicotinamide phosphoribosyltransferase (Nampt) was originally identified as a 
putative cytokine, pre-B enhancing colony factor (Pbef) (Samal et al. 1994, Rongvaux et al. 
2002), and subsequently as a putative insulin-mimetic hormone, Visfatin (Fukuhara et al. 
2005).  Evidence for the former is inconclusive, and the index report for the latter has since 
been retracted (Fukuhara et al. 2007). Bacterial and murine homologues of Nampt were 
later identified as enzymes involved in NAD+ biosynthesis (Martin et al. 2001, Rongvaux 
et al. 2002), and this was enzymatic activity was first confirmed in humans cells in aortic 
SMCs (van der Veer et al. 2005). Nampt is known to catalyze NAD+ synthesis by 
transferring the phosphoribosyl group of 5-phosporibosyl-1-pyrophosphate to NAM, 
forming NMN. NAD+ synthesis is completed by Nmnat, which converts NMN into NAD+ 
(Fig. 1.5) (Rongvaux et al. 2002). Nampt’s catalytic activity is ~46-fold lower than Nmnat 
activity, and thus Nampt catalyzes the rate-limiting step in this two-step pathway of NAD+ 
synthesis from NAM. Thus, even very small changes in Nampt activity levels, but not 
Nmnat levels, can have a profound effect on NAD+ metabolism (Rongvaux et al. 2002, 
Revollo et al. 2004). 
1.4.2 Cellular localization of Nampt 
Nampt is a ubiquitously expressed protein, and expression is variable across tissue 
and cell types.  Nampt is localized intracellularly (mainly in the cytoplasm and nucleus) 
(Kitani et al. 2003), but also has been found extracellularly (Revollo et al. 2007), in which 
case it is generally referred to as eNampt. eNampt has been found in human circulation 
(Korner et al. 2007) and mouse circulation (Revollo et al. 2007), as well as in the 
supernatant of certain cell types including differentiated adipocytes (Revollo et al. 2007, 
Tanaka et al. 2007, Yoon et al. 2015),  
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Figure 1.5 NAD+ salvage by Nampt 
NAD+ is consumed by Parps, Sirts and ADP-ribosylases, releasing the NAM moiety. Nampt catalyzes the 
addition of a phosphoribosyl group in the first step of salvage. The resulting NMN product then gains a 
phosphor-adenine group from ATP to form NAD+, catalyzed by the Nmnat family of enzymes.  NR enters 
this two-step salvage pathway by receiving a phosphate group from ATP to form NMN, catalyzed by Nrk1.  	
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hepatocytes (Garten et al. 2010, Schuster et al. 2014), leucocytes (Friebe et al. 2011), 
cardiomyocytes (Pillai et al. 2013), and neurons (Zhao et al. 2013, Jing et al. 2014). 
However, a secretory pathway for eNampt has not been identified. Some reports claim that 
eNampt is released via a “non-classical secretory pathway”, but these reports cannot 
preclude that intracellular Nampt is simply being released upon cell death (Revollo et al. 
2007, Tanaka et al. 2007, Garten et al. 2010). As well, a cell-surface role for eNampt has 
yet to be identified and the role of eNampt in the extracellular space is still a matter of 
debate. Several studies have measured enzymatic activity of eNampt (Revollo et al. 2007, 
Garten et al. 2010, Friebe et al. 2011, Kover et al. 2013, Zamporlini et al. 2014).  However, 
it has been reported that eNampt is not enzymatically active in mouse plasma owing to the 
low concentrations of PRPP and ATP (Hara et al. 2011). 
1.4.3 Regulation of Nampt expression 
Because Nampt is the rate-limiting enzyme in the regeneration of NAD+, Nampt is 
a key regulator of the intracellular NAD+ pool (Rongvaux et al. 2002, Revollo et al. 2004). 
Through its NAD+-biosynthetic activity, Nampt influences the activity of NAD+-dependent 
enzymes, such as Sirts (Revollo et al. 2004, van der Veer et al. 2007, Yang et al. 2007, 
Borradaile and Pickering 2009, Bruzzone et al. 2009, Ho et al. 2009, Van Gool et al. 2009, 
Koltai et al. 2010, Bowlby et al. 2012) and Parps, (Pillai et al. 2013) and thereby regulates 
cellular metabolism, mitochondrial biogenesis (van der Horst et al. 2004, Bordone et al. 
2006, Rodgers et al. 2008) and adaptive responses to inflammatory, oxidative, proteotoxic 
and genotoxic stress (Luo and Kraus 2012).  
Nampt itself seems to be regulated in a circadian fashion. Levels of Nampt RNA 
display a diurnal oscillation in the liver and white adipose tissue, with a peak around the 
beginning of the dark period (Ramsey et al. 2009), a phenomenon also observed in serum-
entrained mouse embryonic fibroblasts (Nakahata et al. 2009). These robust diurnal and 
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circadian oscillation patterns of Nampt RNA and protein are completely abolished in 
tissues from the circadian rhythm-deficient ClockΔ19 mutant mice, or mice deficient in 
Bmal1, the binding partner of Clock (Ramsey et al. 2009). The Nampt promoter region 
contains putative E-box sequences (CACGTG sequences - DNA response elements acting 
as protein-binding sites that have been found to impact the regulation of transcription). 
Nakahata et al (Nakahata et al. 2009) demonstrated that the Nampt promoter is readily 
activated by Clock:Bmal1 through the E-boxes in a time-dependent manner. Interestingly, 
dual cross-linking ChIP assays showed that Sirt1 binds to the E-boxes in a time-dependent 
manner, following the circadian timing of Clock:Bmal1 recruitment. In addition, Sirt1 
negatively regulates the transcriptional activation of clock genes. Thus, Clock and Sirt1 
contribute to circadian chromatin remodeling at the Nampt promoter. As NAD+ 
intracellular levels directly influence the histone deacetylase activity of Sirt1, an 
enzymatic- transcription feedback loop seems to operate in which NAD+ levels determine 
the oscillatory synthesis of Nampt.  
1.4.4 Biological expression and importance of Nampt 
Several studies have reported Nampt to be highly expressed in lung, liver, kidney, 
heart, and skeletal muscle, with much lower expression in brain and pancreas (Samal et al. 
1994, Revollo et al. 2007). The expression of Nampt was found to be upregulated in 
immune cells upon activation (Samal et al. 1994, Rongvaux et al. 2002, Jia et al. 2004) 
whereas another report identified this protein as a gene strongly expressed in adipocytes 
(Revollo et al. 2007). 
Within vascular tissue we have identified that Nampt is expressed in endothelial 
cells and SMCs, with relatively higher expression in the former (Ho et al. 2009). We have 
also shown that expression in smooth muscle cells is dynamic: Nampt expression is 
decreased in aging and senescent primary human smooth muscle cells, and in HITC6 cells, 
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and an increase in Nampt expression has been correlated with a shift of the SMC 
phenotype from a contractile to a synthetic phenotype (van der Veer et al. 2007). 
Overexpressing Nampt in SMCs and endothelial cells in culture enhances cell life 
span via enhancing Sirt1 activity and p53 degradation (van der Veer et al. 2007). Nampt 
overexpression leads to an increase of NAD+ in the cells, associated with prolonged cell 
survival and resistance to oxidative stress (van der Veer et al. 2007, Borradaile and 
Pickering 2009, Ho et al. 2009).  Exposure of cells with an inhibitor of Nampt, FK866, 
results in the decreased ability of the cell to withstand genotoxic stress (Rongvaux et al. 
2008).  Incubation with FK866 also aggravated brain infarction in a model of mouse 
cerebral ischemia and activated T cells were found to undergo massive NAD+ depletion 
upon treatment with FK866 (Bruzzone et al. 2009, Wang et al. 2011).  
Gene-targeting strategies in mice have revealed a pattern of degenerative or aging-
related tissue dysfunction when Nampt is perturbed in skeletal muscle, adipose tissue, and 
brain (Stein and Imai 2014, Frederick et al. 2016, Stromsdorfer et al. 2016, Zhou et al. 
2016). Mice lacking Nampt in forebrain excitatory neurons showed hippocampal and 
cortical atrophy, astrogliosis, microgliosis, and abnormal CA1 dendritic morphology by 2–
3 months of age (Stein et al. 2014). Ablation of Nampt in adult neural stem cells also 
causes signs of accelerated aging in this neural cell population (Stein and Imai 2014). 
Knockout of Nampt in skeletal muscle contributed to an aging phenotype-related loss mass 
and contractile function (Frederick et al. 2016). Adipocyte-specific Nampt knockout mice 
had severe insulin resistance in adipose tissue, liver, and skeletal muscle, and adipose tissue 
dysfunction. This dysfunction was manifested by increased plasma free fatty acid 
concentrations and decreased plasma concentrations of a major insulin-sensitizing 
adipokine, adiponectin (Stromsdorfer et al. 2016). Additionally, Nampt is critically 
required for the development of both T and B lymphocytes (Rongvaux et al. 2008).  
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 In contrast, there has been some evidence that a decrease in Nampt expression in 
certain tissue may have a limited protective effect. shRNA-mediated knockdown of Nampt 
in mouse liver increased plasma HDL-C levels, reduced the plaque area of the total aorta en 
face and the cross-sectional aortic sinus, decreased macrophage number and apoptosis, and 
promoted reverse cholesterol transport in high fat diet-fed ApoE KO mice (Li et al. 2016). 
Heterozygous Nampt+/− mice were significantly protected when exposed to a model of 
sepsis-induced acute lung injury (Hong et al. 2008), and also were protected from Ang II-
induced cardiac hypertrophy (Pillai et al. 2013). Overexpression of Nampt in 
cardiomyocytes exacerbated Ang II-induced cardiac hypertrophy (Pillai et al. 2013), 
however in another model of cardiomyocyte-specifc overexpression of Nampt, Nampt was 
protective against ischemia-reperfusion injury (Hsu et al. 2009). In addition, female 
Nampt+/− mice show moderately impaired glucose tolerance and reduced glucose-
stimulated insulin secretion, consistent with significant decreases in NAD+ biosynthesis 
and insulin secretion in response to glucose in primary islets isolated from Nampt+/− mice 
(Revollo et al. 2007). 
A very recent report of global Nampt knockout in the adult mouse has shown that 
Nampt is an essential gene, as mice in which Nampt has been ablated do not survive longer 
than 10 days (Zhang et al. 2017). However, the reasons for poor survival were not 
elaborated on beyond an indication that the endothelial cells of the gastrointestinal tract 
were disturbed and death occurred due to a deficiency in gastrointestinal ion transport.  
Taken together, the role of Nampt in vivo has not been clearly defined. The 
evidence presented above speaks to the importance of Nampt with respect to maintaining a 
healthy cell in vitro, and also resistant to the normal physiological stresses in vivo; 
however, not much is know about the role that Nampt plays in normal cell and tissue 
development.  It has been reported that Nampt expression begins in the embryo around e8.5 
and that knockout mice are embryonically lethal before e10.5 (Revollo et al. 2007, Zhang 
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et al. 2017). Additionally, male Nampt heterozygous mice are ostensibly normal (Revollo 
et al. 2007). The extent to which Nampt is required for SMC and endothelial cell 
development and function is, to this point, unknown.   
1.5 Therapeutic augmentation of the NAD+ biosynthesis pathway 
NAD+ levels in the cells depend on several variables, including the cellular redox 
state (NAD+/NADH ratio) and the rates of NAD+ synthesis and NAD+ consumption.  As 
noted in previous sections, they can also fluctuate in a circadian manner, through activation 
of the NAD+ salvage pathway (i.e. through Nampt activity) (Nakahata et al. 2009). In 
addition, NAD+ concentrations increase in response to conditions associated with lower 
energy loads, such as fasting, glucose deprivation, calorie restriction, and exercise 
(Rodgers et al. 2005, Chen et al. 2008, Fulco et al. 2008, Canto et al. 2009, Nakahata et al. 
2009, Ramsey et al. 2009, Costford et al. 2010). In contrast, NAD+ concentrations decrease 
in animals on high-fat diets (Bai et al. 2011, Yoshino et al. 2011, Canto et al. 2012, Kraus 
et al. 2014, Pirinen et al. 2014, Yang et al. 2014), and during aging and senescence 
(Ramsey et al. 2008, Braidy et al. 2011, Yoshino et al. 2011, Massudi et al. 2012, Gomes et 
al. 2013, Mouchiroud et al. 2013, Pugh et al. 2013, Cerutti et al. 2014). 
It is interesting to note the conditions in which NAD+ is upregulated are conditions 
associated with longevity. These data support the idea that decreased NAD+ levels 
contribute to the aging process and that NAD+ supplementation might exert protective 
effects during aging. Indeed, NAD+ supplementation increases life span in yeast and worms 
(Belenky et al. 2007, Mouchiroud et al. 2013).  
Lower overall NAD+ levels have been reported in various aged rat and human tissue 
(Braidy et al. 2011, Massudi et al. 2012). Declining levels can be explained by increased 
NAD+ consumption through hyperstimulation of NAD+-consuming enzymes, particularly 
Parp1, the activity of which increases during aging as DNA damage accumulates (Braidy et 
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al. 2011, Mouchiroud et al. 2013). Additionally, defective circadian rhythm regulation by 
Clock and Bmal1 has been reported to lower levels of Nampt as well as NAD+ (Nakahata 
et al. 2009). Reports of decreased Nampt expression levels in aged mice were associated 
with chronic inflammation and oxidative stress; both lowering Nampt and NAD+ in 
primary hepatocytes (Cavadini et al. 2007, Yoshino et al. 2011). Also, mitochondrial 
homeostasis can be impacted by declining NAD+ levels, requiring more resource input to 
generate ATP in less functional mitochondria in aged tissue (Gomes et al. 2013). Taken 
together, increased consumption, decreased biosynthetic capacity and lower energy 
production efficiency contribute to an NAD+-deficient system in aged models.  
In the face of declining NAD+ levels in pathology, there may be an opportunity for 
augmentation of NAD+ levels either by upregulating Nampt expression or with the delivery 
of NAD+ precursors. Historically, niacin (consisting of NAD+ precursors NAM and NA) 
has been used therapeutically to treat dyslipidemia by lowering triglycerides circulating in 
the blood stream and raising HDL levels (Creider et al. 2012). However, two clinical trials 
have reported that niacin did not reduce cardiac events in high-risk patients (Ginsberg and 
Reyes-Soffer 2013). Additional studies suggest that niacin’s benefits on vascular health act 
independently of its lipid-lowering effects (Wu et al. 2010, Huang et al. 2012, Lavigne and 
Karas 2013). Instead, recent work suggests that niacin can improve endothelial function 
and reduce oxidative stress (Kaplon et al. 2014), thereby enabling stress management in 
models of ischemia & reperfusion injury or stroke (Chen et al. 2007).  
NMN supplementation has been reported to protect the heart from ischemia & 
reperfusion injury (Yamamoto et al. 2014) and to treat diabetes in aged mice (Yoshino et 
al. 2011). Endogenous Nampt is decreased in response to cardiac ischemia and reperfusion 
(Hsu et al. 2009). Augmenting NAD+ levels by NMN supplementation mitigates the effects 
of the ischemia and reperfusion injury in a Sirt1-dependent fashion (Yamamoto et al. 
2014). In diabetic mice induced by a high-fat diet, Nampt-mediated NAD+ biosynthesis is 
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compromised in liver and adipose tissue. NMN administration successfully restored 
NAD+ levels in the liver and adipose of diabetic mice, and even in diabetic skeletal muscle, 
a moderate but significant increase in NAD+ was detected (Yoshino et al. 2011). NMN 
supplementation was also beneficial in models of age-induced type II diabetes (Yoshino et 
al. 2011). In two additional studies, NMN was found to overcome NAD+ decline in skeletal 
muscle induced by age-associated increases in Parp activation (Gomes et al. 2013, 
Mouchiroud et al. 2013). The mechanisms by which extracellular NMN is converted to 
cellular NAD+ also remain elusive. On the one hand, it was claimed that NMN is 
transported intact to hepatocytes (Yoshino et al. 2011). On the other hand, it has been 
proposed that extracellular dephosphorylation of NMN to nicotinamide riboside (NR) is 
required to elevate cellular NAD+ metabolism (Belenky et al. 2007, Nikiforov et al. 2011, 
Grozio et al. 2013, Sociali et al. 2016). 
NR metabolism constitutes an additional path for NAD + biosynthesis. NR has been 
identified as a nutrient naturally present in the human diet including milk. NR offers a 
favourable mechanism of absorption into the cell. NR is transported into cells by 
nucleoside transporters (Nikiforov et al. 2011) and is then phosphorylated by the NR 
kinases 1 and 2 (Nrks) (Bieganowski and Brenner 2004), generating NMN. NR has been 
observed to stably elevate NAD+ levels and increase NAD+ bioavailability in HEK293, 
Neuro2a, AB1, C2C 12 and Hepa1.6 mammalian cell lines (Yang et al. 2007, Canto et al. 
2012). In addition, NR has potential therapeutic benefits over NAM. NAM has been 
reported to negatively affecting Sirt activity, whereas NR increases Sirt activities (Canto et 
al. 2012, Brown et al. 2014). Further, niacin (consisting of NA and NAM) has been known 
to induce painful flushing; these side effects may be avoided by instead administering NR 
(Creider et al. 2012). 
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1.6 Aims of thesis 
In summary, maintaining a pool of bioavailable NAD+ involves the metabolism of 
different precursors, and the regenerative activity of Nampt. In short, it is a complex 
process of biosynthesis that is of vital importance to the health and vitality of a cell. As the 
rate-limiting enzyme in the regeneration of cellular NAD+, Nampt is a point of 
vulnerability in maintaining an equilibrium of NAD+ levels. Work done by Dr. Pickering’s 
research group had previously identified that Nampt is expressed in endothelial cells and 
SMCs (Ho et al. 2009). We have also shown that expression in smooth muscle cells is 
dynamic: Nampt expression is decreased in aging and senescent primary human smooth 
muscle cells, and in HITC6 cells, and an increase in Nampt expression has been correlated 
with a shift of the SMC phenotype from a contractile to a synthetic phenotype (van der 
Veer et al. 2007). Overexpressing Nampt in SMCs and endothelial cells in culture enhances 
cell life span via enhancing Sirt1 activity and p53 degradation (van der Veer et al. 2007). 
Nampt overexpression leads to an increase of NAD+ in the cells, associated with prolonged 
cell survival and resistance to oxidative stress (van der Veer et al. 2007, Borradaile and 
Pickering 2009, Ho et al. 2009).  It has also been established that increases in oxidative 
stress and SMC senescence in vivo has been associated with vascular disease and 
dysfunction. Senescent SMCs and endothelial cells have been identified in human 
atherosclerotic samples (Minamino et al. 2002, Minamino et al. 2003, Matthews et al. 
2006). Senescent aortic SMCs have also been identified in mouse models of hypertension 
(Boe et al. 2013, Vafaie et al. 2014) and aging (Yepuri et al. 2012, Wang and Shah 2015). 
However, the role of Nampt in SMCs in vivo is unknown. Additionally, although there is 
very recent evidence that Nampt is globally important to the adult mouse, the tissue-
specific vulnerabilities of global Nampt ablation are unclear and it is also unclear if a 
global Nampt deficiency could be overcome by augmenting an NAD+ generation pathway.  
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Therefore, the broad aims of my research were two-fold: 1) to the elucidate the role 
that Nampt plays in maintaining the integrity of the vascular tissue; and 2) to determine the 
role that Nampt plays globally and if a global Nampt deficiency is able to be overcome. To 
address these 2 broad goals I generated two new mouse models of Nampt knockout in order 
to characterize the ensuing deficiencies: a smooth muscle-specific Nampt knockout mouse 
and a mouse model in which Nampt could be deleted in the whole body in an inducible 
fashion. 
In order to address the broad aims of my research I had four specific aims:  
1. To determine if Nampt in smooth muscle cells is required to maintain vascular 
stability in the mouse.  
2. To determine if there is a relationship between Nampt biology and life-threatening 
ascending aortic dysfunction in humans.  
3. To determine if Nampt in smooth muscle cells regulates the mechanical structure of 
the aorta.  
4. To determine if there are fundamental Nampt requirements in organs in addition to 
the aorta in the adult mouse. 
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 CHAPTER 2 - NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN 
SMOOTH MUSCLE CELLS MAINTAINS GENOME INTEGRITY AND 
RESISTS AORTIC MEDIAL DEGENERATION 
2.1 Introduction  
The aortic wall is subjected to unrelenting hemodynamic stress.  Although 
structurally designed to withstand this stress, the aorta can nonetheless degenerate over 
time, particularly when also subjected to hypertension, atherosclerosis, or the effects of 
genetic mutations (Schlatmann and Becker 1977, Howard et al. 2013). When the aorta 
degenerates it dilates and becomes vulnerable to dissection and rupture.  Vascular SMCs 
are critical to maintaining aortic integrity, evidenced by the development of thoracic 
aneurysms in individuals with mutations in SMC-specific genes (Milewicz et al. 2008). 
SMCs have a range of functions relevant to aortic homeostasis including contraction, 
synthesis of extracellular matrix (ECM), and the assembly of ECM fibers in accordance 
with local mechanical forces (Li et al. 2003, Humphrey et al. 2014). However, the 
abundance and functionality of SMCs can decline with age and chronic diseases 
(Schlatmann and Becker 1977, Ruiz-Torres et al. 1999, van der Veer et al. 2007, Halushka 
et al. 2016). Understanding the molecular pathways that can be engaged by SMCs to 
survive and retain their repertoire of functions in the stressed environment of the aortic wall 
may be critical to advancing strategies for reducing aortic catastrophes. 
Nicotinamide adenine dinucleotide (NAD+) is an essential dinucleotide that serves 
as a cofactor for the oxidation-reduction events of cellular nutrient metabolism.  NAD+ can 
also serve as a signaling nucleotide that regulates gene expression, genome integrity, and 
mitochondrial function.  When NAD+ participates in signaling reactions, it does so as an 
enzyme substrate rather than a cofactor and is thus consumed in the process.  The most 
potent NAD+-consuming reaction is believed to be the assembly of poly(ADP-ribose) 
(PAR) on histones, an event triggered by DNA strand breakage and catalyzed by the 
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enzyme poly(ADP-ribose) polymerase-1 (PARP1) (Dantzer et al. 2006). Other NAD+ 
consuming enzymes include those of the sirtuin family, which catalyze deacetylation and 
ADP-ribose transfer reactions, and CD38, which generates cADPR (Nikiforov et al. 2015).  
The growing recognition of the importance of NAD+-consuming reactions has 
heightened interest in understanding the pathways by which NAD+ is generated and 
replenished.  NAD+ can be synthesized from dietary sources but the routes to NAD+ 
production are proving to be complex and tissue-specific (Canto et al. 2015).   Important to 
maintaining the NAD+ pool is the salvage pathway, wherein nicotinamide liberated during 
NAD+-consuming reactions is recycled back to NAD+ (van der Veer et al. 2005, Revollo et 
al. 2007, Nikiforov et al. 2015). Nicotinamide phosphoribosyltransferase (Nampt) is the 
rate-limiting enzyme for this salvage pathway, converting nicotinamide to nicotinamide 
mononucleotide (van der Veer et al. 2005). Development of the mouse embryo cannot 
proceed without Nampt (Revollo et al. 2007). As well, gene targeting strategies in mice 
have revealed a pattern of degenerative or aging-related tissue dysfunction when Nampt is 
perturbed, including in the liver, skeletal muscle, and brain (Stein and Imai 2014, Frederick 
et al. 2016, Zhou et al. 2016). 
A role for Nampt in SMC-based vascular health is less clear but the possibility has 
been raised.  Nampt is expressed in cultured SMCs and its content and activity decline 
during advanced SMC aging (van der Veer et al. 2005, van der Veer et al. 2007). As well, 
Nampt has been found to regulate in vitro SMC longevity and migratory behaviour (van 
der Veer et al. 2007, Yin et al. 2012) There are also reports that exogenous delivery of 
Nampt impacts SMC contractile function, although with contradictory findings (Wang et 
al. 2016) Nampt is expressed in peri-aortic adipose tissue (Wang et al. 2009) and altering 
NAD+ metabolism through the diet has been found to suppressed age-related aortic 
dysfunction (de Picciotto et al. 2016).  However it remains unknown whether Nampt is 
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needed for aortic health or if a Nampt-based NAD+ generation system exists within the 
aortic media.   
I have investigated the role of Nampt in the aortic media by in vivo ablation of 
Nampt in SMCs in mice.  My findings reveal the existence of an intrinsic NAD+ fueling 
system in the aortic media and its necessity for maintaining aortic integrity.  The findings 
also shed new insights into DNA repair and senescence resistance cascades in the aortic 
media that may underlie vulnerability in NAD+ homeostasis in thoracic aortopathy.     
2.2 Methods 
2.2.1 Generation of Nampt-deficient mouse models 
 Mouse experiments followed protocols approved by the Western University Animal 
Use Committee.  All mice were on a C57Bl/6 background.  To generate mice with a SMC-
specific knockout of Nampt, an initial cross was undertaken between female mice 
harbouring loxP sites flanking exons 5 and 6 of Nampt (Namptflox/flox)(Rongvaux et al. 
2002) and male transgenic mice expressing Cre recombinase and eGFP under the control of 
the SMC-specific myosin heavy chain promoter (smMHC-Cre/eGFP, Jackson Laboratories, 
Bar Harbor, ME) (Xin et al. 2002). Expression of Cre in the aorta of the latter mice was 
verified by whole tissue epifluorescence microscopy (Zeiss SteREO Lumar V12 
Microscope, Carl Zeiss Canada Ltd, Toronto, ON, Canada) and by immunostaining OCT-
embedded frozen sections using an anti-eGFP antibody (Fig. S1).  In a second round of 
breeding, the male SMC-targeted Nampt heterozygotes (Namptflox/+; smMHC-Cre+) were 
bred with female Namptflox/flox mice.  Because of transient expression of Cre in the sperm of 
male smMHC-Cre/eGFP mice (de Lange et al. 2008), the floxed allele transmitted from the 
Cre-expressing parent is recombined, yielding a global heterozygous null allele of Nampt 
(hereafter referred to as “-”).  Genotyping using PCR primers to amplify floxed, wildtype, 
exon 5/6-deleted Nampt, and the Cre transgene (Rongvaux et al. 2002, Xin et al. 2002) 
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confirmed the four possible genotypes of the offspring: Namptflox/+; smMHC-Cre- (wild-
type), Namptflox/+; smMHC-Cre+ (SMC-specific Nampt heterozygous), Namptflox/-; 
smMHC-Cre- (global Nampt heterozygous), and Namptflox/-; smMHC-Cre+ (SMC-specific 
knockout with a global heterozygous Nampt background, “SMC-Nampt KO”).  We used 
the wild-type mice as control and global Nampt heterozygous as an additional control for 
key endpoints.  Importantly, prior studies have shown that global Nampt heterozygous mice 
are not overtly different from wild-type mice (Revollo et al. 2007). SMC-Nampt KO mice 
in the upper size tertile at 10-12 weeks of age were used for all studies.  
 We also generated mice in which Nampt could be globally and inducibly deleted.  
Namptflox/flox mice were bred with mice expressing Cre recombinase fused to the mutated 
ligand binding domain of the human estrogen receptor (ER) under the control of a chimeric 
cytomegalovirus immediate-early enhancer/chicken ß-actin promoter (B6.Cg-Tg(CAG-
Cre/Esr1)5Amc/J) (Jackson Laboratories, Bar Harbor, ME) (Hayashi and McMahon 2002).  
SMCs harvested from aortas of Namptflox/flox Cre-ERT2 mice were subjected to hydroxyl-
tamoxifen or sunflower oil vehicle for 24 hours.  
2.2.2 NAD+ measurement 
Mouse aortic medial NAD+ levels were determined in freshly harvested aorta after 
removing the adventitial layer by dissection and denuding the endothelial layer by 
scraping.  NAD+ content in the mouse aortic media was determined using a colorimetric kit 
(BioVision Research Products, Mountain View, CA, USA) and expressed relative to total 
protein content.  
2.2.3 Laser capture microdissection and RNA isolation of mouse aortas 
Laser capture was undertaken on 10 µm-thick frozen sections of the mouse 
descending thoracic aorta that had been embedded in OCT compound (Tissue-Tek).  The 
medial layer was micro-dissected (Arcturus 704 Veritas LCM System, Harlow Scientific, 
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Arlington, VA) from 20 sections of an individual aorta and RNA extracted using TRIzol 
(Life Technologies) with the addition of linearized polyacrylamide (2 mg/ml, Sigma) 
following phase separation.  
2.2.4 Drug Delivery in Mice 
Mini-osmotic pumps (Alzet Model 2004, Durect Corp., Cupertino, CA) were 
implanted subcutaneously in the right flank for infusion with either saline or Ang II (1.44 
mg/kg/day) for 7 or 28 days.  Implantation was performed after inducing anesthesia with 
3% isofluorane in 100% oxygen at a flow rate of 1 L/min.  In a subset of mice, 
phenylephrine (Sigma, 30 mg/kg/day) was infused via mini-pump for 14 days, with 
implantation of an Ang II-infusing pump (1.44 mg/kg/day) on the opposite flank on day 7, 
such that both phenylephrine and Ang II were infused for seven days.  Parp activity was 
inhibited by twice daily intraperitoneal injections of olaparib (50 mg/kg, AZD2281, 
Selleckchem, Houston, TX) for eight days, beginning 24 hours prior to implantation of 
saline or Ang II-loaded minpumps. 
2.2.5 Blood pressure measurement 
 Blood pressure and heart rate were measured by noninvasive tail cuff (CODA, Kent 
Scientific Corp., Torrington, CT) (Vafaie et al. 2014). Mice were acclimatized by 
undergoing daily blood pressure recordings for one week prior to data acquisition.  For data 
acquisition, 35 serial blood pressure measurements were performed and the average of the 
last 30 cycles recorded. 
2.2.6 Aortic wall morphometry 
Mice were anesthetized with ketamine/xylazine and perfused via the left ventricle 
with phosphate-buffered saline (PBS) and then paraformaldehyde (4% wt/vol) under 
physiological pressure for 30-45 minutes.  After immersion in 4% paraformaldehyde 
overnight, two-mm segments from four distinct aortic zones (Owens et al. 2010) were 
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embedded in paraffin: ascending aorta (1 mm distal to the aortic valve); descending 
thoracic aorta (5 mm distal to the left subclavian artery); suprarenal abdominal aorta 
(proximal to the superior mesenteric artery); and infrarenal abdominal aorta (distal to the 
left renal artery).  Five-µm sections were stained with hematoxylin-eosin or Movat’s 
pentachrome and visualized with an Olympus BX51 microscope.  Medial area, lumen area, 
and medial cell number were quantified from 3 sections 200 µm apart, in each of the four 
aortic regions, avoiding areas with aortic hematoma or dissection, using ImageJ software 
(NIH, Bethesda, MD).  Focal areas of medial cell loss in the descending thoracic region 
were traced and expressed relative to that of the media.  Aortic dissection was defined by 
the presence of blood in one or more of the aortic medial layers extending contiguously for 
at least 200 µm. 
2.2.7 Immunohistochemistry and apoptosis of mouse aortic tissue 
Immunostaining was performed on paraffin-embedded sections (for Nampt, eGFP, 
8-oxodG, smooth muscle α-actin, p16, γ-H2AX, and cascapse-3).  Primary antibodies 
were: rabbit polyclonal anti-eGFP (AB3080 1:50; EMD Millipore, Billerica, MA), mouse 
monoclonal anti-smooth muscle α-actin (Clone 1A4, A5228 1:500, Sigma, Oakville, ON, 
Canada), rabbit polyclonal anti-Nampt (A300-372A 1:50; Bethyl Laboratory, Montgomery, 
TX), mouse monoclonal anti-8-oxodG (NWA-MOG020 1:50; Northwest Life Sciences, 
Vancouver, WA), rabbit polyclonal anti-p16 (sc-28260 1:50; Santa Cruz Biotechnology, 
Dallas, TX), rabbit monoclonal anti-γ-H2AX (#9718 1:400; Cell Signaling, Danvers, MA), 
rabbit polyclonal anti-active caspase-3 (ab4051 1:50; Abcam, Cambridge, MA), rabbit 
monoclonal anti-Ki67 (ab16667 1:100; Abcam, Cambridge, MA), and rabbit polyclonal 
anti-CD45 (ab10558 1:200; Abcam, Cambridge, MA).  Bound primary antibodies against 
eGFP, Nampt, 8-oxodG, p16, Ki67 and CD45 were detected using goat anti-rabbit or goat 
anti-mouse biotinylated antibody (Vector Labs, Burlington, ON, Canada) and visualized 
using an ABC kit and diaminobenzidine (DAB, Vector Labs) and counterstained with 
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Harris’ hematoxylin. Bound primary antibodies against smooth muscle α-actin and γ-
H2AX were detected using Alexa Fluor 488-conjugated goat anti-mouse and donkey anti-
rabbit secondary antibody, respectively (Molecular Probes; Life Technologies, Burlington, 
ON, Canada) and nuclei were counterstained with propidium iodide.  The proportion of 
immuno-positive cells in a given aortic zone was ascertained from 3 sections, separated by 
200 µm, with a minimum of 500 cells evaluated.  Terminal deoxynucleotide transferase-
mediated dUTP nick end labeling (TUNEL) was used to assess apoptosis on paraffin-
embedded sections (Roche Applied Science).  
2.2.8 Senescence associated ß-galactosidase activity  
 Senescence associated ß-galactosidase (SA ß-gal) activity in the mouse aortas was 
determined as described (Vafaie et al. 2014) Briefly, anesthetized mice were subjected to 
antegrade perfusion via the left ventricle of phosphate-buffered saline (PBS) followed SA 
ß-gal solution (1 mg/ml X-Gal, 5 mmol/l potassium ferrocyanide, 5 mmol/l, potassium 
ferricyanide, 150 mmol/l NaCl, 2 mmol/l MgCl2, 40 mmol/l citrate (titrated to pH 6.0 with 
NaH2PO4).  Aortas were then harvested, incubated in SA-ßGal staining solution at 37°C for 
16 h, fixed in 4% paraformaldehyde for 16 hours.  Whole aortas were imaged with a Nikon 
SMZ800 stereomicroscope (Nikon Instruments, Mississauga, ON, Canada).  Tissue was 
then frozen, embedded in OCT, and 10-µm cryosections were imaged microscopically to 
assess for positively stained blue cells. 
2.2.9 Cell culture 
Mouse aortic SMCs were isolated from aortas of 8-10-week-old mice via chemical 
digestion using type III porcine pancreatic elastase (250 µg/ml, Sigma) and type I 
collagenase (1 µg/ml, Worthington Biochemical Corporation, Lakewood, NJ) (Ray et al. 
2001). SMCs were maintained in DMEM with 10% FBS and SMC identity confirmed by 
immunostaining for smooth muscle a-actin. SMCs harvested from aortas of Namptflox/flox 
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Cre-ERT2+ mice were subjected to 1 µM hydroxy-tamoxifen for 24 hours. In order to 
control for the effect of tamoxifen, Namptflox/flox Cre-ERT2- (control) SMCs were also 
subjected to 1 µM hydroxy-tamoxifen for 24 hours. Rat aortic SMCs were isolated as 
previously described (Small and Pickering 2009) and maintained in DMEM with 10% 
FBS. All cells were studied within the first 4 subcultures.  
2.2.10 Western blot analysis 
Western blot analysis was undertaken with chemiluminescent detection as 
previously described (Frontini et al. 2009). Blots were probed by incubating with primary 
antibodies reacting to PAR (#528815 1:2,000; Calbiochem/EMD Millipore, Billerica, MA), 
Parp1 (ab6079 1:400; Abcam, Cambridge, MA), and α-tubulin (clone B-5-1-2 1:10,000, 
Sigma). 
2.2.11 Detection of double-strand DNA breakage  
Mouse SMCs subjected to irradiation at a dose rate of 1 Gy/minute for ten minutes 
(10 Gy) (Faxitron RX-650, Faxitron Bioptics, Tucson, AZ) or incubated with Ang II (10-7 
mol/L) for 24 hours were fixed in 4% paraformaldehyde for 20 minutes.  Cells were 
permeabilized in 0.5% Triton X-100 and incubated with rabbit antibody to γ-H2AX (#9718 
1:300; Cell Signaling, Danvers, MA).  Signal was detected by incubating with anti-rabbit 
Alexa Fluor 488 secondary antibody (Invitrogen, Burlington, ON, Canada) and nuclei were 
counterstained with 4′,6′-diamidino-2-phenylindole (DAPI, Invitrogen).  γ-H2AX foci were 
quantified from at least 300 cells per condition based on fluorescent pixel density, applying 
a single background threshold for all images and using ImageJ, as described (Fell and 
Schild-Poulter 2012).  
2.2.12 Detection of global DNA strand breakage by Comet assay 
 Mouse SMCs incubated with 1 mM H2O2 (15 minutes) or 10-7 mol/L Ang II (24 
hours) were analyzed for DNA strand breaks by single cell alkaline electrophoresis 
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(CometAssay, Trevigen Gaithersburg, MD).  Cells were trypsinized, suspended in 50 µl of 
low-melting point agar, transferred onto slides, and incubated at 4°C to allow the agar to 
set.  Cells were then lysed in alkaline buffer and electrophoresed for 30 minutes with 300 
mAmps of current.  Cells were subsequently stained with SYBR-gold DNA stain and 
imaged (Olympus BX51). The comet tail moment (product of the tail length and fraction of 
total DNA in the tail) was measured using ImageJ and OpenComet 
(cometbio.org/index.html). 
2.2.13 Time-lapse microscopy response to DNA damage 
 To evaluate the response to specific DNA damaging agents, Namptflox/flox SMCs, 
with or without expression of Cre-ERT2, were incubated with 1µM hydroxyl-tamoxifen for 
24 hours and cultured for an additional 72 hours to ensure Nampt depletion.  Cells were 
incubated with designated concentrations of H2O2 or MMS for 1 hour and morphology 
tracked by video microscopy every 15 minutes for the following 24 hours.  Cell death was 
identified based on either cell rounding with detachment from the plate, or a combination 
of collapse of the cytoskeleton, dissolution of nuclear structure, and complete cessation of 
movement.  The effect of nicotinamide riboside on MMS-induced DNA damage was 
assessed by pre-incubating cells with 100 µM nicotinamide riboside (Chromadex, Irvine, 
CA) for 24 hours in NAD+ precursor-free modified Eagle’s medium (MEM) prior to 
addition of 600 µM MMS.  
2.2.14 Immunocytochemical detection of poly(ADP-ribose) 
 Mouse SMCs fixed in 4% paraformaldehyde were permeabilized in 0.5% Triton X-
100 and incubated with mouse anti-PAR antibody (4335-MC-100, 1:500; Trevigen, 
Gaithersburg, MD).  PAR signal was detected with Alexa Fluor 546-conjugated goat anti-
mouse secondary antibody (Molecular Probes; Life Technologies, Burlington, ON, 
Canada) and nuclei were counterstained with DAPI.  PAR signal was quantified from at 
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least 300 cells per condition based on fluorescent pixel density, applying a single 
background threshold for all images and using ImageJ, as described (Fell and Schild-
Poulter 2012).  
2.2.15 Quantitative real-time reverse transcription–polymerase chain reaction  
Total RNA was isolated from homogenates of the mouse aorta using TRIzol (Life 
Technologies) and the Rneasy Mini Kit following the manufacturer’s protocol (Qiagen, 
Valencia, CA).  Total RNA was isolated from mouse SMCs using the Rneasy Mini Kit 
following the manufacturer’s protocol. Transcript abundance of Nampt and Gapdh in 
microdissected mouse aortas was assessed using TaqMan chemistry-based primer-probe 
sets (Nampt, Mm00451938_m1; Gapdh, Mm99999915_g1, Applied Biosystems). 
Transcript abundance of mouse Nampt, Acta2, Mmp2, Col1a1, Timp1, and 18S were 
assessed using SYBR-green chemistry-based primer sets (mouse Nampt: F-
GGCACCACTAATCATCAGACCTG R-AAGGTGGCAGCAACTTGTAGCC; mouse 
Acta2: F-TGCTGACAGAGGCACCACTGAA R-CAGTTGTACGTCCAGAGGCATAG; 
mouse Mmp2: F-GAGACCATGCAGTCAGCTCTAG R-
TAGAGCTGCCTCTTGTCTGGT; mouse Col1a1: F-
CCTCAGGGTATTGCTGGACAAC R-CAGAAGGACCTTGTTTGCCAGG; mouse 
Timp1: F-TCTTGGTTCCCTGGCGTACTCT R-GTGAGTGTCACTCTCCAGTTTGC; 
mouse 18S F-GTAACCCGTTGAACCCCATT R-CCATCCAATCGGTAGTAGCG). 
Quantitative real-time RT-PCR was performed using an ABI Prism (model 7900HT) and 
Sequence Detection System software (Life Technologies; Applied Biosystems).  For mouse 
aortas and SMCs, relative mRNA abundance was quantified based on critical threshold 
(CT) using the comparative CT formula, 2-ΔΔCT, with Gapdh or 18S mRNA as an internal 
control.   
		 75	
2.2.16 Statistical analyses 
Values are expressed as mean±standard error of the mean. Statistical analyses were 
performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean data 
were compared using Student’s t-test or one- or two-way ANOVA with Holm-Sidak post 
hoc testing.  The prevalence of aortic dissection and of in vivo SA ß-gal activity were 
compared among groups by chi-squared analyses.   
2.3 Results 
2.3.1 Generation of mice with SMC Nampt gene ablation 
To determine if Nampt within SMCs plays a role in aortic health, I generated mice 
with targeted deletion of Nampt in SMCs, using the smMHC-Cre/eGFP expressing mouse 
line(Xin et al. 2002) and Namptflox/flox mice (Rongvaux et al. 2008). Evaluation of eGFP in 
smMHC-Cre/eGFP mice confirmed Cre recombinase in the aorta, as assessed by whole 
organ microscopy and immunostaining (Fig. 2.1).  Analysis of over 200 offspring from a 
two-step breeding protocol revealed close to expected Mendelian ratios for the predicted 
genotypes: 26.7% WT, 29.1% SMC-specific Nampt heterozygous, 20.6% Nampt 
heterozygous, and 23.5% SMC-Nampt KO.  
Laser capture microdissection and quantitative RT-PCR revealed that Nampt 
transcript abundance in thoracic aortic media of SMC-Nampt KO mice was reduced to 
13.5% that of control mice (Fig. 2.2a).  Immunostaining revealed nuclear and extra-nuclear 
Nampt protein in medial SMCs of control aortas, with the nuclear signal being stronger 
(Fig. 2.2b).  Nampt was undetectable in the aortic media of SMC-Nampt KO mice in all but 
rare cells but still detectable in endothelial cells and adventitial cells (Fig. 2.2b).  I also 
determined aortic NAD+ content, using an NAD+ cycling assay.  This revealed a 43.2% 
reduction in NAD+ content in SMC-Nampt compared to control mice (Fig. 2.2c).  Thus,  
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Figure 2.1 eGFP expression in aorta of smMHC-Cre-eGFP+ mice 
Fluorescent stereomicroscopy images of whole thoracic aortas (top) and paraformaldehyde-fixed sections of 
thoracic aorta (bottom), immunostained for eGFP signal in 8-week-old smMHC-Cre-eGFP+ mice. 	
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Figure 2.2 Generation of mice with Nampt-deficient aortas 
A. Graph depicting Nampt transcript abundance in the mouse aortic media harvested using laser capture 
microdissection, measured by quantitative RT-PCR, and normalized to 18S expression.  Medial tissues from 
3 mice for each genotype were studied. *P=0.0034 vs Control, †P<0.0001 vs Control, by 1-way Anova.  B. 
Photomicrographs of thoracic aortic sections from control and SMC-Nampt KO mice, immunostained for 
Nampt.  Black arrows depict Nampt expression in SMCs, red arrows depict Nampt expression in endothelial 
cells.  C. Graph of NAD+ content in acidic extracts of endothelium-denuded aortas of control and SMC-
Nampt KO mice. *P=0.024 vs control, by Student’s T-test.  
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Nampt is expressed in SMCs of the mouse aortic media and its depletion in SMCs, 
obtained using a Cre-lox approach, compromised aortic NAD+ homeostasis.   
2.3.2 Mice with SMC Nampt deletion have modestly dilated thoracic aortas 
SMC-Nampt KO mice were viable and displayed no gross evidence of vascular 
anomalies.  The average mean arterial pressure and heart rate of 8-week old SMC-Nampt 
KO mice were not significantly different than those of control mice (Fig. 2.3a).  
Immunostaining revealed abundant smooth muscle α-actin in medial SMCs, a normal 
number of lamellar units throughout the aorta, and unaltered medial SMC content (Fig. 
2.3b-c).  Quantification of lumen area of aortas fixed at physiologic pressure did however 
reveal modest dilatation of the ascending and descending thoracic aortic regions (by 16.7% 
and 12.4%, Fig. 2.3d).  As well, the aortic medial areas of SMC-Nampt KO mice were 
mildly reduced in the ascending, descending thoracic, and suprarenal regions (by 13.2, 
17.0, 24.5%, respectively, Fig. 2.3e).  Transcript analysis revealed a modest (27.2%) 
decrease in mRNA abundance of SM-a-actin (P=0.001) and a 1.4-fold increase in Mmp2 
expression (P=0.005) with no change in Timp1 expression (P=0.010). 
2.3.3 Mice with SMC Nampt deletion are susceptible to Ang II-induced aortic 
dissection 
 To ascertain the response of the Nampt-deficient aorta to disease-associated stress, 
mice were subjected to continuous delivery of Ang II (1.44 mg/kg/day) by subcutaneous 
mini-pump.  Interestingly, this was associated with a 54% decrease in aortic Nampt 
transcript abundance (P=0.009) and a concordant trend for NAD+ content (P=0.063, Fig. 
2.4a,b). Mean arterial blood pressure increased at 7 days, with no significant differences 
among the groups (25.3±4.3, 16.5±18.0, and 34.5±22.3 mm Hg for WT control, Nampt 
heterozygous control, and SMC-Nampt KO, respectively, p=0.285). However, there was 
striking aortic hemorrhage in SMC-Nampt KO mice, evident microscopically and grossly.   
Half of the mice displayed aortic hematomas after 7 days and this increased to 62.5% on  
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Figure 2.3 Deletion of Nampt in SMCs in mice yields modest aortic dilatation 
A. Blood pressure and heart rate measurements of wild-type, Nampt heterozygous, and SMC-Nampt 
knockout mice were obtained weekly for 6 weeks for each mouse and averaged.  Values depict mean data 
from 10-12 mice per genotype. B-E. Graphs showing the number of elastic lamellae per regional cross 
section (E), medial cell density (F), regional aortic lumen area (G) and medial area (H). *P=0.023 and 
†P=0.029 vs. respective lumen area control, *P=0.029, †P=0.004, and ‡P=0.027 vs. respective medial area 
control. N=5-6 mice per group. 
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Figure 2.4 Angiotensin II decreases Nampt expression and NAD+ content in mSMCs and mouse aortas 
A. Graph depicting Nampt transcript abundance as normalized to 18S transcript abundance in the media of the 
thoracic aorta of C57Bl/6 mice infused with Ang II (1.44mg/kg/day) or vehicle for 7 days, measured by 
quantitative RT-PCR (n=3 mice per group)  B. Graph of NAD+ content in acidic extracts of aortic media of 
vehicle- or Ang II-infused mice (n=4 mice per group). 	
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day 28.  The hemorrhage typically was within the outer one or two medial layers and could 
be extensive, with local elastin breakage (Fig. 2.5a).  The hematomas did not rupture into 
the adventitia, as typically seen in Ang II-infused atherosclerotic mice, but instead could be 
found at multiple sites and dissecting along the length of the aortic media.  In contrast, 
there was no grossly detectable hemorrhage in control mice subjected to Ang II, although 
microscopic hemorrhage in the ascending aorta was found in 24% of mice. These small 
bleeds, also noted in other reports (Rateri et al. 2014), had resolved by 28 days of Ang II 
delivery (Table 2.1).  A similar profile was observed for Nampt heterozygous mice (14% 
microscopic hemorrhage in the ascending aorta).  Transcript analysis of whole aortas 
revealed that SM-a-actin expression was 22.2% lower in Ang II-infused SMC-Nampt KO 
than Ang II-infused control mice (P=0.0001) and expression of Col1a1 was 37.4% lower 
(P=0.002).  However, the Mmp2/Timp1 ratio did not increase and in fact reduced somewhat 
(20.9% P=0.002).  Immunostaining for CD45 showed no differences between control and 
SMC-KO mice before or after Ang II infusion (data not shown). 
Because of a trend toward greater Ang II-induced blood pressure response in SMC-
Nampt KO mice, I determined if blood pressure elevation, in and of itself, might be 
responsible for the more striking aortic disruption.  For this, control mice were subjected to 
double infusion of phenylephrine and Ang II, which elevated the mean arterial pressure by 
37.2±16.4 mmHg.  This increase was associated with only localized hemorrhage confined 
to the ascending aorta in 25% of mice (n=8), a profile not different than that of control 
mice.  Collectively, these findings reveal that aortas in SMC-Nampt KO mice are prone to 
Ang II-induced disruption by hematoma and dissection, with minor changes in expression 
of SM-α-actin and type I collagen chains.  Furthermore, whereas control mice adapted to 
the disrupting potential of Ang II over 28 days, SMC-Nampt KO mice remained 
vulnerable. 	 	
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Figure 2.5 SMC-Nampt KO mice are susceptible to aortic wall degeneration and dissection 
A. Light micrographs of sections of the descending thoracic aorta of a control (left) and SMC-Nampt KO 
(middle) mouse following 28 days of infusion with Ang II, stained with hematoxylin and eosin.  The right 
panel depicts an adjacent section of the KO aorta stained with elastin trichrome, showing confinement of 
hemorrhage to the aortic media.  B. Photomicrographs of sections of the ascending aorta stained with 
hematoxylin and eosin from vehicle- and Ang II-infused (28 days) control and SMC-Nampt KO mice.  C. D. 
Graphs depicting cell content of the media cross-section after Ang II infusion in ascending (C), *P<0.0001 vs 
control, and descending thoracic (D) aortas *P=0.002 vs. control.	
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Table 2-1 Angiotensin II-induced aortic medial hemorrhage in mice 
 
  
! "' !
Online Table II. Angiotensin II-induced aortic medial hemorrhage in mice 
 
 WT Nampt Heterozygous SMC-Nampt KO 
Ang II (7 days) 
(n=17) 
Ang II (28 days) 
(n=10) 
Ang II (7 days) 
(n=7) 
Ang II (28 days) 
(n=7) 
Ang II (7 days) *  
(n=14) 
 Ang II (28 days) †  
(n=8) 
Ascending 4 (23%) 0 1 (14%) 1 (14%) 6 (43%) 1 (13%) 
Thoracic 0 0 0 0 1 (7%) 1 (13%) 
Suprarenal 0 0 0 0 2 (14%) 4 (50%) 
Infrarenal 0 0 0 0 0 0 
Total 
(all regions) 4 (5.9%) 0 1 (3.6%) 1 (3.6%) 9 (16%) 6 (18.7%) 
Total 
(all mice) 4 (23%) 0 1 (14%) 1 (14%) 7 (50%) 5 (62.5%) 
 
*P=0.0002 vs 7-day WT distributions, P=0.0068  vs 7 -day Nampt  Heterozygous distributions  
†P=0.0106 vs. 28-day WT distributions, P=0.0328 vs 28-day Nampt Heterozygous distributions
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2.3.4 Ang II-induced cell loss in mice with SMC-Nampt KO mice 
Twenty-eight days of Ang II infusion in control mice resulted in a 1.8-fold increase 
in medial SMC content in the ascending aorta (Fig. 2.5b,c) but no change in SMC content 
in the descending thoracic aorta, confirming a site-specific response that has been 
previously noted (Owens et al. 2010) In contrast, in SMC-Nampt KO mice medial SMC 
content in the ascending aorta did not increase in response to Ang II and in the descending 
thoracic aorta SMC content actually fell by 25.2% (Fig. 2.5d).  These aberrant responses 
occurred despite evidence for residual SMC proliferation in Ang II-infused SMC-Nampt 
KO mice, as indicated by Ki67 immunostaining (Fig. 2.6a,b), supporting a turnover profile 
skewed toward cell loss.  This loss of SMCs was evident both as scattered SMC dropout 
and cell-free foci of proteoglycan-rich matrix (Fig. 2.6c).  Cell-poor zones were 
occasionally observed in control aortas subjected to Ang II but were 70% larger in aortas of 
SMC-Nampt KO mice (Fig 2.6d).  Thus Nampt-depleted SMCs failed to adaptively fortify 
the ascending aorta and repopulate damaged regions in the descending aorta.  
2.3.5 SMCs within the aorta of SMC-Nampt KO mice are susceptible to stress-
induced premature senescence  
To determine if the aberrant SMC responses to Ang II were due to induction of 
apoptosis, aortas were evaluated using TUNEL and active caspase-3 immunostaining.  
Surprisingly, although Ang II-induced apoptosis was evident in adventitial cells, I did not 
identify apoptosis signals in the ascending or descending thoracic aortic media of either 
control or Nampt-deficient mice (Fig. 2.7a,b).  I next asked if SMCs instead developed 
features of senescence, recognizing that in vitro studies have implicated Nampt in slowing 
SMC aging (van der Veer et al. 2007). Intravenous infusion and ex vivo immersion in X-
Gal solution (Vafaie et al. 2014) revealed no SA ß-gal activity in the aorta of control mice  
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Figure 2.6 Aortas of SMC-Nampt KO mice are not proliferative and have areas of cell-free zones 
A. Mouse aortic medial SMC proliferation as determined by immunostaining for Ki67. Micrographs of 
mouse ascending aorta 7 days after infusion with vehicle or Ang II (1.44 mg/kg/day), depicting Ki-67 
immunoreactivity in control and SMC-Nampt KO mice (arrows). N=4 mice per group. B. Quantitative data 
for both ascending and descending thoracic aorta sections are shown in the graph. C. Sections of descending 
thoracic aorta from control (left) and SMC-Nampt KO (middle, right) mice following 28 days of infusion 
with Ang II illustrating focal cell loss. The right panel is an adjacent section to that in the middle and stained 
with Movat’s pentachrome.  Arrow depicts proteoglycan-rich cell-poor zone.   D. Graph depicts the area of 
focal zones of SMC loss in the thoracic aorta, *P=0.0003 vs. control. N=5 mice per group. 
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Figure 2.7 Assessment of apoptosis in aortas by TUNEL and active caspase-3 expression 
A.  Fluorescent photomicrographs of ascending aorta of mice infused with Ang II for 7 days stained using 
TUNEL (green). Nuclei were counter-stained with propidium iodide (red). Arrow indicates a TUNEL-
positive nucleus in the adventitia.  Lu, lumen; Adv, adventitia  B. Ascending aorta sections of mice infused 
with vehicle or Ang II for 7 days and immunostained for active caspase-3 and counterstained with 
hematoxylin.  Arrows indicate active caspase-3 positive endothelial cell and adventitial cell nuclei	
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subjected to Ang II.  Remarkably however, in SMC-Nampt deficient mice there was SA ß-
gal activity throughout the ascending aorta, arch, and proximal descending thoracic aorta 
after 7 days of Ang II infusion (Fig. 2.8a).  Microscopy established that SA ß-gal activity 
was confined to the medial layers of the aorta and particularly the outer medial layers (Fig 
2.8b).   
As an additional test for cell senescence, I immunostained aortic sections for the 
cell cycle inhibitor, p16INK4a.  This revealed a 6.1-fold increase in the abundance of p16-
expressing cells in the media of the ascending aorta of Ang II-infused SMC-Nampt KO 
mice relative to Ang II-infused control mice and a 4.7-fold increase in the thoracic aorta 
(Fig 2.8e).  Therefore, Nampt deficiency impacts the fate of SMCs in the aorta, whereby 
Ang II sends them into a state of premature senescence.  
2.3.6 Nampt-deficient SMCs accumulate oxidized DNA lesions and single-stranded 
DNA breaks 
To explore why Nampt-ablated SMCs were prone to senescence I assessed for DNA 
integrity. I first immunostained for the oxidized nucleoside, 8-oxo-2'-deoxyguanosine (8-
oxodG), recognizing that ROS can drive cell senescence (Yin and Pickering 2016). The 
proportion of ascending aorta medial SMCs with oxidized DNA was 3-fold higher in SMC-
Nampt KO mice than in control mice.  After a 7-day infusion of Ang II, DNA oxidation in 
SMC-Nampt KO aortas was even more prevalent and was 2.5-fold greater than in Ang II-
infused control mice (Fig 2.9a,b).  The oxidized DNA profile for SMCs in the thoracic 
aorta was similar although less striking (Fig. 2.9b).  
I next asked if Nampt-deficient SMCs accumulated overt breaks in the DNA.  For 
this, I established a culture system that enabled us to time the ablation of Nampt and 
evaluate different DNA break pressures.  SMCs were cultured from aortas of Namptflox/flox 
mice expressing Cre recombinase under the control of a tamoxifen-inducible promoter 
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Figure 2.8 Nampt-deficient SMCs within the aorta undergo cellular senescence in response to Ang II 
infusion 
A. Whole mount images of ascending, arch, and proximal descending thoracic aortas harvested after 7 days of 
Ang II infusion and stained for senescence-associated β-galactosidase (SA-ßGal) activity (blue).  B. 
Cryosections of the ascending aorta depicting SA-ßGal activity localized to the aortic media.  C.  Chart 
showing proportion of aortas (n=16) with SA-ßGal activity. *P=0.0011  D. Micrographs of ascending aorta 
subjected to 7 days of vehicle or Ang II infusion and immunostained for p16.  Arrows depict p16-postive 
nuclei.  E. Graph depicting prevalence of p16-positive nuclei. 	
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Figure 2.9 Nampt deficient aortas are susceptible to oxidative DNA damage 
A.  Micrographs of ascending aorta 7 days after infusion with Ang II, depicting oxidative DNA lesions as 
indicated by 8-oxo-2’-deoxyguanosine (8-oxodG) immunoreactivity.  B. Graph showing the percentage of 8-
oxodG-positive cells in the ascending and descending thoracic aortas. N=4 mice per group. 	
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(Cre-ERT2). I then evaluated electrophoretic migration of cleaved DNA out of harvested 
nucleoids (“Comet” assay) after delivery of vehicle or hydroxy-tamoxifen.  That latter 
induced robust Nampt knockdown (Fig. 2.10a).  Interestingly, there was evidence for 
cleaved DNA in Nampt-ablated SMCs under baseline culture conditions (Fig. 10b,c).  
Incubation with H2O2, (100 µM, 1 h) to induce single strand DNA breaks yielded more 
striking DNA fragment tails and these were substantially more prominent in Nampt-ablated 
SMCs.  Incubation with Ang II (10-7 mol/L, 24 h) yielded a modest DNA fragment signal 
that was significantly greater in Nampt-ablated SMCs (Fig 2.10b,c). 
To further assess the response to DNA break-inducing agents, SMCs were tracked 
by video microscopy.  This revealed a striking death response in Nampt-depleted SMCs, 
with cell rounding, anoikis, and cessation of cell membrane activity (Fig. 2.11a,b).  
Incubating SMCs with MMS, another single-strand DNA breaking reagent, led to similarly 
worse survival for Nampt-ablated SMCs (Fig. 2.11a,c).  Notably, incubating SMCs with 
nicotinamide riboside prior to MMS inhibited the death response (Fig. 2.11d).  Together, 
these studies reveal that Nampt protects SMCs from accumulating both oxidized DNA 
lesions and a toxic burden of single-strand DNA breaks. 
2.3.7 Nampt-deficient SMCs have impaired double-strand DNA break repair 
Double-strand DNA breaks are a particularly stressful form of DNA damage and 
potent driver of cell senescence (d'Adda di Fagagna 2008). Using the above culture system, 
I assessed the potential for accumulating double-strand breaks by subjecting SMCs to 
irradiation (10 Gy) and immunostaining for phosphorylated histone (γ-H2AX).  
Interestingly, DNA damage foci were found in low abundance in Nampt-ablated SMCs 
prior to irradiation.  Upon irradiation, damage foci accumulated and were significantly 
more abundant in Nampt-ablated SMCs.  This difference was evident after 15 minutes but 
also after 24 hours, at which time control SMCs showed near-complete resolution of the  
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Figure 2.10 Nampt deficiency and susceptibility to oxidative DNA damage 
A. Conditional deletion of Nampt in mouse aortic smooth muscle cells: SMCs were harvested and cultured 
from aortas of Namptflox/flox; CreERT2+ mice and incubated with vehicle or hydroxy-tamoxifen for 24 hours. 
Abundance of Nampt mRNA was evaluated by RT q-PCR and normalized to expression of Gapdh mRNA. 
*P<0.0001 B. Fluorescent micrographs of fragmented DNA “comet” tails from mouse aortic SMCs subjected 
to vehicle, 100 µM H2O2 (1 h), and 10-7 mol/L Ang II (24 h).  C. Graph depicting mean±SEM SMC comet tail 
moments, relative to controls SMCs incubated with vehicle.  *P=<0.0001  
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Figure 2.11 Nampt-depleted mouse SMCs are susceptible to death following exposure to H2O2 and 
MMS 
A. Time-lapse video images of control (vehicle-treated) and Nampt-deleted (hydroxy-tamoxifen-treated) 
aortic SMCs harvested from Namptflox/flox; CreERT2+ mice.  SMCs were incubated for one hour with H2O2 
(1 mM), methyl methanesulfonate (MMS, 600 µM), or respective vehicles, and tracked for 24 hours. 
Asterisks and cell tracings depict individual cells over the 24 h time course, with tracings denoting cells 
undergoing anoiksis.  Arrows depict a zone of cell content disintegration. B, C. Graphs depicting survival of 
mouse aortic SMCs, 24 hours after incubation with H2O2 (*P=0.012, †P=0.014, ‡P=0.0001) or MMS 
(*P=0.009, †P<0.0001). N=3 experimental replicates  E. Graph depicting the survival of mouse aortic SMCs, 
24 hours after incubation with 600 µM MMS, with and without the addition of 100 µM nicotinamide riboside 
(NR), *P=<0.0001. N=3 experimental replicates  
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breaks (Fig. 2.12a,b).  Incubation of Nampt-ablated SMCs with Ang II (24 h) also 
increased double-strand DNA damage foci and this effect was still evident 24 h after Ang 
II washout (Fig. 2.12c). 
I next assessed if this form of DNA damage could be found in vivo.  There were no 
γ-H2AX-positive SMCs in the aortic media of mice subjected to vehicle infusion.  Rare 
(<0.5%) γ-H2AX-positive cells were found in control mice subjected to Ang II infusion 
(Fig. 2.13a,b).  In contrast, γ-H2AX-positive-SMCs were consistently detected in both 
ascending (4.0%) and descending (3.8%) thoracic aortas of Ang II-infused SMC-Nampt 
KO mice (Fig. 2.13b).  
2.3.8 Parp activity is impaired in Nampt-deficient SMCs and its inhibition in vivo 
promotes aortic SMC DNA damage and senescence  
Parp1 has roles in repairing multiple types of DNA damage (Dantzer et al. 2006). 
To determine if Parp1 activity was impacted by the disrupted NAD+ metabolism, I assessed 
PAR assembly by Western blot analysis following irradiation of rat aortic SMCs.  
Irradiation-induced PAR formation was markedly suppressed in SMCs incubated with the 
Nampt inhibitor, FK866 (100 nM, Fig. 2.14a).  The abundance of PARP1 itself did not 
change upon Nampt inhibition. I also immunostained mouse aortic SMCs for PAR.  
Abundant nuclear PAR signal emerged 15 minutes after control SMCs were exposed to 
H2O2.  However, there was barely detectable nuclear PAR in Nampt-ablated SMCs 
subjected to H2O2 (Fig. 2.14b,c).  In the presence of nicotinamide riboside, PAR assembly 
in irradiated Nampt-ablated SMCs was restored.  Nuclear PAR also accumulated upon 24 h 
of Ang II exposure.  As seen with H2O2, the Ang II-induced PAR response was not evident 
in Nampt-ablated SMCs, but was restored in the presence of nicotinamide riboside (Fig. 
2.14d).   
  
		 94	
	
Figure 2.12 Reduced Nampt and doubled-stranded DNA damage in mouse SMCs 
A.  Fluorescent micrographs depicting the response of mouse aortic SMCs to irradiation (10 Gy).   Cells were 
immunostained for γ-H2AX (green) and nuclei were labeled with Hoechst 33258 dye (blue).  B.  Graph 
showing the cumulative pixel intensity per cell of γ-H2AX signal.  C. γ-H2AX signal in control and Nampt-
ablated mouse aortic SMCs incubated with vehicle or 10-7M Ang II for 24 hours, and 24 hours after Ang II 
washout. 
 
No IR 15 min post IR 24 hrs post IR
Co
nt
ro
l
KO
A
0
100
200
300
400
500
No IR 15 min 24 h
B
P=0.020
P=0.049
P<0.0001
γ-H
2A
X 
sig
na
l in
te
ns
ity
 (a
.u
.)
Control
KO
0
50
100
150
Control
KO
Vehicle AngII Washout 
P=0.011
P=0.003
P=0.0004
γ-H
2A
X 
sig
na
l in
te
ns
ity
 (a
.u
.)
C
		 95	
	
 
 
Figure 2.13 Reduced Nampt and double-stranded DNA damage in mouse aortas 
A. Micrographs showing γ-H2AX-positive foci (green) in nuclei in the aortic media of mice subjected to a 7-
day infusion of Ang II.  Nuclei were counterstained with propidium iodide (red).  B. Graph depicting the 
proportion of γ-H2AX-positive cells in the aortic media of mice subjected to a 7-day infusion of Ang II, 
*P=0.044 vs. Control, ascending aorta; *P=0.022 vs. Control, thoracic aorta.   	
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Figure 2.14 Parp inactivation in Nampt-depleted SMCs 
A. Western blots depicting poly(ADP-ribose) (PAR) moieties, Parp1, and tubulin content in rat aortic smooth 
muscle cells incubated with FK866 (24 h) and subjected to irradiation (50 Gy).  B. Immunofluorescence 
images showing the presence of PAR moieties (green) in control and Nampt-KO SMCs subjected to 1 mM 
H2O2 for 15 minutes. Nuclei were counterstained with DAPI (red).  C. Graph depicting cumulative pixel 
intensity per cell of PAR signal, *P<0.0001 vs. KO. D. Nuclear PAR signal, assessed by immunofluoresence, 
in mouse aortic SMCs subjected to 10-7M Ang II  or 24 hours, with and without the addition of 100 µM 
nicotinamide riboside (NR) *P<0.0001 vs. KO. 
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In addition, in vivo inhibition of Parp by IP injections of olaparib produced SMC 
defects in control mice subjected to Ang II that were similar to those in Ang II-infused 
SMC-Nampt KO mice.  The proportion of p16-expressing medial SMCs increased by 2.7-
fold and 3.7-fold in the ascending and descending thoracic aorta, respectively (p=0.002, 
p=0.023) and the proportion of SMCs positive for 8-oxodG increased by 2.2-fold and 1.9-
fold (p=0.0003, p=0.003, Fig. 15a,b). As well, γ-H2AX-positive SMCs were identified in 
the media of Ang II-infused mice that received olaparib, and in a range similar to that of 
Ang II-infused SMC-Nampt KO mice (Fig. 2.15c).   
Collectively, these data indicate the presence of a NAD+-PARP1-DNA repair axis 
in aortic SMCs and the dependence of this cascade on Nampt.   
2.4 Discussion 
This study reveals that aortic integrity depends on an intrinsic NAD+ generating 
system within SMCs.  By evaluating the consequences of Nampt knockout in these new 
mouse models, I demonstrate that: i) ablation of Nampt in SMCs reduces NAD+ content in 
the aortic wall and renders it vulnerable to dissection; ii) Ang II sends Nampt-depleted 
SMCs in the aorta into a state of premature senescence; and iii) Nampt-deficient SMCs are 
prone to accumulating a range of DNA lesions and are susceptible to exhaustion of Parp 
activity. 
The finding that SMC-Nampt KO mice have reduced aortic medial NAD+ content is 
important given the multiple routes for synthesizing NAD+.  There are at least five dietary 
precursors to NAD+, four of which do not require Nampt.  As well, NAD+ itself may be 
directly delivered to cells from nearby cellular sources and an extracellular supply of 
Nampt has been characterized (eNampt) (Revollo et al. 2007, Nikiforov et al. 2015). 
However, the 43% drop in NAD+ in the aortic media revealed that none of these potential 
alternative pathways circumvented the local loss of Nampt in SMCs.  Given the resulting  
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Figure 2.15 Effect of Parp inhibition on aortic SMC senescence and susceptibility to oxidative DNA 
damage 
 A. Micrographs of ascending aorta sections 7 days after infusion with Ang II (1.44 mg/kg/day) as well as 
daily i.p. injections of the Parp inhibitor, olaparib (50 mg/kg).  Sections were immunostained for p16 
(arrows).   Graph depicting the prevalence of p16-positive nuclei in the ascending and descending thoracic 
aorta is shown on the right.  B. Sections of ascending aorta depicting oxidative DNA lesions, as indicated by 
8-oxo-2’-deoxyguanosine (8-oxodG) immunoreactivity.  Graph on the right depicts the abundance of 8-
oxodG-positive SMCs.  C. Micrographs showing γ-H2AX-positive foci (green) in nuclei in the aortic media 
of mice subjected to Ang II infusion and PARP inhibition with olaparib.  Nuclei were counterstained with 
DAPI (pseudocoloured red).  Lu, lumen; Adv, adentitia.  Data on the right depict the proportion of γ-H2AX-
positive cells in the ascending and descending thoracic aortic media. 
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aortic compromise, and our prior studies showing no evidence for secretion of Nampt by 
SMCs (van der Veer et al. 2005), the current data indicate that an autonomous, Nampt-
dependent NAD+ production cascade in SMCs serves as a vital metabolic hub for the aorta. 
The observed drop in aortic medial NAD+ was sufficient to lead to mild dilation, 
but more striking consequences became apparent with the stress of Ang II.  Rather than 
adapt to this stress, the Nampt-deficient aortic wall degenerated, with abrogated SMC 
hyperplasia, overt SMC dropout, and medial hematomas and dissections.  The latter had 
similar distributions to that of other models of aortic disruption (Rateri et al. 2014), 
suggesting that the reduced Nampt acted on a background of prevailing aortic 
susceptibilities.  The additional finding of widespread SMC senescence provides an 
intriguing mechanistic basis for the Nampt-driven maladaptive response to Ang II.  Ang II 
has been found to induce SMC senescence in vitro and in atherosclerotic arteries (Kunieda 
et al. 2006, Matthews et al. 2006) and the current data thus expand the in vivo contexts for 
SMC senescence.  Several attributes of senescent or otherwise aged SMCs could adversely 
impact aortic stability including the relative inability to replicate, perturbed contractility, 
and an altered secretory profile that favours a pro-degeneration phenotype (Liu et al. 2013, 
Yin and Pickering 2016).  
The inability to maintain genomic integrity is a hallmark of accelerated aging and a 
key stimulus for cellular senescence.  The range of DNA lesions that I identified places 
Nampt as an important guardian of genomic health.  The presence of oxidized guanine 
residues in SMCs reflects a persistent ROS burden that could promote senescence through 
several mechanisms, including lipid oxidation and interference with cellular metabolism 
(Yin and Pickering 2016). In addition, 8-oxodG DNA lesions themselves have been found 
to be pathological and their continuous clearance is required to prevent the cell from 
entering a senescent cascade (Rai et al. 2009). Single-strand DNA breaks, readily detected 
in aortic SMCs depleted of Nampt, is also linked to cellular senescence, either directly or 
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by predisposing to double-strand DNA breakage (Kuzminov 2001, Nassour et al. 2016). 
Double-strand DNA breakage in turn is a well established driver of cellular senescence 
(d'Adda di Fagagna 2008). Taken together, the findings establish that compromised NAD+ 
constitutes an intracellular milieu that is hazardous for DNA integrity. 
Although several upstream defects may contribute to the observed DNA lesions, 
these findings point to incapacitation of Parp1 as an important mechanism.  One of the 
best-understood roles of Parp1 is the sensing and repair of single-strand DNA breaks, 
effectively serving as the first line of defense to this common DNA assault (Dantzer et al. 
2006). More recent evidence has established that protein PARylation, mediated in part by 
Parp1, also functions in double-strand break repair (Wang et al. 2006, Beck et al. 2014). As 
well, Parp1 participates in clearance of oxidized nucleotides through binding to 8-
oxoguanine-DNA glycolase, an enzyme fundamental to removing 8-oxodG base lesions 
(Fisher et al. 2007, Noren Hooten et al. 2011, Beck et al. 2014). The possibility cannot be 
excluded that molecular perturbations arising from NAD+ depletion other than Parp 
incapacitation may have contributed to aortic wall degeneration.  In this regard, Sirt1 
activity in SMCs has been shown to depend on a Nampt-mediated supply of NAD+ (Ho et 
al. 2009) and Sirt1 has been found to protect against aortic disruption in response to Ang II 
(Fry et al. 2015, Chen et al. 2016) As well, substantially reduced NAD+ can lead to critical 
ATP depletion and energetic stress, which has been found to cause muscle degeneration in 
skeletal muscle-specific Nampt-knock out mice (Frederick et al. 2016). However, the 
threshold NAD+ level below which ATP production becomes compromised in the aorta 
remains to be elucidated.  
In summary, I demonstrate that Nampt within SMCs protects the aorta from 
degenerating.  My findings indicate that low Nampt, while not necessarily an inciting 
event, can substantially compromise the manner in which the aorta responds to stress.  I 
speculate that an “NAD+ fatigue” phenomenon may underlie progression in aortopathy  
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(Fig. 2.16). Nampt fuels a critical DNA repair system in the medial aortic layer and resists 
premature cellular senescence.  These findings raise the possibility that disturbed local 
NAD+ metabolism renders the aortic tissue susceptible to forces that lead to disruption. 
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Figure 2.16 Schematic depicting aortic wall consequences of reduced SMC Nampt 
In the setting of aortic wall insults and compromised NAD+ (right), SMC DNA damage accumulates and is 
inadequately repaired.  This can lead to accelerated SMC aging and destabilization of the aortic wall.  
Deleterious DNA events that can be exacerbated by low Nampt are outlined in red.  A proposed route to 
decreasing Nampt and a self-sustaining damage cycle are noted by the dashed lines.  SSB, single strand 
break; DSB, double strand break; PAR, poly(ADP ribose).	  
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 CHAPTER 3 - NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN 
SMOOTH MUSCLE CELLS IS SUPPRESSED IN HUMAN THORACIC 
AORTIC ANEURYSM DISEASE 
3.1 Introduction 
The aorta is a highly important conduit vessel that collects oxygenated blood from 
the heart and delivers it to the branching and peripheral vessels supplying every organ and 
tissue in the body. Failure of this vessel is often catastrophic. As outlined in previous 
chapters, the aorta is structurally designed to withstand stress; however, it can nevertheless 
degenerate over time when subjected to hypertension, atherosclerosis, or the effect of 
genetic mutations (Schlatmann and Becker 1977, Howard et al. 2013) 
Thoracic aortic diseases (TAD) encompass dilation as well as aneurysms and 
dissections of the ascending or descending thoracic aorta (Ramanath et al. 2009). 
Population-based studies estimate an annual incidence of 6-16 cases per 100,000, and 
aortic dissection is the most devastating complication of TAD (Kuzmik et al. 2012, 
Andelfinger et al. 2016). Clinical studies have suggested that a familial predisposition 
exists for TADs: up to 20% of individuals who do not have features of Marfan syndrome, 
vascular Ehlers Danlos syndrome, or Loeys-Dietz syndrome have a familial history of 
TAD (Milewicz and Regalado 1993, Biddinger et al. 1997). In these individuals there is at 
least one genetic cause. To date, there are a number of causative genes identified, including 
those associated with extracellular matrix regulation, cytoskeleton, and the TGF-β 
signalling pathway (Coady et al. 1999, Zhang et al. 2013, Zhang and Wang 2016). 
It has recently become evident that Nampt is a determinant of SMC health and 
longevity. Nicotinamide phosphoribosyltransferase (Nampt) is the rate-limiting enzyme for 
the NAD+ salvage pathway, converting nicotinamide to nicotinamide mononucleotide (van 
der Veer et al. 2005). As outlined in previous chapters, nicotinamide adenine dinucleotide 
(NAD+) is an essential dinucleotide that serves as a cofactor for the oxidation-reduction 
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events of cellular nutrient metabolism.  NAD+ can also serve as a signaling nucleotide that 
regulates gene expression, genome integrity, and mitochondrial function. I have previously 
shown that Nampt is crucial to the aortic resistance of hemodynamic stress in a mouse 
model of SMC Nampt depletion (Watson et al. 2017). In this model, SMC Nampt depletion 
led to an absence of Parp1 activity (the activity of which depends on the requisite 
bioavailability of NAD+) and an accumulation of DNA damage. This accumulation was 
associated with an increase in aortic dissection events. 
I have studied the expression of NAMPT in the aortic media of patients with life-
threatening thoracic aortic dilation disease. The findings reveal that the expression of 
NAMPT is in the aortic media of human aotopathy patients is negatively correlated with 
aortic diameter. Additionally, low levels of NAMPT expression in dilated human 
aortopathy samples are associated with the presence of double-strand DNA breaks in aortic 
smooth muscle cells. The findings also shed new light on the epigenetic mechanisms that 
may underlie vulnerability in NAD+ homeostasis in human thoracic aortopathy.     
3.2 Methods 
3.2.1 Human aorta material 
 Human ascending aortic tissue was obtained from patients undergoing ascending 
aortic replacement, coronary bypass surgery, or cardiac transplantation, as approved by the 
institutional review board of Western University Research Ethics Committee.  Maximum 
aortic diameter was determined from contrast-enhanced CT scan or echocardiogram 
obtained prior to surgery.  NAMPT levels were assessed by histology of the aortopathy 
material, performed on the maximally dilated region of the ascending aorta.  NAMPT 
transcript abundance was assessed in human aortic medial tissue from which the adventitial 
and intimal layers were dissected away. RNA was isolated using TRIzol (Life 
Technologies) and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen, 
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Valencia, CA). Human aortic SMCs were isolated by explant outgrowth as previously 
described (Vafaie et al. 2014). 
3.2.2 Immunohistochemistry of human aortic tissue 
NAMPT immunostaining was performed on paraformaldehyde-fixed, paraffin-
embedded sections as above.  NAMPT staining was quantified in 5 equally spaced fields of 
view (x40 objective) across the specimen, avoiding regions of inflammatory cell infiltration 
and vascularization to restrict analyses to medial SMCs.  Signal was quantified using 
ImageJ software (NIH) with a DAB Deconvolution Plugin that separates the hematoxylin 
from the DAB signal.  Background signal was ascertained in each tissue by capitalizing on 
the normal presence of interlamellar regions that do not contain SMCs.  An area of at least 
300 µm2 was utilized for this.  The SMC NAMPT signal was determined as the cumulative 
signal intensity and expressed relative to the number of nuclei in the field of view. 
Sections were also double-stained for NAMPT and γ-H2AX (ab26350, 1:100; 
Abcam, Cambridge, MA).  Bound primary antibodies were visualized with Alexa Fluor 
488-conjugated donkey anti-rabbit secondary antibody and Alex Fluor 546-conjugated 
anti-mouse secondary antibody, respectively (Molecular Probes). Nuclei were 
counterstained with DAPI. NAMPT and γ-H2AX signal intensities were determined a cell-
by-cell basis (total of 524 cells) using ImageJ. 
3.2.3 Quantitative real-time reverse transcription–polymerase chain reaction  
Total RNA was isolated from homogenates of aortic media using TRIzol (Life 
Technologies) and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen, 
Valencia, CA).  Total RNA was isolated from human SMCs using the RNeasy Mini Kit 
following the manufacturer’s protocol. Transcript abundance of NAMPT and 18S were 
assessed using SYBR-green chemistry-based primer sets (human NAMPT F-
AGGGTTACAAGTTGCTGCCACC R-CTCCACCAGAACCGAAGGCAAT; human 18S 
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F-ACCCGTTGAACCCCATTCGTGA R-GCCTCACTAAACCATCCAATCGG). 
Quantitative real-time RT-PCR was performed using an ABI Prism (model 7900HT) and 
Sequence Detection System software (Life Technologies; Applied Biosystems). For human 
aortic medial tissue and human primary SMCs, mRNA abundance was quantified based on 
the standard curve method, with 18S mRNA as an internal reference control, and expressed 
as relative units (r.u.) 
3.2.4 Analysis of DNA methylation  
Human aortic media was isolated by laser capture microdissection of 10 µm-thick 
frozen sections.  Genomic DNA was harvested from this tissue and from cultured human 
SMCs using the DNeasy Blood and Tissue Kit (Qiagen).  DNA was subjected to selective 
digestion-based PCR to quantify methylation status using the Epitect Methyl DNA 
Restriction Kit (Qiagen) and the pre-designed Epitect qPCR Methyl Promoter Primer set 
(335002 EPHS113392-1A).  The amount of input DNA that was methylated was 
determined using the manufacturer-supplied algorithm.  
3.2.5 Statistical analyses 
Values are expressed as mean±standard error of the mean. Statistical analyses were 
performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean data 
were compared using Student’s t-test or one- or two-way ANOVA with Holm-Sidak post 
hoc testing. The relationship between NAMPT content and human aortic dilatation was 
determined using linear regression analysis (SPSS, IBM Corp. Armonk, NY).  To assess 
the single-cell relationship between NAMPT and g-H2AX signal, within-patient cellular 
NAMPT content was segregated into tertiles. 
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3.3 Results 
3.3.1 Medial SMCs in dilated human thoracic aortas have reduced NAMPT  
To determine if NAMPT is expressed in SMCs of the human aorta, I evaluated 
ascending aortas surgically harvested from patients with dilated ascending aortopathy 
(n=20, mean age 58.4±16.4) and compared the findings with those of non-dilated 
ascending aorta harvested from individuals undergoing heart transplantation or coronary 
artery bypass surgery (n=16, mean age 68.7±14.1).  The mean aortic diameter of diseased 
ascending aortas measured at the maximally dilated point was 54.3±9.5 mm. The mean 
aortic diameter of control ascending aortas was 31.1±2.8 mm (P<0.0001). Individual 
patient demographic data, aortic diameter, and aortic valve configuration and function are 
presented in Table 3.1.   
Immunostaining revealed widespread NAMPT expression in medial SMCs of the 
normal calibre aortas, with signal in both cytoplasm and nucleus (Fig. 3.1a).  Medial cell 
NAMPT expression was also evident in dilated aortas.  However, the NAMPT signal was 
more heterogeneous, and largely absent from the nucleus (Fig.3.1 b-c) DAB intensity 
analysis revealed that the NAMPT staining signal was 34% lower in dilated aortas (Fig. 
3.2a).  Reduced NAMPT expression in the media of dilated aortas was also observed at the 
transcript level (Fig. 3.2b).   Interestingly, there was an inverse relationship between aortic 
medial NAMPT content and the maximal diameter of the ascending aorta (R2=0.44, 
P<0.0001).  This inverse relationship existed for both the entire patient cohort as well as 
only those patients with ascending aortopathy (R2=0.31, P=0.009, Fig. 3.2c), and persisted 
after adjusting for patient age (P=0.016). These findings implicate a NAMPT-based NAD+ 
biosynthesis pathway within SMCs of the human aorta.  Moreover, they suggest that this 
local biosynthetic machinery is related to aortic medial integrity. 
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Table 3-1 Demographic and clinical characteristics of study subjects 
Age Sex Aortic valve  configuration 
Aortic Valve  
Dysfunction 
Maximum 
diameter of 
ascending 
aorta (mm) 
64 Female Bicuspid Severe AR 54 
82 Male Tricuspid Moderate AR 57 
37 Male Bicuspid None 57 
44 Male Bicuspid Severe AR 68 
73 Male Bicuspid Moderate AR/AS 55 
55 Male Tricuspid Severe AR* 77 
59 Male Bicuspid Severe AS 42 
40 Male Bicuspid Severe AR/AS 57 
64 Male Bicuspid Severe AS 43 
80 Female Tricuspid Moderate AR 56 
79 Male Bicuspid None 56 
75 Female Tricuspid None 63 
52 Male Bicuspid Moderate AR 61 
56 Male Bicuspid None 53 
32 Male Bicuspid Severe AR 40 
62 Male Tricuspid Moderate AR 60 
61 Male Bicuspid Severe AS 43 
49 Female Bicuspid Severe AS 41 
30 Female Tricuspid Mild AR* 50 
75 Male Bicuspid Moderate AR 54 
83 Male Tricuspid None (CAD) 35 
53 Male Tricuspid None (CAD) 30 
85 Female Tricuspid None (CAD) 33 
ND ND ND None (Transplant donor) ND 
70 Female Tricuspid None (Transplant recipient) 24 
39 Female Tricuspid None (Transplant recipient) 29 
70 Male Tricuspid None (CAD) 34 
78 Male Tricuspid None (CAD) 32 
79 Female Tricuspid Moderate AS 28 
86 Female Tricuspid None (CAD) 33 
78 Male Tricuspid None (Mitral valve insufficiency) 
)insufficiency) 
31 
50 Male Tricuspid None (CAD) 31 
68 Female Tricuspid None (CAD) 29 
72 Male Tricuspid None (CAD) 32 
66 Male Tricuspid None (CAD) 34 
54 Male Tricuspid None (CAD) 32 
*Marfan syndrome; AR-Aortic Regurgitation; AS-Aortic Stenosis; CAD-coronary artery 
disease
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Figure 3.1 NAMPT is present in the nucleus and cytoplasm of SMCs in the media of human aortic 
media 
Photomicrographs of paraformaldehyde-fixed non-dilated (A) and dilated (B, C) human aorta sections 
immunostained for NAMPT and counterstained with hematoxylin.  Arrow in zoomed image of A depicts 
nuclear signal and arrowhead depicts cytoplasmic signal.  Arrows in zoomed image of B indicate NAMPT-
negative cells.  Arrow in zoomed image of C indicates absent nuclear signal and arrowhead depicts weak 
cytoplasmic signal.	
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Figure 3.2 Human ascending aortic dilation is associated with reduced NAMPT 
A. Graph depicting NAMPT content – immunostaining signal per cell - in aortas from patients with control, 
non-dilated aortas (n=16) and dilated aortas (n=20). *P<0.0001  B. Graph depicting NAMPT mRNA 
abundance in control (n=6) and dilated (n=6) aortas.  P=0.038 NAMPT mRNA abundance was normalized to 
18S mRNA abundance C. Inverse relationship between NAMPT content in dilated aortas and aortic diameter; 
n=20. 
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3.3.2 The media of dilated human thoracic aortas is populated by SMCs with DNA 
strand breaks and low NAMPT  
Given my previous work demonstrating compromised genomic integrity in the 
mouse models (Watson et al. 2017), I asked if DNA integrity was compromised in SMCs 
within the human ascending aorta.  This was of interest because although double-strand 
DNA breaks have been found in atherosclerotic lesions (Gray et al. 2015), the media of the 
non-atherosclerotic aorta is considered a more quiescent vascular setting.  Remarkably, γ-
H2AX-immunostaining revealed that 25% of normal caliber aortas contained unrepaired 
DNA strand breaks in the medial layer cells.  On average, 2.4% of medial cells displayed 
DNA damage foci (range 0-10.1%).  Even more striking was that 90% of aortopathy 
samples had evidence of unrepaired DNA strand breaks, with an average of 28.7% SMCs 
with DNA damage foci (range 7.3-60.0% of cells, Fig. 3.3a).  To more precisely define the 
relationship between NAMPT expression and unrepaired DNA damage, I double-
immunolabeled aortas for NAMPT and γ-H2AX (Fig. 3.3b).  NAMPT content was then 
quantified in a total of 524 individual SMCs, which were separated into tertiles based on 
NAMPT expression.  SMCs in the lowest tertile had more than 5-fold greater DNA damage 
signal than those in the mid and highest NAMPT tertiles (Fig. 3.3c).   
3.3.3 Hypermethylation of the NAMPT promoter in dilated human thoracic aortas 
Given the linkages between low NAMPT and DNA damage, I assessed what might 
underlie the low NAMPT in human thoracic aortopathy.  Epigenetic control of genes 
relevant to aortopathy has recently been described (Gomez et al. 2013). To determine if this 
might be the case for NAMPT, I first assessed if the expression profile of NAMPT in human 
aortic SMCs was preserved between in vivo and culture environments.   This revealed that 
NAMPT transcript abundance in early passage SMCs correlated with NAMPT abundance 
in the corresponding aortic media (R2=0.72, P=0.004, Fig. 3.4a).  Furthermore, NAMPT 
transcript abundance in SMCs derived from both normal and dilated aortas was stable over  
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Figure 3.3 Correlation of double-strand DNA damage with reduced NAMPT in human aortic SMCs 
A. Prevalence of medial SMCs in aortas with γ-H2AX signal (Right, *P=0.047) and intensity of γ-H2AX 
signal (Left, *P=0.021).  B. Confocal photomicrographs illustrating reciprocal relationship between NAMPT 
(green) and γ-H2AX-positivity (red) in human ascending aorta.   Nuclei were counterstained with DAPI.  C. 
Cellular DNA damage signal, stratified by cellular NAMPT content in 524 independent cells. *P=0.034 vs. 
upper NAMPT tertile, †P=0.013 vs. mid NAMPT tertile.	
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Figure 3.4  Cultured SMCs from patients with dilated ascending aortopathy express NAMPT 
A.  Relationship between NAMPT transcript abundance in human SMCs cultured from the ascending aorta 
and NAMPT content in situ in the corresponding aortic media, as assessed by immunostaining.   B.  NAMPT 
transcript abundance in early passage human SMCs derived from control and dilated patients measured over 
early serial cell subcultures, showing stability. 	
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3 serial subcultures and differences between patient SMCs were maintained (Fig. 3.4b).  To 
determine if there was potential for epigenetic control by DNA methylation, I performed a 
bioinformatic assessment (http://genome.ucsc.edu/) of the NAMPT gene locus. 
Bioinformatic tools provided by the UCSC genome browser predicted a ~1000-base CpG 
island surrounding the NAMPT transcriptional start site (Fig. 3.5).  CpG islands are regions 
with a high frequency of CpG sites. Methylation of cytosine residues in the region of the 
transcriptional start site (in the context of CpG dinucleotides) could serve as an epigenetic 
repression of gene transcription (Jones 2012). Methylation analysis using selective 
digestion-based PCR revealed little to no methylation of NAMPT promoter DNA from non-
dilated human aortas.  However, 13.0±4.1% of input DNA from dilated aortas was 
methylated (P=0.044, Fig. 3.6a).  Furthermore, in SMCs cultured from the ascending aorta, 
the level of promoter methylation inversely correlated with NAMPT mRNA abundance in 
the corresponding SMCs (R2=0.028, P=0.024). This also revealed that the NAMPT 
promoter in SMCs from patients with dilated aortas was hypermethylated relative to that of 
SMCs cultured from control aortas (P=0.004, Fig. 3.6b,c). 
3.4 Discussion 
 By evaluating human aortopathy material, I demonstrate that: i) NAMPT is reduced 
in the aortic media of patients with aneurysmal thoracic aortic disease, ii) SMCs with low 
NAMPT and unrepaired DNA damage constitute a previously unrecognized SMC 
phenotype in human aortopathy, and iii) low NAMPT levels in human aortopathy are 
associated with hypermethylation of the NAMPT promoter.   
The possibility that the functional linkage between low SMC Nampt and aortic 
degeneration in mice translates to human aortopathy was supported by several findings.  
SMC NAMPT content was lower in dilated human aortas that in non-dilated aortas.  
Moreover, there was an inverse relationship between the aortic diameter and medial SMC  
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Figure 3.5 The promoter region of NAMPT is associated with a potential CpG locus 
Scale diagrammatic representation of the NAMPT gene locus including the genome base position (Top row), 
the percentage of G (guanine) and C (cytosine) bases in 5-base windows (Second row; low to high GC 
content is expressed by light to very dark colour), the transcription start site of NAMPT (TSS, third row), 
NAMPT exon position (Fourth row), and the putative location of a CpG island (Fifth row).  	
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Figure 3.6 Hypermethylation of the NAMPT promoter in the aortic media and cultured SMCs of 
patients with dilated ascending aortopathy 
A. Methylation of the NAMPT promoter in the media of control, non-dilated (n=3) and dilated (n=6) aortas, 
*P=0.044 vs. control.  B.  Relationship between methylation of the NAMPT promoter in primary early 
passage (1-4) human SMCs and NAMPT transcript abundance in the respective SMCs.  C. Methylation of the 
NAMPT promoter in early passage human SMCs derived from the ascending aorta of patients with non-
dilated (n=8) and dilated (n=10) aortas, *P=0.004 vs. control.  
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NAMPT content.  This fits an emerging pattern of reduced Nampt in aged or compromised 
tissues (Yoshino et al. 2011, Stein and Imai 2014), and the current study may be the first to 
identify such a relationship in human diseased tissue. It is noted that aortic medial 
dissection, prominent in the previous mouse model work, was not represented in the patient 
series.  Nonetheless, ascending aortic diameter is a strong predictor of dissection risk in 
patients (Hiratzka et al. 2010). Also remarkable was the discovery of unrepaired DNA 
breaks in aortic medial SMCs in situ and the relatively high prevalence of this genome 
pathology in the aorta of individuals with aortopathy.  Although the data do not prove 
causation, the single-cell relationship between low NAMPT and unresolved DNA strand 
breaks strengthens the potential for a mechanistic relationship.  Moreover, the combination 
of unresolved DNA breaks and low Nampt can be considered to denote a SMC phenotype 
of substantially declined cellular vitality.   
The findings indicate that low Nampt, while not necessarily an inciting event, can 
substantially compromise the manner in which the aorta responds to stress independent of 
the primary cause of the aortopathy.  Low aortic NAMPT was observed not only the dilated 
aortas of patients with a bicuspid aortic valve but also those with a tricuspid aortic valve 
and Marfan syndrome.  A larger series would be required to determine if there are aortic 
disease-specific differences in NAD+ control and also if NAD+ homeostasis in SMCs is 
relevant to atherosclerotic abdominal aortic aneurysms.  The chronic nature of aortic 
dilation disease is such that a suboptimal NAD+ regenerating system could both potentiate 
and sustain aortic wall degeneration. 
In summary, I demonstrate that low Nampt within medial SMCs is associated with a 
degenerative aortic phenotype; findings that raise the possibility that disturbed local NAD+ 
metabolism underlies the progression of degenerative aortic disease. 
				 124	
3.5  References 	
Andelfinger, G., Loeys, B., & Dietz, H. (2016). A Decade of Discovery in the Genetic 
Understanding of Thoracic Aortic Disease. Can J Cardiol, 32(1), 13-25 
Biddinger, A., Rocklin, M., Coselli, J., & Milewicz, D. M. (1997). Familial thoracic aortic 
dilatations and dissections: a case control study. J Vasc Surg, 25(3), 506-511 
Coady, M. A., Davies, R. R., Roberts, M., Goldstein, L. J., Rogalski, M. J., Rizzo, J. A., 
Hammond, G. L., Kopf, G. S., & Elefteriades, J. A. (1999). Familial patterns of 
thoracic aortic aneurysms. Arch Surg, 134(4), 361-367 
Gomez, D., Kessler, K., Michel, J. B., & Vranckx, R. (2013). Modifications of chromatin 
dynamics control Smad2 pathway activation in aneurysmal smooth muscle cells. 
Circ Res, 113(7), 881-890 
Gray, K., Kumar, S., Figg, N., Harrison, J., Baker, L., Mercer, J., Littlewood, T., & 
Bennett, M. (2015). Effects of DNA damage in smooth muscle cells in 
atherosclerosis. Circ Res, 116(5), 816-826 
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Jr., 
Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., Kouchoukos, 
N. T., Lytle, B. W., Milewicz, D. M., Reich, D. L., Sen, S., Shinn, J. A., Svensson, 
L. G., Williams, D. M., (2010). 2010 Guidelines for the diagnosis and management 
of patients with Thoracic Aortic Disease: a report of the American College of 
Cardiology Foundation/American Heart Association Task Force on Practice 
Guidelines, American Association for Thoracic Surgery, American College of 
Radiology, American Stroke Association, Society of Cardiovascular 
Anesthesiologists, Society for Cardiovascular Angiography and Interventions, 
Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for 
Vascular Medicine. Circulation, 121(13), e266-369 
Howard, D. P., Banerjee, A., Fairhead, J. F., Perkins, J., Silver, L. E., Rothwell, P. M., & 
Oxford Vascular, S. (2013). Population-based study of incidence and outcome of 
acute aortic dissection and premorbid risk factor control: 10-year results from the 
Oxford Vascular Study. Circulation, 127(20), 2031-2037 
				 125	
Jones, P. A. (2012). Functions of DNA methylation: islands, start sites, gene bodies and 
beyond. Nat Rev Genet, 13(7), 484-492 
Kuzmik, G. A., Sang, A. X., & Elefteriades, J. A. (2012). Natural history of thoracic aortic 
aneurysms. J Vasc Surg, 56(2), 565-571 
Milewicz, D. M., & Regalado, E. (1993). Heritable Thoracic Aortic Disease Overview. In 
R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya, L. J. H. 
Bean, T. D. Bird, N. Ledbetter, H. C. Mefford, R. J. H. Smith, & K. Stephens 
(Eds.), GeneReviews(R). Seattle (WA). 
Ramanath, V. S., Oh, J. K., Sundt, T. M., 3rd, & Eagle, K. A. (2009). Acute aortic 
syndromes and thoracic aortic aneurysm. Mayo Clin Proc, 84(5), 465-481 
Schlatmann, T. J., & Becker, A. E. (1977). Histologic changes in the normal aging aorta: 
implications for dissecting aortic aneurysm. Am J Cardiol, 39(1), 13-20 
Stein, L. R., & Imai, S. (2014). Specific ablation of Nampt in adult neural stem cells 
recapitulates their functional defects during aging. EMBO J, 33(12), 1321-1340 
Vafaie, F., Yin, H., O'Neil, C., Nong, Z., Watson, A., Arpino, J. M., Chu, M. W., Wayne 
Holdsworth, D., Gros, R., & Pickering, J. G. (2014). Collagenase-resistant collagen 
promotes mouse aging and vascular cell senescence. Aging Cell, 13(1), 121-130 
van der Veer, E., Nong, Z., O'Neil, C., Urquhart, B., Freeman, D., & Pickering, J. G. 
(2005). Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein 
deacetylase activity and promotes vascular smooth muscle cell maturation. Circ 
Res, 97(1), 25-34 
Watson, A., Nong, Z., Yin, H., O'Neil, C., Fox, S., Balint, B., Guo, L., Leo, O., Chu, M. W. 
A., Gros, R., & Pickering, J. G. (2017). Nicotinamide Phosphoribosyltransferase in 
Smooth Muscle Cells Maintains Genome Integrity, Resists Aortic Medial 
Degeneration, and Is Suppressed in Human Thoracic Aortic Aneurysm Disease. 
Circ Res, 120(12), 1889-1902 
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S. (2011). Nicotinamide mononucleotide, a 
key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced 
diabetes in mice. Cell Metab, 14(4), 528-536 
Zhang, L., & Wang, H. H. (2016). The genetics and pathogenesis of thoracic aortic 
aneurysm disorder and dissections. Clin Genet, 89(6), 639-646 
				 126	
Zhang, P., Zhang, E., Fan, J., & Gu, J. (2013). Non-syndromic thoracic aortic aneurysms 
and dissections--a genetic review. Front Biosci (Landmark Ed), 18, 305-311 
 
  
				 127	
 CHAPTER 4 - NAMPT IN SMOOTH MUSCLE CELLS REGULATES 
EXTRACELLULAR MATRIX GENE EXPRESSION HOMEOSTASIS 
4.1 Introduction 
Vascular smooth muscle cells (SMCs) perform a number of functions that are 
relevant to withstanding hemodynamic stress, including contraction and the synthesis and 
assembly of extracellular matrix (ECM) components (Li et al. 2003, Humphrey et al. 
2014). The aorta is an elastic artery of which the main structural components, outside of 
smooth muscle cells, are elastin, collagen fibres, and a proteoglycan-rich ground substance. 
In most instances of thoracic aortic disease, regardless of etiology, there is a disruption in 
the extracellular matrix (Ishii and Asuwa 2000, Koullias et al. 2004, Borges et al. 2009). 
The underlying molecular mechanisms that control how SMCs in the aorta tightly regulate 
ECM production during environmental stress remains poorly understood. 
My work in previous chapters has shown that the regeneration of nicotinamide 
adenine dinucleotide (NAD+) by Nampt in SMCs is essential to maintaining an aorta that is 
resistant to hemodynamic stress. Nampt is expressed in cultured SMCs and its content and 
activity decline during advanced SMC aging (van der Veer et al. 2005, van der Veer et al. 
2007). As well, Nampt has been found to regulate in vitro SMC longevity and migratory 
behavior (van der Veer et al. 2007, Yin et al. 2012). I have shown that NAMPT content is 
decreased in aortic samples from aortopathy patients and that this decrease is correlated 
with an increase in DNA lesions and SMC senescence (Watson et al. 2017). However, it is 
unclear if there is a direct link between a decrease in Nampt in the aorta and the integrity of 
the ECM. 
To elucidate relationships between expression of Nampt in SMCs and gene 
expression profiles, I have undertaken genome-wide assessment of mouse aortic SMCs. I 
report that when Nampt is ablated in SMCs, there is a striking change in overall gene 
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transcription. Importantly, this includes the expression of transcripts associated with 
collagen and proteoglycan expression and assembly. I further report that there is a decrease 
in fibrillar collagen in SMC-Nampt KO mouse aortas and an increase in proteoglycan 
accumulation. Bioinformatic analysis suggested that these changes are potentially mediated 
by an upstream shift in the transcription regulator Smad7.  
4.2 Methods 
4.2.1 Generation of Nampt-deficient smooth muscle cells in vitro 
 Mouse experiments followed protocols approved by the Western University Animal 
Use Committee.  All mice were on a C57Bl/6 background. We generated mice in which 
Nampt could be globally and inducibly deleted.  Namptflox/flox mice (Rongvaux et al. 2008) 
were bred with mice expressing Cre recombinase fused to the mutated ligand binding 
domain of the human estrogen receptor (ER) under the control of a chimeric 
cytomegalovirus immediate-early enhancer/chicken ß-actin promoter (B6.Cg-Tg(CAG-
Cre/Esr1)5Amc/J) (Jackson Laboratories, Bar Harbor, ME) (Hayashi and McMahon 2002). 
Aortas were harvested from 8-10-week-old mice anesthetized mice in one piece, and 
placed in sterile PBS. The adventitial layer was removed, and the endothelial layer scraped 
away. Aortas were minced into 3-4 mm pieces and mouse aortic SMCs were isolated via 
digestion using type III porcine pancreatic elastase (250 µg/ml, Sigma) and type I 
collagenase (1 µg/ml, Worthington Biochemical Corporation, Lakewood, NJ) (Ray et al. 
2001).  Aortic tissue was digested at 37°C with agitation for 1-4 hours. SMCs were 
maintained in DMEM-F12 with addition of a SMC-specific bullet kit: smGM-2 BulletKit 
(Lonza, Allendale, NJ). SMC identity was confirmed by immunostaining for smooth 
muscle α-actin. SMCs harvested from aortas of Namptflox/flox Cre-ERT2+ mice were 
subjected to 1 µM hydroxy-tamoxifen for 24 hours. In order to control for the effect of 
tamoxifen, Namptflox/flox Cre-ERT2- (control) SMCs were also subjected to 1 µM hydroxy-
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tamoxifen for 24 hours. SMCs underwent a maximum of five subcultures, and experiments 
were performed with cells from the third or fourth subculture.  
4.2.2 Generation of SMC-Nampt deficient mice 
We generated mice with a SMC-specific knockout of Nampt as previously 
described (Watson et al. 2017). Briefly, an initial cross was undertaken between female 
mice harbouring loxP sites flanking exons 5 and 6 of Nampt (Namptflox/flox) (Rongvaux et 
al. 2008) and male transgenic mice expressing Cre recombinase and eGFP under the 
control of the SMC-specific myosin heavy chain promoter (smMHC-Cre/eGFP, Jackson 
Laboratories, Bar Harbor, ME) (Xin et al. 2002). In a second round of breeding, the male 
SMC-targeted Nampt heterozygotes (Namptflox/+; smMHC-Cre+) were bred with female 
Namptflox/flox mice to generate Namptflox/+; smMHC-Cre- (control) and Namptflox/flox; 
smMHC-Cre+ (SMC-Nampt KO) mice.  
4.2.3 RNA isolation, quality assessment, probe preparation and GeneChip 
hybridization 
Total RNA was prepared from three independent cell cultures of control mouse 
aortic smooth muscle cells, and three independent cell cultures of mouse aortic smooth 
muscle cells wherein Nampt had been knocked out (Nampt-KO SMCs). All six 
independent cells cultures were harvested at passage three. Cell monolayers were harvested 
using trypsin and lysed with QIAshredder columns (Qiagen). Total RNA was isolated 
using an RNeasy Mini Kit (Qiagen), and eluted with nuclease-free water.  
All subsequent sample handling, labeling, and GeneChip (Human Gene 1.0 ST 
arrays) processing was performed at the London Regional Genomics Center (Robarts 
Research Institute, London, Ontario, Canada; http://www.lrgc.ca). RNA quality was 
assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA) 
and the RNA 6000 Nano kit (Caliper Life Sciences, Mountain View, CA). Single stranded 
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complimentary DNA was prepared from 100 ng of total RNA as per the Affymetrix 
GeneChip WT PLUS Reagent Kit (Affymetrix, Santa Clara, CA). Total RNA was first 
converted to cDNA, followed by in vitro transcription to make cRNA. 5.5 µg of single 
stranded cDNA was synthesized, end labeled and hybridized, for 16 h at 45 °C, to Mouse 
Gene 2.0 ST arrays (Affymetrix). All liquid handling steps were performed by a GeneChip 
Fluidics Station 450 and GeneChips were scanned with the GeneChip Scanner 3000 7G 
(Affymetrix) using Command Console v3.2.4. 
4.2.4 Statistical analyses of changes in global gene expression 
All microarray data complies with MIAME guidelines. Probe level (.CEL file) data 
was generated using Affymetrix Command Console v3.2.4. Probes were summarized to 
gene level data in Partek Genomics Suite v6.6 (Partek) using the robust multi-array average 
(RMA) algorithm (Irizarry et al. 2003). Partek was used to determine gene level 
ANOVA P-values and fold changes. A filtered gene list was generated for expression 
changes of least 1.5 fold and having a P-value of less than 0.05.  A Fisher’s exact test was 
used to create P-values for GO and KEGG Pathway enrichment. Gene ontology (GO) and 
KEGG pathway analysis was performed using the online resource DAVID (available at 
https://david.ncifcrf.gov) (Huang da et al. 2009, Huang da et al. 2009). Upstream 
Regulators were generated through the use of QIAGEN’s Ingenuity Pathway Analysis 
(IPA®) and the Biological Processes and QIAGEN’s Ingenuity® iReport (QIAGEN 
Redwood City, www.qiagen.com/ingenuity).  
4.2.5 NAD+ measurement 
Mouse aortic SMC NAD+ levels were determined in freshly harvested cells.  NAD+ 
content in the mouse aortic media was determined using a colorimetric kit (BioVision 
Research Products, Mountain View, CA, USA) and expressed relative to total protein 
content.  
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4.2.6 Real time quantitative PCR 
Changes in the expression of selected genes were independently assessed by real 
time quantitative PCR (qRT-PCR). cDNA was synthesized from RNA samples from 
control and Nampt-KO SMCs (isolated as noted above), in addition to total RNA  isolated 
from homogenates of de-endothelialized mouse aortas using TRIzol (Life Technologies) 
and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen, Valencia, CA), 
using a High Capacity RNA-to-cDNA kit (Applied Biosystems). Transcript abundance of 
mouse Nampt, Mmp2, Mmp9, Mmp13, Col1a1, Fibronectin, Tenascin C, Decorin, Perlecan, 
Biglycan, Versican, N-cadherin, and 18S, were assessed using SYBR-green chemistry-
based primer sets (Nampt: F-GGCACCACTAATCATCAGACCTG R-
AAGGTGGCAGCAACTTGTAGCC; Mmp2: F-GAGACCATGCAGTCAGCTCTAG R-
TAGAGCTGCCTCTTGTCTGGT; Mmp9: F-GCTGACTACGATAAGGACGGCA R-
TAGTGGTGCAGGCAGAGTAGGA; Mmp13: F- GATGACCTGTCTGAGGAAGACC 
R-GCATTTCTCGGAGCCTGTCAAC; Col1a1: F-CCTCAGGGTATTGCTGGACAAC 
R-CAGAAGGACCTTGTTTGCCAGG; Fn1: F-CCCTATCTCTGATACCGTTGTCC R-
TGCCGCAACTACTGTGATTCGG; Tnc: F-GAGACCTGACACGGAGTATGAG R-
CTCCAAGGTGATGCTGTTGTCTG; Dcn: F-ACTCTCCAGGAACTTCGTGTCC R-
AGTCCCTGGAAGGCTCCGTTTT; Hspg2: F-CATTCAGGTGGTCGTCCTCTCA R-
AGGTCAAGCGTCTGTCCTTCAG; Bgn: F-TGAACCAGGAGCCTTTGATGGC R-
GTCCTCCAACTCAATAGCCTGG; Vcan: F-GGACCAAGTTCCACCCTGACAT R-
CTTCACTGCAAGGTTCCTCTTCT; Cdh2: F-CCTCCAGAGTTTACTGCCATGAC R-
CCACCACTGATTCTGTATGCCG; 18S: F-GTAACCCGTTGAACCCCATT R-
CCATCCAATCGGTAGTAGCG). Quantitative real-time RT-PCR was performed using 
an ABI Prism (model 7900HT) and Sequence Detection System software (Life 
Technologies; Applied Biosystems).  Relative mRNA abundance was quantified based on 
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critical threshold (CT) using the comparative CT formula, 2-ΔΔCT, with 18S mRNA as an 
internal control. 
4.2.7 Assessment of collagen fibrils by circular polarization microscopy 
 Paraformaldehyde-fixed aortic sections were stained with Picrosirius red using a 
commercially available kit from Polysciences, Inc (Warrington, PA). Briefly, 
deparaffinized sections were incubated with 0.1% Sirius red F3BA in saturated picric acid 
for 30 minutes and rinsing twice with 0.01 mol/L HCl. Collagen organization was assessed 
using circular polarization microscopy. Picrosirius red–stained sections of aorta were 
visualized as described (Nong et al,  2011).  Briefly, measurements were obtained using an 
Olympus BX51 microscope (Olympus Canada, Inc., Richmond Hill, ON, Canada) with 
polarizer-interference filters, a liquid crystal compensator, a charge-coupled device video 
camera, and Abrio software (Abrio LC-PolScope; Cambridge Research and 
Instrumentation, Inc., Hopkinton, MA). This system enabled measurement of light 
retardation by collagen, in absolute terms (nanometers), in defined fields of view. Mean 
collagen birefringence was assessed in the medial layers of n=5 mice: the full medial field 
of view (objective, ×60) yielding the sum of retardation signals (in nanometers) for all 
pixels in the images. Mean collagen fiber width was determined by measuring a minimum 
of 20 equidistant widths of per-elastic collagen fibers in one field of view, from a minimum 
of n=5 mice.  
4.2.8 Glycosaminoglycan assessment of aortas by Movat’s staining 
Paraformaldehyde-fixed aortic sections were stained according to Movat’s 
pentachrome protocol. Briefly, sections were first deparaffinized and incubated with Alcian 
blue in order to stain acid polysaccharides. They are then stained with 
Verhoeff hematoxylin, crocein scarlet combined with acidic fuchsine and saffron. The 
percentage of area occupied by blue-stained proteoglycan was quantified from 3 sections 
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200 µm apart, in the ascending and descending thoracic aorta regions, avoiding areas with 
aortic hematoma or dissection, using ImageJ software (NIH, Bethesda, MD).   
4.2.9 Statistical analyses 
Values are expressed as mean ± standard error of the mean. Statistical analyses 
were performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean 
data were compared using Student’s t-test or one- or two-way ANOVA with Holm-Sidak 
post hoc testing.  
4.3 Results 
4.3.1 Nampt knockout elicits a change in the gene expression pattern in aortic 
SMCs.  
I previously demonstrated that Nampt in smooth muscle cells is required to 
maintain vascular integrity by maintaining genomic integrity. Here, I sought to determine 
whether there were other processes impacted by Nampt that may contribute to vascular 
integrity. To address this question, I generated mice wherein Nampt could be conditionally 
deleted with the use of the CreER recombinase/LoxP system. Mouse aortic smooth muscle 
cells were isolated from the aortas of 3 Namptflox/flox;CreERT2+ and 3 
Namptflox/flox;CreERT2- (control) mice and subjected to 1 µm 4-hydroxytamoxifen for 24 
hours in order to induce Nampt deletion in culture. Seventy-two hours following Nampt 
ablation, Nampt mRNA transcript level in KO mSMCs was decreased by 86.5% 
(P<0.0001, Fig. 4.1a). Additionally, NAD+ levels measured in these cells were decreased 
by 84.9% (P<0.0001, Fig. 4.1b).  
To explore how Nampt reduction in SMCs might impact vascular associated 
processes, I undertook a global, unbiased comparison of gene expression in control and 
Nampt-KO SMCs using Affymetrix high-density microarray analyses. Gene expression 
microarray analysis was performed using RNA isolated from 3 independent primary  
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Figure 4.1 Nampt knockout in SMCs leads to decreased NAD+ levels 
A. Smooth muscle cells were harvested and cultured from aortas of Namptflox/flox;CreERT2+ mice and 
incubated with vehicle or hydroxy-tamoxifen for 24 hours. Abundance of Nampt mRNA was evaluated by 
RT q-PCR and normalized to expression of Gapdh mRNA (n=3 mice per condition, *P<0.0001) B. Nampt-
depleted cells were harvested 72 hours following Nampt knockdown. Graph of NAD+ content in acidic 
extracts of control and Nampt-depleted smooth muscle cells (SMCs). (n=3 independent cultures per 
condition, *P=0.024).  	
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cultures of Nampt-KO SMCs and WT control SMCs. As illustrated by Volcano plot, 
Nampt knockout evoked a transcriptional response in SMCs, with balance of statistically 
significantly up-regulated and down-regulated genes (Fig. 4.2). Lists of differentially 
expressed genes in response to Nampt depletion were generated using the criteria of 1.5-
fold change in expression level with P<0.05. Within 72 hours of Nampt disruption in 
SMCs 856 genes were upregulated and 633 genes were downregulated (as illustrated by 
heatmap in Fig. 4.3).   
4.3.2 Transcriptome alteration in Nampt-deficient aortic SMCs indicates a defect in 
extracellular matrix 
To determine what gene expression patterns were changed in Nampt-KO SMCs, I 
utilized DAVID Bioinformatics Resources (available at https://david.ncifcrf.gov) and 
analyzed Gene Ontology (GO) and Kegg Pathway terms that were statistically 
overrepresented in the lists of up- and down-regulated genes (P<0.05). The most 
overrepresented down-regulated genes in the Biological Process and Cellular Compartment 
GO categories were those belonging to the Extracellular Matrix categories (Fig. 4.4a). 
Additionally, analysis of genes in Kegg Pathway categories showed that the most 
overrepresented down-regulated genes belong to the ECM-receptor interaction group (Fig. 
4.4b). The most significant GO terms for Biological Processes and Kegg Pathway 
categories corresponding to genes upregulated in Nampt-KO SMCs were those relating to 
RNA, specifically Poly(A) RNA Binding and Ribosome Biogenesis in Eukaryotes (Fig. 
4.5a,b). Interestingly, the most significant GO terms for Cellular Compartments category 
corresponding to genes upregulated in Nampt-KO SMCs also corresponded to Extracellular 
Matrix.  
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Figure 4.2 Nampt knockout in SMCs induces global transcriptome changes 
Volcano plot depicting differences in gene expression between SMCs with or without Nampt ablation. The x-
axis represents the log-transformed fold-change (log2 fold change) of transcript abundance between the two 
groups. The y-axis represents the negative log transformed p value (-log10 p value).  	
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Figure 4.3 Nampt knockout in SMCs and gene expression changes 
 Heatmap depicting the microarray analysis of differentially expressed genes (greater than 1.5-fold change, 
P≤0.05) between 3 independent cultures of control, vehicle-treated SMCs and 3 independent cultures of 
Nampt-ablated SMCs. Each column represents one independent SMC culture and each row represents one 
mRNA transcript. Transcript abundance across the 6 independent cultures was normalized and the Z-score is 
depicted; Green indicates relative higher expression, Red indicates relative lower expression. Rows and 
columns were ordered by hierarchical clustering according to the similarity of expression patterns. 					
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Figure 4.4 GO and KEGG pathways most significantly over-represented in the transcripts 
downregulated in SMCs after Nampt ablation 
A. Bar graphs depicting the top 5 overrepresented GO categories from each of the GO classifications: 
Biological Processes, Cellular Components, and Molecular Functions. B. Graph depicting the top 
overrepresented KEGG pathways as determined by DAVID analysis.  	
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Figure 4.5 GO and KEGG pathways most significantly over-represented in the transcripts upregulated 
in SMCs after Nampt ablation 
A. Bar graphs depicting the top 5 overrepresented GO categories from each of the GO classifications: 
Biological Processes, Cellular Components, and Molecular Functions. B. Graph depicting the top 
overrepresented KEGG pathways as determined by DAVID analysis. 	
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4.3.3 Transcripts associated with collagen and proteoglycan equilibrium are altered 
in Nampt-deficient SMCS. 
To further define the changes in ECM as a consequence of Nampt ablation in 
SMCs, I curated the differentially expressed transcripts for genes known to be associated 
with pathology of the vascular ECM. I identified a number of transcripts among the 
overrepresented genes in the ECM categories that were associated with the production or 
degradation of extracellular collagen (Table 4.1). Notably, there was a 3.65-fold decrease 
in the expression of col3a1 (P=0.022), a 1.75-fold decrease in the expression of col1a1 
(P=0.021), and a 4.97-fold decrease in col14a1 (P=0.046). Matrix metalloproteinase 13 
(Mmp13) was significantly upregulated in Nampt-KO SMCs, which also may contribute to 
a disturbed collagen balance in the extracellular environment of these SMCs.  
As a corollary to this collagen depletion phenotype, I identified a number of 
transcripts in the lists of overrepresented genes in the ECM categories that were associated 
with the production of vascular proteoglycans (Table 4.2). These include a 1.54-fold 
increase in versican (P=0.006), and an increase in the enzymes that synthesize the 
glycosaminoglycan hyaluronan (or, hyaluronic acid): hyaluronan synthases 1 and 2 (1.99-
fold and 1.57-fold, P=0.001 and 0.034, respectively).  
I next confirmed differential expression of ECM components including MMPs, 
collagens, fibronectin, and proteoglycans in Nampt-KO SMCs, by quantitative RT-PCR. 
Expression of MMPs 2, 9, and 13 were all significantly upregulated by 1.78-, 10.40-, and 
3.90-fold, respectively (P=0.0001, <0.0001, and <0.0001, respectively, Fig. 4.6). The 
expression of col1a1 was decreased by 57.9% (P=0.021) while the expression of 
fibronectin increased 1.85-fold (P<0.0001).  Interestingly, the expression of various 
proteoglycans associated with the vascular space was increased. Versican was upregulated  
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Table 4-1 Microarray analysis identifies that Nampt ablation in SMCs changes expression of genes 
associated with collagen production and assembly 	
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Table 4-2 Microarray analysis identifies that Nampt ablation in SMCs changes expression of genes 
associated with proteoglycan production and assembly 
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Figure 4.6 Nampt ablation in SMCs changes expression of ECM transcripts 
Graphs depicting the relative transcript abundance of A) Mmp2, B) Mmp9, C) Mmp13, D) Col1a1, E) 
Fibronectin, F) Tenascin C, G) Decorin, H) Perlecan, I) Biglycan, and J) Versican, in control and in SMCs 
after Nampt ablation, as assessed by quantitative RT-PCR. mRNA data are expressed as ΔΔCT (n=3 
independent cultures per condition, transcript abundance of 18s was used as an internal normalizing 
reference).  
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1.96-fold (P=0.009), decorin was upregulated 3.07-fold (P<0.0001) and perlecan was 
upregulated 1.63-fold (P=0.001) (Fig. 4.7). Additionally, the expression of the glycoprotein 
tenascin C was increased by 3.24-fold (P<0.0001), Taken together, these transcriptional 
data are evidence for a disruption in the SMC ECM environment when Nampt is ablated. 	
4.3.4 Collagen deposition and organization is abrogated in SMC-Nampt deficient 
aortas at baseline and following Ang II infusion  
We have previously shown that mice with Nampt ablated in their smooth muscle 
cells were prone to Ang II-induced aortic disruption. Because of our evidence that collagen 
expression is suppressed in Nampt-KO SMCs in culture, I next determined whether the 
collagen component of the aorta was compromised in SMC-Nampt deficient mouse aortas. 
It has been shown that aortic fibrosis, caused by increased collagen content, is detectable in 
the mouse aorta as early as 7 days after initiation of Ang II infusion (Xu et al. 2011). 
Therefore, I infused Namptflox/flox;smMHC-Cre+ (SMC-Nampt KO) mice and 
Namptflox/+;smMHC-Cre- (control) mice Ang II for 7 or 28 days (1.44 mg/kg/day). 
Following Ang II infusion the aortas were perfusion-fixed and sectioned. Fibrillar collagen 
content and organization was assessed using circular polarization images of picrosirius red-
stained aortic cross sections (Fig. 4.7a). This revealed that, consistent with previous 
studies, control mice substantially increased the fibrillar collagen content in response to 
Ang II at both 7 and 28 days. These changes were evident in both the ascending and 
descending thoracic aortic segments. Strikingly, this fibrillar response was completely 
absent in the aortas of SMC-Nampt KO mice (Fig. 4.7b).  
To further evaluate the impact of Nampt knockout on the architecture of the 
collagen fibers, and the possibility that this might predispose to medial dissection, we 
resolved the collagen fibers into two distinct components: 1) tracks of collagen that were 
closely opposed to either side of each elastic lamella (Fig. 4.7c); and 2) collagen fibers that  
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Figure 4.7 Collagen deposition and organization in response to Ang II is abrogated in the aortas of 
SMC-Nampt KO mice 
Control and SMC-Nampt KO mice were infused with Ang II (1.44mg/kg/day) or vehicle (PBS) for 7 or 28 
days. Following infusion, paraformaldehyde-perfusion fixed ascending and descending thoracic aortas were 
harvested and stained with picrosirius red (PSR). Micrographs depict digitally acquired light retardation 
images of the ascending aortas, imaged with polarized light and liquid crystal compensation. The resulting 
retardation images are independent of illumination intensity, such that images can be directly compared; A. 
Representative images of control and SMC-Nampt KO ascending aortas infused with Ang II for 7 days; B. 
Quantification of the area fraction of birefringent collagen in the media of the ascending and thoracic aortas; 
C. Graph depicting the mean retardation values (a measure of collagen deposition and organization) of the 
inter-lamellar spaces (white arrows) in the ascending and thoracic aortas of KO mice; D. Graph depicting the 
mean retardation values of peri-elastin lamellae collagen tracks (white arrowheads); E. Graph depicting the 
thickness of the inter-lamellar tracks of collagen, (n = 4-5 mice per group). 
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existed between elastic lamellae and oriented primarily orthogonal to the peri-elastic 
collagen fibers (Fig. 4.7d). Notably, both collagen components in Nampt KO aortic media 
were attenuated at baseline, and not responsive to Ang II stimulation. Interestingly, the 
mean thickness of the peri-elastic collagen tracks in SMC-Nampt KO mice was also less 
than that of control mice, even before Ang II stimulation. In control mice, the mean 
thickness of the peri-elastic collagen tracks increased with Ang II stimulation. However, no 
increase was noted in SMC-Nampt deficient aortas (Fig. 4.7e). Taken together, these 
findings suggest an inability of Nampt-deficient SMCs to produce and/or assemble 
collagen fibrils at both baseline and under Ang II-induced biochemical and biomechanical 
stress. 
4.3.5 Glycosaminoglycan elaboration is increased in SMC-Nampt deficient aortas at 
baseline and following Ang II infusion 
 I next sought to determine if the ECM elaboration response to Ang II in SMC-
Nampt deficient aortas shifted to other, non-collagen ECM components. Quantitative 
transcript analysis by RT-PCR of aortas infused with Ang II for 7 days revealed that 
Col1a1 expression in SMC-Nampt KO aortas was 27.3% lower than that in control aortas 
infused with Ang II (P=0.0002, Fig. 4.8a). Surprisingly, fibronectin expression was also 
lower in Ang II-infused SMC-Nampt KO aortas than infused control aortas (42.5%, 
P=0.0004, Fig. 4.8b). Additionally, N-cadherin, important in maintaining SMC adhesion, 
was also 43.4% lower in Ang II-infused aortas as compared to control infused aortas 
(P=0.002, Fig. 4.8c). In contrast, expression of the small leucine-rich repeat proteoglycan 
biglycan was higher in SMC-Nampt KO aortas than control aortas infused with Ang II 
(1.91-fold, P=0.002, Fig. 4.8d).  
To further determine whether proteoglycan moieties were accumulating in the Ang 
II-infused SMC-Nampt KO mouse aortas, I stained paraformaldehyde-fixed sections of 
aorta with Movat’s petachrome stain (Fig. 4.8e). This stain contains alcian blue, which  
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Figure 4.8 ECM expression in response to Ang II is perturbed in the aortas of SMC-Nampt KO mice 
Graphs depicting the relative transcript abundance (ΔΔCT) of A) Col1a1, B) Fibronectin, C) N-Cadherin, and 
D) Biglycan, in control and Nampt-KO mouse aortic medias, as assessed by quantitative RT-PCR (n=3 
independent cultures per condition, transcript abundance of 18s was used as an internal reference). E. 
Representative images of control and SMC-Nampt KO ascending aortas infused with Ang II, 1.44 mg/kg/day 
for 7 days, and stained with Movat’s pentachrome stain. Areas of blue stain are predominantly enriched with 
GAG (white arrowhead). F.  Quantification of blue GAG stain expressed as the percentage of the medial area 
of both the ascending and thoracic aorta (n = 4-5 per group, by one-way ANOVA with Holm-Sidak post hoc 
testing). 
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binds to acidic polysaccharides such as glycosaminoglycans (GAGs) – the side chains that 
together with a core protein make up a proteoglycan. Interestingly, even without Ang II 
infusion, SMC-Nampt KO aortas have a detectable amount of GAG accumulation while 
GAG accumulation in control aortas was virtually undetectable, both in the ascending and 
thoracic regions (P=0.03 and P=0.007, respectively, Fig. 4.8f). Following 7 days of Ang II 
infusion the area fraction of GAG accumulation was 4.2-fold higher in SMC-Nampt KO 
ascending aortas (P<0.0001) than that of Ang II-infused control ascending aortas. 
Similarly, both KO and control thoracic aortas had an increase in the area fraction of 
proteoglycan present in response to Ang II (P=0.02). This evidence of proteoglycan 
accumulation, along with reduction in the more structurally resistant ECM components 
(e.g. collagen), points to a vascular structural weakening in response to Nampt ablation. 
4.3.6 Smad7 is a potential upstream regulator of Nampt-dependent changes in the 
ECM equilibrium 
 To screen for potential drivers of the gene-expression phenotypes related to Nampt-
ablation in the SMCs, I performed Ingenuity Pathway Analysis (IPA) on the up- and down-
regulated genes revealed by the microarray analysis data. Specifically, I evaluated the data 
set using the Upstream Regulator Analytic. Transcription regulators potentially affected by 
SMC-Nampt depletion were identified based on the number of up- and down-regulated 
genes that were statistically overrepresented in the potential downstream target gene set 
(Fig. 4.9a). The transcription factor predicted to be most significantly impacted by Nampt 
ablation was Smad7 (P=5.52x10-14), and it was predicted to be activated (activation Z-
score=2.27). Smad7 was followed by Jun, Myc, Foxm1 and Nupr1. Interestingly, the 
putative downstream targets of Smad7, as predicted by the IPA platform, include a number 
of ECM components that were differentially expressed in Nampt depleted SMCs (Fig. 
4.9b). Although the involvement of Smad7 remains to be validated, it may represent a key 
node through which Nampt regulates the ECM environment of SMCs.  
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Figure 4.7 Predicted transcription factors mediating transcript changes by loss of Nampt 
A. The 5 upstream transcription regulators most strongly predicted to be impacted by Nampt depletion in 
SMCs as identified by Ingenuity Pathway Analysis of SMC-Nampt knockout microarray data. B. Heatmap of 
specific ECM transcripts downstream of Smad7, as identified by IPA, which are also differentially expressed 
(greater than 1.5-fold change, P<0.05) in Nampt-KO SMCs. Each column represents one independent SMC 
culture and each row represents one mRNA transcript. mRNA Transcript expression across the 6 independent 
cultures was normalized and the Z-score is depicted; Yellow indicates relative high expression, Blue indicates 
relative low expression. 
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4.4 Discussion 
 This study reveals that ECM homeostasis in the aortic media depends on a NAD+ 
fueling system. By evaluating changes in Nampt-KO SMCs and in SMC Nampt-deficient 
aortas we show that: 1) Nampt knockdown in SMCs profoundly changes the expression 
pattern of SMC gene transcripts, 2) there were reciprocal shifts in the expression of 
transcripts associated with collagen synthesis and assembly, and proteoglycan synthesis, 3) 
Nampt-deficient mouse aortas displayed decreased content and organization of fibrillar 
collagen at baseline and following infusion with Ang II, 4) Nampt-deficient mouse aortas 
had increased proteoglycan accumulation at baseline, and following Ang II infusion, and 5) 
the Smad7 signaling pathway may be altered in response to Nampt knockdown in SMCs.  
 Nampt was originally identified as a putative cytokine, pre-B enhancing colony 
factor (PBEF) (Samal et al. 1994, Rongvaux et al. 2002), and subsequently as a putative 
insulin-mimetic hormone, Visfatin (Fukuhara et al. 2005).  Evidence for the former is 
inconclusive, and the index report for the latter has been retracted (Fukuhara et al. 2007). 
Our previous work has established Nampt as a phosphoribosyltransferase, impacting the 
ability of SMCs in vitro to withstand the effects of replicative stress in culture (van der 
Veer et al. 2007). Additionally, my recent findings have revealed the importance of an 
autonomous, Nampt-dependent NAD+ production cascade in SMCs that serves as a vital 
metabolic hub for the aorta. The current findings highlight the magnitude of transcript 
control exerted by this hub. Two major NAD+-dependent enzyme families are likely central 
to this transcript program, Parps and Sirtuins. Parp’s actions include ADP-ribosylation of 
histones (Verdone et al. 2015). Sirtuins couple NAD+ breakdown to the deacetylation 
and/or ADP-ribosylation of target proteins. Numerous target proteins, including histones 
and a variety of transcription factors, have been reported for sirtuins (Dai and Faller 2008, 
Imai 2009). Major gene expression changes have been found in mouse fibroblasts with 
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increased Nampt, which is at least partly due to augmenting the transcriptional regulatory 
activity of Sirt1 by increasing NAD+ bioavailability (Revollo et al. 2004). The current data 
shed light on the converse paradigm, i.e. decreased Nampt content depressed total cellular 
NAD+ and re-wired gene expression in SMCs.  
 Remarkably, both the Gene Ontology (GO) terms and KEGG pathways that were 
most particularly enriched by altered Nampt-KO SMC transcripts are those associated with 
extracellular matrix production and assembly.  In particular, this revealed an abundance of 
genes associated with the synthesis and assembly of collagens, with a profile suggesting a 
collagen depletion phenotype. Consistent with this, I found that aortas of SMC-Nampt KO 
mice had reduced collagen content and organization. Ang II has been found to directly 
contribute to vascular smooth muscle cell growth and vessel remodeling, including an 
upregulation of collagen synthesis (Intengan and Schiffrin 2001, Sparks et al. 2011), and 
this was also impaired in the SMC-Nampt KO mice. It has been reported that the 
deacetylation activity of Sirt1 increases the expression of collagen type I (Col1a2) 
transcription in vascular SMCs by directly antagonizing the Col1a2 repressor, RFX5 (Xia 
et al. 2012). As well, Y. Wang et al. have reported that the inhibition of Parp1 prevented 
fibrosis in response to Ang II (Wang et al. 2013). Under baseline conditions, Parp1 
associates in the nucleus with the transcription factor Smad3. When activated by DNA 
damage, Parp1 poly-ADP-ribosylates target histones, but also undergoes auto-poly-ADP-
ribosylation. This modification caused it to dissociate from Smad3, and Smad3 was able to 
bind to the promoter of its target genes: including Col1a1 and Col11a1, thus increasing 
collagen production by vSMCs (Huang et al. 2011). These findings, together with my data, 
support that idea that the reduced collagen in the aortas of KO mice may be due to 
decreased Sirt1 and Parp1 activity.  
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  The observed decrease in collagen production, both at baseline and in response to 
Ang II, was accompanied by an increase in proteoglycan transcripts. The molecular basis 
of this reciprocal relationship is unclear, however the end-result is associated with both 
structural weakness of the aorta and the pathology of human aortopathy (Lakatta et al. 
2009, Humphrey 2013, Roccabianca et al. 2014). 
The statistical determination that Smad7 is an upstream transcription factor that 
drives the expression profile is noteworthy. NAD+-dependent Sirt1-mediated deacetylation 
of Smad7 has been documented. Deacetylation of Smad7 targets it for degradation, and 
inhibition of Smad7 deacetylation leads to greater Smad7 stability and activity (Kume et al. 
2007). Smad7 is a key negative regulator of TGF-β signalling (Yan and Chen 2011, Beppu 
2013). In the vascular compartment TGF-β has been implicated in matrix deposition and in 
matrix degradation, positioning it as a critical regulator of the vascular ECM (Jones and 
Ikonomidis 2010). In particular, TGF-β can enhance collagen and fibronectin synthesis and 
deposition (Ignotz and Massague 1986), increase elastin expression (Kucich et al. 2002), 
and repress MMPs (Yan and Boyd 2007). TGF-β signalling also can increase the size of 
glycosaminoglycan chains on both bigylcan and decorin (Schonherr et al. 1993, Dadlani et 
al. 2008). A Nampt-regulated shift in TGF-β signalling due increased Smad7 stability could 
well be responsible for unbalancing the homeostasis of the aortic extracellular 
environment, leaving the aorta vulnerable to disruption. 
 In summary, I demonstrate that a SMC-autonomous supply of NAD+ generated 
Nampt is necessary for vascular SMCs to synthesize maintain a physiologic balance of 
collagen versus proteoglycans. Upsetting this Nampt-regulated balance may weaken the 
aorta and increase its susceptibility to dissection.  
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 CHAPTER 5 - NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IS 
ESSENTIAL FOR ADULT MICE SURVIVAL 
5.1 Introduction 
 Nampt is required for the regeneration of NAD+ when NAD+ has been depleted by 
NAD+-consuming reactions, including the ADP ribosylation of proteins, protein 
deacetylation, and the production of cyclic ADP ribose (Sauve and Schramm 2004, Lee 
2012, Luo and Kraus 2012). Several studies have reported Nampt to be highly expressed in 
lung, liver, kidney, heart, adipose, and skeletal muscle, with much lower expression in 
brain and pancreas (Samal et al. 1994, Revollo et al. 2007).  
Tissue-specific gene targeting strategies in mice have revealed a pattern of 
degenerative or aging-related tissue dysfunction when Nampt is perturbed in skeletal 
muscle, adipose tissue, and brain (Stein and Imai 2014, Frederick et al. 2016, Stromsdorfer 
et al. 2016, Zhou et al. 2016), in addition to the data presented in earlier chapters outlining 
the degenerative consequences of Nampt knockout in SMCs.  
 Mice lacking Nampt in forebrain excitatory neurons showed hippocampal and 
cortical atrophy, astrogliosis, microgliosis, and abnormal CA1 dendritic morphology by 2–
3 months of age (Stein et al. 2014). Ablation of Nampt in adult neural stem cells also 
causes signs of accelerated aging in this neural cell population (Stein and Imai 2014). 
Knockout of Nampt in skeletal muscle contributed to an aging phenotype-related loss mass 
and contractile function (Frederick et al. 2016). Adipocyte-specific Nampt knockout mice 
had severe insulin resistance in adipose tissue, liver, and skeletal muscle, and adipose tissue 
dysfunction, manifested by increased plasma free fatty acid concentrations and decreased 
plasma concentrations of a major insulin-sensitizing adipokine, adiponectin (Stromsdorfer 
et al. 2016). Additionally, Nampt is critically required for the development of both T and B 
lymphocytes (Rongvaux et al. 2008). Interestingly, this dysfunction was shown to be at 
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least partially ameliorated in some cell types by the exogenous delivery of NAD+ 
precursors, such as nicotinamide (NAM) or nicotinamide riboside (NR).  However, due to 
the variability of the limited tissue-specific Nampt knockout data available, it is unclear 
which may be the most vulnerable systems.  
 Nampt has been understood to be an essential enzyme for embryo development 
based on reports that the development of the mouse embryo cannot proceed past e10.5 
without Nampt (Revollo et al. 2007). A very recent report has emerged in which this 
finding is confirmed. Nampt begins to be expressed at e8.5 in mouse development, and 
Nampt deficient embryos cannot develop past e10.5 (Zhang et al. 2017). The essentiality of 
Nampt was further confirmed in the adult mouse when knocked out using tamoxifen-
regulated Cre activity. These mice did not survive longer than 10 days post Nampt 
knockout. The authors report severe atrophy of the villi of the gastrointestinal tract, an 
increase in serum triglyceride levels, and a catastrophic decrease in abdominal adipose 
stores (Zhang et al. 2017). However, their findings were limited, as they did not present 
data on any other tissues that may have been affected by Nampt knockout. Additionally, 
although these pathologies are attributed to liver dysfunction caused by liver Nampt 
depletion, the model of Nampt knockout they used for their studies only yielded 20% 
decrease in Nampt expression in the liver. 
Here, I investigate the role of global expression of Nampt in a mouse model by 
inducing knockout in an adult mouse, thus circumventing the embryonic lethality. My 
findings reveal that Nampt is an essential gene necessary to sustain life. The findings also 
reveal the different tissues are seemingly more resistant to the depletion of Nampt. 
Additionally, I was able to extend the lifespan of Nampt KO mice by supplying the mice 
with NR, an exogenous NAD+ precursor. These findings shed new light on the tissue-
specific requirements for Nampt.    
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5.2 Methods 
5.2.1 Generation of Nampt-deficient mouse model 
 Mouse experiments followed protocols approved by the Western University Animal 
Use Committee.  All mice were on a C57Bl/6 background. I generated mice in which 
Nampt could be globally and inducibly deleted.  Namptflox/flox mice were bred with mice 
expressing Cre recombinase fused to the mutated ligand binding domain of the human 
estrogen receptor (ER) under the control of a chimeric cytomegalovirus immediate-early 
enhancer/chicken ß-actin promoter (B6.Cg-Tg(CAG-Cre/Esr1)5Amc/J) (Jackson 
Laboratories, Bar Harbor, ME) (Hayashi and McMahon 2002). To induce Namptflox/flox 
recombination and excision by Cre recombinase, 8-10 week old Namptflox/flox;Cre-ERT2(+) 
mice (denoted as Nampt KO) were i.p. injected with (1 mg/kg/day) tamoxifen (Tmx) in 
sunflower oil vehicle, for five consecutive days. Namptflox/flox;Cre-ERT2(-) (denoted as WT 
control) were also injected concomitantly with Tmx in sunflower oil to control for any 
effects due to Tmx toxicity. For NR studies, mice were given a daily single dose (1000 
mg/kg body weight) by i.p. injection. Initial necropsy studies were performed by the 
CMHD Pathology Core at the Toronto Centre for Phenogenomics (Toronto, Ontario, 
Canada).  
5.2.2 Serum collection and analysis 
 Serum was collected using an approved standard protocol. Briefly, mice were 
anaesthetized and blood was immediately collected by cardiac puncture. Blood was 
allowed to clot for 20-30 minutes and then centrifuged for 10 mins at 1,500g to separate the 
clotted material from the serum. Serum was then flash frozen and stored at -80°C for future 
analysis. Clinical chemistry parameters were measured by standard protocols by Charles 
River Laboratories (Wilmington, MA). Plasma insulin was determined by mouse-specific 
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ELISA as per manufacturer’s instructions (ALPCO Diagnostics, Salem, NH: mouse 
ultrasensitive ELISA #80-NSMSU-E01). 
5.2.3 Histology and immunohistochemistry of mouse tissues 
 Mouse tissues were collected and fixed intact (with the exception of the intestinal 
tract which was split open and rolled in order to survey the entire organ) overnight in 4%-
paraformaldehyde and embedded in paraffin. 10 mm-thick sections were stained with 
hematoxylin and eosin (H&E) to broadly evaluate tissue architecture. Immunostaining was 
performed on paraffin-embedded sections for Nampt using a rabbit polyclonal anti-Nampt 
(A300-372A 1:50; Bethyl Laboratory, Montgomery, TX). Bound primary antibodies 
against Nampt were detected using goat anti-rabbit biotinylated antibody (Vector Labs, 
Burlington, ON, Canada) and visualized using an ABC kit and diaminobenzidine (DAB, 
Vector Labs) and counterstained with Harris’ hematoxylin.  
5.2.4 Morphology of esophagus and intestine 
 Mouse esophagus was removed intact 4%-paraformaldehyde fixed and paraffin 
embedded sections were stained with H&E and visualized with an Olympus BX51 
microscope. Epithelial structure thickness was quantified from an average of 10 equidistant 
measurements around 3 sections 200 µm apart using ImageJ software (NIH, Bethesda, 
MD). Mouse intestine was dissected and prepared with the adapted Swiss roll technique to 
visualize the entire organ (Williams et al. 2016). Abnormal mucosal architecture was 
evaluated in 3 regions of the jejunum 200 µm apart by measuring irregular crypts, and 
crypt and villous blunting (Erben et al. 2014). 
5.2.5 Laser capture microdissection and RNA isolation of pancreatic islets and 
acinar cells.  
Laser capture was undertaken on 10 µm-thick frozen sections of WT control and 
Nampt KO pancreas (15 days after initiation of Tmx injections) that had been embedded in 
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OCT compound (Tissue-Tek).  Islet cells and acinar cells were micro-dissected (Arcturus 
704 Veritas LCM System, Harlow Scientific, Arlington, VA) from 10 pancreas sections 
and RNA extracted using TRIzol (Life Technologies) with the addition of linearized 
polyacrylamide (2 mg/ml, Sigma) following phase separation. 
5.2.6 Quantitative real-time reverse transcription–polymerase chain reaction  
Total RNA was isolated from homogenates of the mouse aorta using TRIzol (Life 
Technologies) and the RNeasy Mini Kit following the manufacturer’s protocol (Qiagen, 
Valencia, CA).  Total RNA was isolated from mouse and human SMCs using the RNeasy 
Mini Kit following the manufacturer’s protocol. Transcript abundance of mouse Nampt, 
Nrk1, and 18S were assessed using SYBR-green chemistry-based primer sets (Nampt: F-
GGCACCACTAATCATCAGACCTG R-AAGGTGGCAGCAACTTGTAGCC; Nrk1: F- 
AGAGCTTGCAGAAGCACCTTCC R-CATCCAACAGGAAACTGCTGACA; 18S F-
GTAACCCGTTGAACCCCATT R-CCATCCAATCGGTAGTAGCG). Quantitative real-
time RT-PCR was performed using an ABI Prism (model 7900HT) and Sequence 
Detection System software (Life Technologies; Applied Biosystems).  For Nampt 
expression in LCM islet and acinar cell samples, relative mRNA abundance was quantified 
based on critical threshold (CT) using the comparative CT formula, 2-ΔΔCT, with 18S 
mRNA as an internal control.  For Nampt and Nrk1 expression in whole tissues, mRNA 
abundance was quantified based on the standard curve method, with 18S mRNA as an 
internal reference control, and expressed as relative units (r.u.) 
5.2.7 Statistical analyses 
Values are expressed as mean±standard error of the mean. Statistical analyses were 
performed using GraphPad Prism software (GraphPad, La Jolla, CA, USA). Mean data 
were compared using Student’s t-test or one-ANOVA with Holm-Sidak post hoc testing.  
				 164	
Kaplan–Meier survival analysis was used to assess mouse longevity, and data were 
compared using log-rank (Mantel-Cox) testing.  
5.3 Results 
5.3.1 Nampt knockout specifically in adult mice is lethal 
 To determine whether Nampt expression is a requisite necessity for survival, I 
generated a mouse in which Nampt could be globally deleted in the adult. Because Nampt 
knockout is embryonically lethal before e10.5 (Revollo et al. 2007, Zhang et al. 2017), the 
deletion needed to be inducible in an adult animal and therefore Namptflox/flox;Cre-ERT2(+) 
mice were generated. Mice (8-10 weeks old) were injected with tamoxifen (Tmx) for five 
days to induce recombination and excision of the Namptflox/flox allele. To determine the 
amount of Nampt depletion I evaluated the expression of Nampt mRNA in peri-mortem 
Namptflox/flox;Cre-ERT2 (Nampt KO) mice by quantitative PCR. Nampt expression was 
reduced in the heart (93.1%, P<0.0001, Fig. 1a), skeletal muscle (94.8%, P=0.0003, Fig. 
5.1b), kidney (75.0%, P=0.004, Fig. 5.1c), brain (78.0%, P<0.0001, Fig. 5.1d), and 
intestine (77.7%, P=0.003, Fig. 5.1e). There was no significant change in Nampt 
expression in the liver (P=0.790, Fig. 5.1f)  
Median survival time of Nampt KO mice was 16 days and no mouse survived past 
20 days following the initiation of Tmx injection (n=12, P=0.003, Fig. 5.2a). An onset of 
rapid weight loss began five days after Tmx injections were initiated and Nampt KO mice 
had a 13.2 ± 5.44% decrease in body weight at time of death (P=0.001, Fig. 5.2b).  
5.3.2 Nampt knockout is accompanied by gross pathological changes in the intestine 
and pancreas 
 To help determine cause of death following Nampt knockout, a gross pathological 
analysis of peri-mortem mice was undertaken. In addition to the weight loss described 
above, Nampt KO peri-mortem mice were slow to move and were hunched (Fig. 5.2c). 	  
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Figure 5.1 Nampt expression is decreased in heart, skeletal muscle, kidney, brain and small intestine in 
Nampt KO mice  
Graphs depicting the amount of Nampt expression in the A) heart, B) skeletal muscle, C) kidney, D), brain, 
E) intestine, and F) liver of Nampt KO mice as compared to WT control mice, as measured by quantitative 
RT-PCR. Nampt expression was normalized to the internal 18S expression. Tissues were harvested in peri-
mortem mice, on average 15 days following the initiation of Tmx injections (n=3-4 per group, Student’s T-
test).  	
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Figure 5.2 Nampt knockout is lethal in adult mice 
A) Kaplan-Meier survival curve of WT and Nampt KO mice following tamoxifen injection for 5 days (n=8 
per group, *P<0.002, Log-rank (Mantel-Cox) test). B) Graph depicts change in weight at the end of lifespan 
as compared to the animal’s individual starting weight. C) Images of WT control and peri-mortem Nampt KO 
mice at time of death. D) Gross dissection of abdominal cavity of WT control and peri-mortem Nampt KO 
mice. Third panel demonstrates gross evidence of intestinal distension (black arrowheads). 	  
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These observations consistently preceded death within 24 hours. Upon abdominal 
dissection, it was apparent that the esophagus, stomach, and the small and large intestine 
were distended with food materials (Fig. 5.2d). In addition, there was gross evidence of a 
loss of pancreatic parenchymal integrity and enlarged lymph nodes. Examination of the 
kidney, heart, skeletal muscle, brain, and liver revealed no gross pathology (Table 5.1).  
5.3.3 Nampt knockout changes liver serum chemistry parameters  
 To further characterize the decline of Nampt KO mice, the serum chemistry of a 
subset of mice was analysed.  Serum was collected 5 days, 10 days, and 15 days following 
initiation of Tmx injection (n=3 per group). Five days after initiation of Tmx injection 
serum parameters were not significantly different from the range of expected values. 
However, ten days after initiation of Tmx injections there was a significant change in levels 
of alanine aminotransferase (8.3-fold increase, P=0.02, Fig. 5.3), aspartate 
aminotransferase (27.6-fold increase, P=0.04, Fig. 5.3), alkaline phosphatase (2.9-fold 
increase, P=0.01, Fig. 5.3), and glucose (55.9% decrease, P=0.03, Fig. 5.3). Interestingly, 
15 days after Tmx injections these levels returned to the range of expected values, except 
for aspartate aminotransferase. These serum chemistry changes indicate a possible early 
disruption in liver processes.  
5.3.4 Nampt knockout affects the epithelial layers of the gastrointestinal tissues 
To determine which tissues are affected by the knockout of Nampt, I evaluated 
histological sections of the Nampt KO mice. There was no evidence of histological changes 
in the heart, liver, kidney, or skeletal muscle of Nampt KO mice (Fig. 5.4). Surprisingly, 
while there was gross appearance of dysfunction in the gastrointestinal tract (i.e. distension 
of the esophagus, small intestine and colon), there was limited evidence for cellular 
disruption. Villus height was variable; villi were midly, but not significantly, blunted in the 
intestine (21.2% decrease 15 days after Tmx, P=0.080, Fig. 5.5a,b) with  
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Table 5-1 The number of Nampt KO mice with tissue-specific gross pathology 5 days, 10 
days, and 15 days following injection of tamoxifen and induction of Nampt knockout 
Tissue  Pathology finding (if present) 
5 days 
post Tmx 
(n=3) 
10 days 
post Tmx 
(n=3) 
15 days 
post Tmx 
(n=8) 
Pancreas Loss of parenchymal integrity 3 3 8 
Esophagus Abnormal esophagus morphology, dilated with food (partially digested) 1 1 6 
Stomach Dilated stomach filled with food materials 0 2 7 
Jejunum Dilated with thickened wall filled fully with liquid and green fecal material,  0 3 8 
Ileum 
Enlarged, dilated with thickened wall 
filled fully with liquid and green fecal 
material 
0 3 8 
Colon 
Abnormal colon morphology, dilated 
with thicken wall, and filled fully with 
liquid and green fecal material 
0 3 8 
Cecum Enlarged cecum 0 3 8 
Kidney Small kidney 0 0 2 
Testis Seminal vesicles are smaller. Small testis 0 0 2 
Lymph nodes Enlarged lymph nodes 0 0 2 
Adrenal gland Small adrenal glands 0 0 2 
Heart None 0 0 0 
Skeletal muscle None 0 0 0 
Liver None 0 0 0 	
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Figure 5.3 Nampt knockout increases serum levels of aspartate aminotransferase, alanine 
aminotransferase, and alanine phosphatase, and decreases circulating glucose levels 
Serum was collected from WT control and Nampt KO mice by cardiac puncture 5 days, 10 days, and 15 days 
following the initiation of tamoxifen injections (1000ng/mg/ml). Basic serum clinical chemistry was 
measured for A) alanine aminotransferase, B) aspartate aminotransferase, C) alkaline phosphatase, D) 
glucose. N=3 mice at each time point. Graph depicts data points in addition to mean ± standard deviation, by 
one-way ANOVA with Holm-Sidak post hoc testing  
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Figure 5.4 Nampt knockout does not have an effect on the histological appearance of the heart, liver, or 
kidney 
Micrographs of H&E-stained WT control and Nampt KO A) heart (cardiac myocytes), B) liver, and C) 
kidney depicting no apparent differences.	
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Figure 5.5 Nampt knockout is associated with a blunted villus and crypt architecture in the small 
intestine 
A) Micrographs of H&E-stained sections of WT control and Nampt KO small intestine. The effect that Nampt 
KO had on the tissue was heterogenous; some villi (Vi) and crypts (Cr) were slightly blunted (panel 2), others 
were significantly blunted (panel 3). B) Average length of villi in the small intestine (WT control n=3, early 
(5 day) n=3, late (10-15 day) n=6, one-way ANOVA with Holm-Sidak post hoc testing). C) Average depth of 
crypts in the small intestine (WT control n=3, early (5 day) n=3, late (10-15 day) n=6, one-way ANOVA with 
Holm-Sidak post hoc testing). 
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some evidence of villus loss in patchy areas. There was also crypt architecture that 
appeared mildly, but not significantly, compressed 5 days after the initiation of Tmx 
injections (26.2% decrease in crypt depth, P=0.313, Fig. 5.5a,c), and persisted through the 
decline of the mice to day 15 (26.9% decrease in crypt depth 15 days after Tmx injection, 
P=0.090, Fig. 5.5a,c). Additionally, there was a thinning of the epithelial layer of the 
esophagus (Fig. 5.6a,b). Specifically, there was a 52.9% decrease in the average thickness 
of the epithelial layer starting 5 days after the initiation of Tmx injections (P=0.0002, Fig. 
5.6d).  
5.3.5 Nampt knockout affects integrity of the pancreas 
Evaluation of the pancreas as early as five days following the initiation of Tmx 
injection, I observed evidence of multifocal to coalescing pancreatic acinar atrophy and 
islet hyperplasia. Throughout the organ, there is histological evidence that localized acinar 
cells have been replaced by ductal cells (acinar-to-ductal metaplasia Fig. 5.7a) and the islet 
areas appear enlarged due to increased number of cells (3.1 ± 0.78-fold increase, P=0.03). I 
also observed an appearance of interstitial stellate cells, which are often activated upon 
injury. Additionally, there was an observed 89.5% decrease in serum insulin levels in peri-
mortem Nampt KO mice (Fig. 5.7b); evidence of a dysfunction of islet cells.   
 This adverse pancreatic affect was particularly surprising as the baseline expression 
of Nampt in the pancreas is reportedly very low to non-existent, particularly in comparison 
to Nampt expression in other tissues (Fig. 5.7c) (Samal et al. 1994, Revollo et al. 2007). I 
sought to confirm the result in the pancreas using both immunohistochemistry (Fig. 5.7c) 
and also the more stringent approach of isolating pancreatic RNA specifically from islet 
cells versus acinar cells by laser-capture microdissection. The results revealed that at 
baseline Nampt is expressed only in islet cells of the pancreas (Fig. 5.7d,e). There is no 
expression detected either by qPCR or immunohistochemistry in acinar cells.  
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Figure 5.6 Nampt knockout is associated with a thinning of the epithelial layer of the esophagus 
A) Micrographs depicting cross-sections of the dilated Nampt KO esophagus, still containing remnants of 
mouse chow (second panel). B) Higher magnification view of the Nampt KO esophagus, depicting the thin 
epithelial layer (black line). C) Graph depicting the average area occupied by the epithelial layer in a cross 
section of the esophagus (WT control n=3, early (5 day) n=3, late (10-15 day) n=6, *P<0.0001 vs. WT 
control, †P<0.0001 vs. WT control, by one-way ANOVA with Holm-Sidak post hoc testing). D) Graph 
depicting the average thickness of the epithelial layer in a cross section of the esophagus (WT control n=3, 
early (5 day) n=3, late (10-15 day) n=6, *P<0.0001 vs. WT control, †P<0.0001 vs. WT control, by one-way 
ANOVA with Holm-Sidak post hoc testing).  
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Figure 5.7 Nampt knockout affects the integrity of the pancreas 
A) Representative micrographs of the multifocal to coalescing pancreatic acinar atrophy and islet cell 
hyperplasia throughout the pancreas at 5, 10 and 15 days following the initiation of Tmx injections. Is: Islet 
cells, Ac; Acinar cells, Du: Ductal cells. Black arrows in inset indicate examples of acinar-to-ductal 
metaplasia. B) Serum insulin levels measured in peri-mortem Nampt KO mice  (WT control n=5, Nampt KO 
n=7) C) Graph depicting Nampt mRNA as measured by RT-PCR and normalized to 18S expression in WT 
Control mouse tissues (n=3 mice) D) Representative micrographs of immunohistochemistry for Nampt 
expression in WT control pancreas harvested from peri-mortem mice (Is: islet cells; Ac: acinar cells). E) 
Nampt mRNA signal detected by RT-PCR and expressed as absolute CT values in islet cells and acinar cells 
isolated by laser-capture microdissection. Pancreatic tissue from a minimum of 10 sections from 2 mice was 
evaluated. 
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5.3.6 Nicotinamide riboside delays the decline of Nampt KO mice, but is unable to 
ultimately prevent death.  
To determine whether delivery of NR, an exogenous precursor to NAD+, would be 
sufficient to compensate for the loss of the NAD+-regenerating activity of Nampt, I first 
measured the expression of Nrk1. Nrk1 is the enzyme that converts NR to NAD+. The 
natural source of oral NR (and other NAD+ precursors NAM and NA) is largely in the food 
we eat as broken down by digestion and the microbiome (Bogan and Brenner 2008, Canto 
et al. 2015) Interestingly, it was recently shown that the human cytosolic 5′-nucleotidase 
CD73 can catalyse the conversion of NMN into NR and that at least some cells are able to 
release this nucleoside precursor of NAD+ (Kulikova et al. 2015), suggesting that NR is in 
available in the circulation. Nrk1 expression was assessed by qPCR in the heart, skeletal 
muscle, liver, and pancreas of control and Nampt KO mice, both at baseline and also in 
mice that had been supplemented with daily i.p. injections of NR. In Nampt KO mice 
supplemented with NR there was an increase in Nrk1 expression in the liver as compared to 
the WT control (2.80-fold, P=0.043, Fig. 5.8a) and a trend towards increase in the heart, 
although the data were not significant (1.25-fold, Fig. 5.8b). Interestingly, in the pancreas 
of Nampt KO mice, both with and without NR supplementation, there was an increase of 
Nrk1 expression (4.48-fold, P=0.182 and 4.82-fold, P=0.009, respectively, Fig. 5.8d). This 
suggests a pancreatic dependence on a bio-available source of NAD+, or a precursor to 
NAD+. 
It was also of interest to deduce whether NR supplementation would be sufficient to 
overcome decline and death due to Nampt knockout. I was able to demonstrate that 
administration of NR can prolong the survival of Nampt KO mice, doubling the median 
survival time from 16 to 34 days (P=0.001, Fig. 5.9a). Interestingly, at 20 days following 
Tmx injection (the point at which all Nampt KO mice had died) Nampt KO mice 
supplemented with NR began to regain weight, although this was not sustained (Fig. 5.9b).   	 	
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Figure 5.8 Expression of Nrk1 is increased in the liver and the pancreas of Nampt KO mice  
Graphs depicting the expression of Nrk1 in the A) liver, B) heart, C) skeletal muscle, and D) pancreas of WT 
control and Nampt KO mice, both at baseline or supplemented with daily i.p. injections of NR (1000 
mg/kg/day). Nrk1 expression was normalized to the internal expression of 18s. N=4 mice per group, one-
ANOVA with Holm-Sidak post hoc testing. 		
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Figure 5.9 Global loss of Nampt-mediated NAD+ biosynthesis in the adult mouse in lethal and is 
partially rescued by administration of nicotinamide riboside (NR) 
A) Kaplan-Meier survival curve of WT and Nampt KO mice. NR (1000 mg/kg/day) was i.p. injected daily 
until day of death (n=8 per group, *P=0.001 vs. Nampt KO, by log-rank [Mantel-Cox] testing). B) Graph 
depicting weights of mice until time of death (n=8 per group). 		
  
0 10 20 30 40 50
0
50
100
Days elapsed
S
ur
vi
va
l (
%
)
WT control
WT control + NR
Nampt KO 
Nampt KO + NR
*
A
0 10 20 30 40 50
60
80
100
120
140
days
%
st
ar
tin
g 
w
ei
gh
t
WT control
WT control + NR
Nampt KO 
Nampt KO + NR
B
				 178	
5.4 Discussion 
 This study is one of the first reports on the essentiality of Nampt expression. Nampt 
KO mice i) did not survive longer than 20 days without Nampt expression; ii) underwent 
extreme pancreatic atrophy; iii) died with a GI tract filled with food materials; iv) had their 
lifespans doubled by supplementing them with NR, but ultimately succumbed to the Nampt 
deficiency.  
 The finding that global Nampt KO is quickly lethal in an adult animal is 
noteworthy. Previous reports have mentioned as an observation that Nampt knockout is 
lethal in the developing embryo prior to e10.5 (Rongvaux et al. 2002, Fukuhara et al. 2005, 
Revollo et al. 2007). Our previous findings have demonstrated that knocking out Nampt 
specifically in smooth muscle cells does not lead to the complete failure of SMC-rich 
vessels and organs. However, there is a propensity to DNA damage, abnormal expression 
of matrix components and senescence in vascular smooth muscle cells along with a 
dysfunction, albeit not complete failure, of bladder and intestinal smooth muscle (Watson 
et al. 2017). Other reports have indicated that Nampt ablation in the liver, skeletal muscle, 
and brain does not lead to the failure of these organs, but it does predispose to a pattern of 
aging or degenerative tissue disorder (Stein and Imai 2014, Frederick et al. 2016, Zhou et 
al. 2016). Concordantly, our initial expectation was that a global Nampt knockout would 
lead to an aging or degenerative phenotype. These results were unexpected; however, my 
findings of quick decline and death corroborate the very recent report of a global inducible 
Nampt knockout in an adult animal (Zhang et al. 2017).  
 Nampt-depleted mice demonstrated a striking atrophy of the exocrine pancreas. 
This was first observed in peri-mortem Nampt KO mice, but upon further examination this 
atrophy began as early as five days after the initiation of Tmx injection. This atrophy was 
accompanied by acinar nuclear dysplasia, fibrosis, some necrotic cells, and a striking 
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occurrence of acinar-to-ductal metaplasia (ADM). Notably, there was a lack of 
inflammatory cells, even with the appearance of a few necrotic cells. ADM is thought to be 
a response to pancreatic injury, and has been observed in several conditions including 
pancreatitis, chemically induced carcinogenesis, duct ligation, pancreatectomy, chronic 
hyperglycemia and animal models of diabetes (reviewed in (Storz 2017)). It was shown 
that exocrine cells might also trans-differentiate into ß cells (Minami et al. 2005). Although 
there was little evidence for local Nampt expression in the pancreas there was strong 
evidence of organ-wide dysfunction, pointing to the requisite need for a source of Nampt or 
bioavailable NAD+. This source could, in theory, be i) supplied locally even with Nampt 
expression in islet cells, ii) delivered from circulating extracellular Nampt, or iii) 
circulating nucleoside NAD+ precursors, such as NR. It has not been established whether or 
not the pancreas can use distal sources of Nampt or NAD+ precursors. However, paradigm 
of dependence on a distal supply of Nampt has been reported in the case of hippocampal 
cells requiring Nampt secreted from adipose tissue (Yoon et al. 2015). 
 Nampt KO mice had a dilated and chow-filled alimentary canal - from the 
esophagus to the colon. There was a thinning of the structure composed of epithelial cells 
in these tissues, which may suggest that cell types with high turnover rates are more 
dependent on a bioavailable source of NAD+. Dilation and chow arrest may have stemmed 
from a malfunctioning exocrine pancreas as reduced secretion of pancreatic enzymes may 
result in an increase of undigested food material in the intestines and an increase in water 
content due to compensatory osmotic reactions. However, reduced pancreatic enzyme 
availability, as seen in cases of pancreatic insufficiency, is often associated with cases of 
diarrheal steatorrhea, and not cessation of motility (DiMagno et al. 1973, Pongprasobchai 
2013), although these conditions do not have to be exclusive. It is also possible that an 
altered motility of the alimentary system affects the propulsion of the content. One 
mechanism could be an altered electrical activity of the smooth muscle or altered 
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neuro/hormonal regulation of motility. Motility disorders, including diabetic enteropathy, 
slow-transit constipation, and ageing-associated motility disorders are linked, directly or 
indirectly, to defects in the neural control of the GI tract (Bassotti and Villanacci 2006, 
Camilleri et al. 2008, Lomax et al. 2010). An important component of enteric inhibitory 
neurotransmission is mediated by a purine neurotransmitter binding to purinoreceptors 
(Wood 2006, Gallego et al. 2008, Grasa et al. 2009). NAD+ is a purine substance (ß-NAD+) 
released by nerve stimulation in vascular and visceral smooth muscles and neuro-secretory 
cells (Smyth et al. 2004, Smyth et al. 2006, Mutafova-Yambolieva et al. 2007, Yamboliev 
et al. 2009), raising the possibility that NAD+ could be playing an important role in the 
control of gut motility at the neural level.  
 NAD+ is made available to the cell through more than one pathway. There are at 
least five dietary precursors to NAD+, four of which do not require Nampt and NAD+ itself 
may be directly delivered to cells from nearby cellular sources (Revollo et al. 2007, 
Nikiforov et al. 2015). The last aim of this study was to determine whether supplying 
Nampt KO mice with NR, an exogenous precursor that is metabolized to NAD+ via a 
Nampt-independent pathway (i.e. Nrk1), could overcome decline and death. Work in our 
lab and in others has shown that NR supplementation can increase cellular NAD+ levels. 
This NR-derived increase in NAD+ has been protective against various environment-
induced pathologies including noise-induced hearing loss (Brown et al. 2014), high fat diet-
induced obesity (Canto et al. 2012), and age-induced muscle dysfunction (Frederick et al. 
2016). Supplementing with NR was able to double the lifespan of Nampt KO mice, 
suggesting that NR can bolster the effects of the local loss of bioavailable NAD+.   
However, NR supplementation was only successful for a time. NR supplemented Nampt 
KO mice eventually succumbed to decline and death. 
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 By evaluating the consequences of Nampt KO in the newly developed inducible 
mouse model I am able to propose that i) Nampt expression is essential on a global level, 
ii) Nampt expression is variable from tissue to tissue, and even tissues that don’t normally 
markedly express Nampt may be susceptible to a global Nampt depletion, iii) exogenous 
supplementation of a Nampt-independent NAD+ precursor is not sufficient to completely 
compensate for the global loss of Nampt expression; however, lifespan is doubled when 
NR is administered. In summary, these data demonstrate that loss of Nampt in the adult is 
catastrophic. While the exact pathway of death on a cellular level may still be yet to be 
elucidated, it is clear that supplementation with an exogenous NAD+ precursor is powerful, 
but cannot overcome the need for a local NAD+-regeneration system.  
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 CHAPTER 6 - DISCUSSION 
Maintaining SMC health and vitality is crucial to protecting vascular stability in the 
face of hemodynamic and environmental insults. This is particularly true as these insults 
increase and accumulate over time and with age. Expanding our understanding of how 
SMCs resist stress is critical to developing strategies that enable a well-functioning 
vascular system over a long period of time.  
The novel findings presented in this thesis contribute to understanding how the 
NAD+-regenerating enzyme, Nampt, enables SMCs in vivo to resist key stresses that are 
exacerbated with aging. First, I developed a novel mouse knockout model wherein Nampt 
was knocked out in SMCs. The aortas of these knockout mice were susceptible to stress-
induced dissections, and the Nampt-KO aortic SMCs were compromised. These SMCs 
accumulated a range of DNA lesions that, I propose, pushed the cells to a fate of early cell 
senescence and cell loss. Second, I determined that the paradigm of low NAMPT 
expression correlating with a higher occurrence of DNA damage also exists in human 
aortic tissue obtained from patients with dilated aortas. Remarkably, the pattern of NAMPT 
expression in these aortas was associated with changes in the methylation status of the 
NAMPT promoter region, suggesting epigenetic control over NAMPT expression. Third, I 
determined that ablating Nampt expression in SMCs leads to a global shift in gene 
expression involving the downregulation of genes that produce collagens and the 
upregulation of genes that favour the production and assembly of certain proteoglycans. 
Fourth, I have demonstrated that Nampt is an essential gene in the adult mouse, and the 
knockout of Nampt is fatal within 20 days. Interestingly, I also determined that delivering 
NR to the knockout animal (NR is available as a dietary supplement) was sufficient to 
double its lifespan. Collectively, these findings reveal new functions for Nampt in the 
context of supporting SMC health and longevity. 
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6.1 Nampt knockout in SMCs 
Previous work done in Dr. Pickering’s lab established that Nampt is a 
phosphoribosyltransferase and that it plays a role in vitro in extending the lifespan of 
SMCs. However, the role of Nampt in SMCs in vivo had not been established.  My finding 
that Nampt-KO SMCs were part of a vasculature that developed largely normally was 
somewhat surprising. This is because prior reports indicated that global Nampt knockout 
was embryonic lethal (Revollo et al. 2007). Additionally, specific knockout of Nampt in T 
and B cells led to a near complete loss of these cells in mice (Rongvaux et al. 2008). 
 Recently, additional cell-specific Nampt knockouts have been reported. Nampt 
knockout in forebrain excitatory neurons lead to hippocampal and cortical atrophy, 
astrogliosis, microgliosis, and abnormal dendritic morphology by 2-3 months of age (Stein 
et al. 2014). Adipose-specific Nampt KO mice were found to have severe insulin resistance 
in adipose tissue, liver, and skeletal muscle, as well as adipose tissue dysfunction 
(Stromsdorfer et al. 2016). The deletion of Nampt in mice in both heart and skeletal muscle 
was embryonically lethal, whereas a skeletal muscle-specific deletion led to exhibited 
progressive weakness and loss of both endurance and bone structure, along with an 
increase of senescence markers in the skeletal muscle cells (Frederick et al. 2016). Thus, 
together with my data, it is becoming clear that different tissues have different 
requirements for Nampt. 
6.2 Nampt knockout and SMC DNA   
 A striking consequence of Nampt knockout in SMCs was the accumulation of DNA 
lesions. These included oxidative damage, as indicated by the presence of 8-oxo-dG, and γ-
H2AX foci, an indication of double stranded DNA breaks. Classically, DNA damage in 
uncovered in the context of tumours. In this regard, it is noteworthy that Nampt is 
				 189	
overexpressed in various cancers, including prostate, pancreatic, ovarian, fibrosarcoma, 
lung, colon, and myeloid (Hasmann and Schemainda 2003, Beauparlant et al. 2009, 
Watson et al. 2009, Olesen et al. 2010, Wang et al. 2011, O'Brien et al. 2013, Xiao et al. 
2013, Chan et al. 2014, Chini et al. 2014), and that the inhibition of Nampt is studied as 
tumour therapy. Inhibition of Nampt in some cancer cells can induce apoptosis, inhibit 
glycoloysis and nucleotide metabolism, decrease carbon flux through the TCA cycle, and 
suppress ATP synthesis (Tan et al. 2013, Tolstikov et al. 2014). Cell death follows a >90% 
reduction in ATP (Watson et al. 2009, Tan et al. 2013, Chan et al. 2014, Del Nagro et al. 
2014). However, with less catastrophic ATP depletion, inhibition of Nampt has been found 
to sensitize tumour cells to oxidative stress and DNA-damaging agents (Hasmann and 
Schemainda 2003, Yang et al. 2007, Watson et al. 2009, Bi et al. 2011, Wang et al. 2011). 
Importantly, the work presented in Chapter 2 is the first report in non-cancerous, well-
differentiated cells of the association of Nampt depletion with a susceptibility to DNA 
damage.  
6.3 Nampt knockout and senescence 
 Widespread evidence of senescence in the aortic media of SMC-Nampt KO mice 
infused with Ang II was another striking finding. Previous studies in Dr. Pickering’s lab 
demonstrated that inhibiting Nampt in SMCs in culture led to premature senescence, while 
overexpressing Nampt protected SMCs from undergoing replicative senescence (van der 
Veer et al. 2007). Additionally, it has been demonstrated that infusion of Ang II in vivo has 
been associated with an increase of SA β–gal activity the media of C57Bl/6 mice (Chen et 
al. 2016). Ang II has also been shown to induce SA β–gal activity in that aortic media of 
Sirt1 KO mice, aged mice, and aged Col1a1-/- mice (Vafaie et al. 2014, Chen et al. 2016). 
Interestingly, although I found senescence markers to be more abundant following Ang II 
infusion, I also detected evidence of senescence in the aortas of SMC-knockout mice at 
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baseline. Baseline senescence was not observed in Sirt1 KO mice (Chen et al. 2016), 
suggesting that the senescence-promoting effects of Nampt knockout are not exclusively 
mediated via a decrease in Sirt1 activity, but also involve the activity of other NAD+-
dependent processes.  
6.4 Nampt knockout and Parp1 activity 
 It is well established that knocking down Nampt activity can lead to a depletion of 
bioavailable NAD+(Revollo et al. 2004). As Parp1 requires NAD+ to function, a depletion 
could compromise the PAR-moiety forming activity of Parp1. I observed this paradigm in 
SMC-Nampt KO mouse aortas, as detailed in Chapter 2. Notably, levels of Parp1 were 
unchanged, but the ability to form poly-ADP-ribose moieties was abrogated. This was 
associated with impaired repair of damaged DNA, consistent with the body of evidence of 
Parp1’s involvement in multiple DNA damage repair pathways (Ray Chaudhuri and 
Nussenzweig 2017). Upon supplying the Nampt KO SMCs with NR, a precursor to NAD+, 
I was able to restore the ability of the cells to form PAR moieties; the hypothesis being that 
Parp1 retained its catalytic capacity, but the building blocks required to form PAR moieties 
(i.e. NAD+, acting as cosubstrate) were unavailable.  
Recently there has been evidence that low bioavailable NAD+ not only limits the 
PAR-synthetic activity of Parp1, but directly promotes the protein-protein interaction of 
Parp1 and its inhibitor DBC1. NAD+ interacts with DBC1 via nudix homology domains 
(NDHs) (Li et al. 2017). NDHs have been considered protein homology domains of 
previously unknown function that have recently been discovered to be NAD+ binding 
domains that regulate protein-protein interactions (Srouji et al. 2017). A decline in NAD+ 
promotes the binding of DBC1 to Parp1, which inhibits Parp1’s ability to mediate DNA 
repair (Li et al. 2017). It is speculated that this function allows a cell to adapt to 
fluctuations in NAD+ abundance without degrading it, and to serve as a negative-feedback 
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loop to prevent Parp1 from depleting NAD+ down to lethal levels during DNA damage 
(Yang et al. 2007). It is possible that this paradigm explains the predisposition to DNA 
damage in SMC-Nampt KO mice, without widespread medial cell death.  
6.5 SMC Nampt knockout and future directions 
 The studies carried out in Chapter 2 provide insight into the role Nampt plays in 
vivo in SMCs. Using a mouse model of SMC-specific Nampt knockout I uncovered that 
Nampt deficient SMCs developed into a close-to normal aorta.  However, when this 
vasculature was subjected to hemodynamic stress of Ang II, the Nampt-deficient aortas 
were prone to dissection. These dissections were associated with an increased burden of 
cells with DNA damage and senescent cells.  
 The main phenotype uncovered in the SMC-Nampt KO aortas was related to a 
deficiency in Parp1 activity, activity very much dependent on the bioavailability of NAD+. 
It would be interesting to determine whether supplying an exogenous source of NAD+ to 
the animal would regenerate Parp1 activity. I have demonstrated in vivo that delivering the 
NAD+ precursor, NR, to Nampt-KO SMCs in vitro restored Parp1 activity. Thus, 
undertaking Ang II-infusion experiments in SMC-Nampt KO mice, while supplementing 
the animal with NAD+ precursors, either NR or NMN, would be important. NR may be of 
particular interest as it can be obtained in a dietary fashion. As Nampt levels have been 
shown to decrease in aged tissues (Stein and Imai 2014), along with concomitant drops in 
NAD+ levels, it is of particular interest to know if a dietary supplement could offset the 
effects of this drop.  
 Furthermore, the bulk of my studies were restricted to the largest vessel, the aorta. 
While the failure of this vessel occurs often in an acute and catastrophic fashion, 
compromised function of smaller arteries can have important long-term effects on blood 
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pressure and flow. Therefore, it would be interesting to characterize the consequences of 
Nampt knockout in the more distal vasculature this mouse model.   
6.6 Nampt expression in human aortopathy 
 The correlation between low Nampt in mouse aortic SMCs and susceptibility to 
aortic dissection and hemorrhage caused me to consider whether this correlation exists in 
human aortic pathologies. As presented in Chapter 3, I uncovered that NAMPT content 
was lower in dilated human aortas that in non-dilated aortas, with an inverse relationship 
between the aortic diameter and medial SMC NAMPT content.  This fits an emerging 
pattern of reduced Nampt in aged or compromised tissues (Yoshino et al. 2011, Stein and 
Imai 2014). The current study may be the first to identify such a relationship in human 
diseased tissue. It is interesting to note that a downregulation of the NAD+-dependent 
enzyme Sirt1 has been associated with aortic aneurysms in humans (Chen et al. 2016), and 
decreased Sirt1 activity has been found in the dysfunctional vasculature of aged mice (de 
Picciotto et al. 2016). As Sirt1 activity is dependent on the bioavailability of NAD+, the 
described Sirt1 effects could depend, at least in part, on the NAD+-regenerating activity of 
Nampt.  
6.7 Nampt expression and DNA damage in human aortopathy 
 A remarkable discovery presented in Chapter 3 was the presence of double-stranded 
DNA breaks in human aortic medial tissue. While there were rare breaks (indicated by the 
presence of γ-H2AX foci) detected in the media of normal control tissue, the incidence of 
γ-H2AX foci was significantly increased in tissue obtained from patients with dilated 
aortas. This is the first in situ evidence for double-stranded DNA lesions in non-
atherosclerotic human aortic media (Gray et al. 2015). Cells in which these foci were 
detected also demonstrated low Nampt expression. Although the data do not prove 
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causation, the single-cell relationship between low NAMPT and unresolved DNA strand 
breaks strengthens the potential for a mechanistic relationship.  
Although the activity of DNA damage repair enzymes was not evaluated in the 
human aortopathy samples, I propose that the persistence of DNA breaks was due to a 
deficiency of repair mechanisms. There has been uncertainty as to whether DNA damage 
occurs in “post-mitotic” tissues, and if it does occur, whether repair of DNA breaks occurs 
in post-mitotic tissues. However, studies of post-mitotic neural tissue have found that these 
tissues do endure DNA damage, and also have the capability to repair DNA damage (Chow 
and Herrup 2015). Much of the damage is attributable to radiation or reactive oxygen 
species, but also to gene transcription that generates DNA damage through topoisomerase I 
cleavage complexes (Katyal et al. 2014). Additionally, even in post-mitotic cells, DNA 
damage repair processes such as base excision repair, single-strand break repair, and non-
homologous end joining have been detected (Iyama and Wilson 2013). Importantly, the 
activities of a number of NAD+-dependent enzymes have been associated with these repair 
pathways, including Parp1, Sirt1, and Sirt6, thus strengthening the case for a potential 
mechanistic relationship with Nampt (Mostoslavsky et al. 2006, Mao et al. 2011, Dobbin et 
al. 2013, Ray Chaudhuri and Nussenzweig 2017).  
6.8 Epigenetic control of Nampt expression 
 The discovery that NAMPT expression varied from patient to patient prompted an 
investigation into what could potentially be regulating NAMPT expression. To date it has 
been understood that Nampt expression was regulated by the binding of the circadian 
transcription factors Bmal1 and Clock (Nakahata et al. 2009). Expression of Clock:Bmal1 
is in turn mediated by Sirt1 activity (Nakahata et al. 2008), and thus Nampt expression is 
regulated by its own NAD+-regenerating activity.  
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 To facilitate transcription, the Clock:Bmal1 complex binds to enhancer-box (E-box) 
sites in the Nampt promoter region. My analysis of the Nampt promoter region also 
revealed CpG islands; regions that are susceptible to DNA hypermethylation, which 
interferes with gene transcription. Accordingly, patient samples with low levels of Nampt 
expression in their aortic media had higher levels of DNA methylation in the Nampt 
promoter region. There is a growing body of evidence that local CpG islands undergo DNA 
hypermethylation with aging (Jones et al. 2015). Hypermethylation of the Nampt promoter 
region during aging could be part of the sequence of events driving cells to a low NAD+-
state, and perpetuating an aging or frailty phenotype.  
6.9 Future directions for human aortic Nampt studies 
 The data presented in Chapter 3 represented predominantly bicuspid aortic valve 
patients. However, low aortic NAMPT was observed not only the dilated aortas of patients 
with a bicuspid aortic valve but also those with a tricuspid aortic valve and Marfan 
syndrome.  A larger series would be required to determine if there are aortic disease-
specific differences in NAMPT expression and also if NAMPT expression in SMCs is 
relevant to atherosclerotic abdominal aortic aneurysms. It would also be beneficial to 
attempt to correlate NAMPT expression with NAD+ levels in the aortic media, although this 
could require larger pieces of human aorta to be harvested.  
 DNA methylation is a heritable epigenetic mark involving the covalent transfer of a 
methyl group to the C-5 position of the cytosine ring of DNA by DNA methyltransferases 
(DNMTs) (Chen and Li 2006). It would be interesting to evaluate the expression or activity 
status of DNMTs, particularly DNMT1 (responsible for maintaining DNA methylation 
patterns) and DNMT3a or 3b (which are responsible for de novo methylation of DNA), in 
the aortic media of patients with dilated aortas (Robert et al. 2003, Hino et al. 2009, Daniel 
et al. 2011). 
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6.10 SMC Nampt and extracellular matrix 
 Studies in Chapter 2 revealed that SMC-Nampt depletion conveyed a vulnerability 
to the aorta and a susceptibility to SMC dropout. Thoracic aortic aneurysm and dissection 
disease (TAAD) is classically associated with SMC dropout, but also damaged elastic 
fibers, compromised smooth muscle function, pooled mucoid material, and remodeled 
collagen fibers (Humphrey et al. 2015).  
 The studies in Chapter 4 involved transcriptome profiling of Nampt-knockout 
SMCs. RNA expression array analysis revealed a notable change in the transcriptome. The 
expression of genes related to collagen production and assembly was significantly 
depressed and the expression of genes related to mucoid/proteoglycan material was 
significantly increased. This is consistent with an aortic wall environment seen in aged 
tissues, and in TAAD tissues (Humphrey et al. 2015). Loss of collagen fiber integrity 
decreases mechanical strength, which can render the aortic wall vulnerable to rupture 
(Wenstrup et al. 2006). Proteoglycans that can accumulate and pool in localized areas with 
aging and as part of the pathology in TAADs contribute to the risk of dissection 
(Roccabianca et al. 2014). 
6.11 SMC Nampt knockout and SMAD signalling  
 Identifying a mechanistic link between Nampt knockdown and ECM transcriptome 
changes was outside the scope of the work presented in Chapter 4. However, I was able to 
identify Smad7 as a potential upstream driver of these changes using a prediction algorithm 
built into the Upstream Analysis tool from IPA. Smad7 is an inhibitor of TGF-β signaling 
by preventing formation of Smad2/3:Smad4 complexes that initiate the TGF-β signalling 
(Shi and Massague 2003). TGF-β signaling is associated with enhanced collagen and 
fibronectin synthesis and deposition (Ignotz and Massague 1986), increased elastin 
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expression (Kucich et al. 2002), and direct repression of MMPs (Yan and Boyd 2007). 
TGF-β signaling also increases the size of glycosaminoglycan chains on both bigylcan and 
decorin (Schonherr et al. 1993, Dadlani et al. 2008). Interestingly, NAD+-dependent Sirt1-
mediated deacetylation of Smad7 has been documented. Deacetylation of Smad7 targets it 
for degradation, and inhibition of Smad7 deacetylation leads to greater Smad7 stability and 
activity (Kume et al. 2007). This may be significant as disruptions in TGF-β signalling 
have been identified in aortic pathologies such as Marfan syndrome and in Loeys-Dietz 
syndrome (Loeys and Dietz 1993, Jones and Ikonomidis 2010). TGF-β signaling has been 
implicated not only in matrix deposition, but also in matrix degradation, positioning it as a 
critical mediator of the balance of structure and composition of the vascular ECM (Jones 
and Ikonomidis 2010). Accordingly, my data raise the possibility of a Nampt-Smad7 
dependency that is relevant to health and disease.  
6.12 Future directions for the link between Nampt expression and the control of 
ECM transcription. 
  The NAD+-dependent activity of Sirt1 has been found to regulate the stability of 
Smad7 by deacetylation (Kume et al. 2007). Therefore a depletion of Nampt-generated 
NAD+ in the cell could, consistent with my hypothesis, have an effect on the stability of 
Smad7. It would be important to evaluate the acetylation status of Smad7 and consequent 
Smad7 protein levels in WT and Nampt KO SMCs. Loss-of-function and overexpression of 
Smad7 and measuring the expression of key ECM proteins would help to illuminate its 
role. A change in the phosphorylation status of Smad2/3 would also indicate functionally a 
change in Smad7 activity, as Smad7 is a key regulator of the TGF-β signalling pathway 
(Yan and Chen 2011, Beppu 2013). 
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6.13 Global Nampt knockout  
 Studies presented in Chapters 2, 3, and 4 all focus on the role of Nampt specifically 
in SMCs. Chapter 5 explored the role Nampt plays in all other organs, and how the need 
for Nampt in SMCs can compare to the requirements of different tissues. Reports to date 
have indicated that Nampt knockout is embryonically lethal prior to e10.5 (Revollo et al. 
2007). Therefore I developed a mouse model wherein Nampt could be conditionally 
deleted at a post-natal time-point. Nampt KO mice did not survive longer than 20 days the 
acute knockout event. Interestingly, this early death was not due to vascular SMC 
abnormalities but was associated with rapid degeneration of the exocrine pancreas, gut 
epithelial abnormalities, and halted gastrointestinal transit of undigested food. It is 
interesting to note that soon after these studies had been undertaken, reports of a similar 
knockout model were published (Zhang et al. 2017). A similar time-course of decline was 
reported; rapid weight loss after the induction of the knockout with death occurring within 
5-10 days of knockout. The authors report severe atrophy of the villi of the gastrointestinal 
tract, an increase in serum triglyceride levels, and a catastrophic decrease in abdominal 
adipose stores (Zhang et al. 2017). These results were attributed to liver dysfunction caused 
by liver Nampt depletion, however, the model of Nampt knockout they used for their 
studies only yielded 20% decrease in Nampt expression in the liver. Also, mice that are 
subjected to calorie restriction for any reason can reduce their body fat stores remarkably 
quickly – i.e. up to 20% within 72 hours (Tang et al. 2017). Their findings were limited, as 
they did not present data on any other tissues that may have been affected by Nampt 
knockout.   
The results of my Nampt knockout study suggest that some tissues are more quickly 
vulnerable to knockout than others, indicating cell differences in their requirement for 
NAD+ bioavailability. In tissue-specific knockout of Nampt, mice lacking Nampt in 
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forebrain excitatory neurons showed abnormal morphology and accelerated aging (Stein et 
al. 2014). Ablation of Nampt in adult neural stem cells also causes signs of accelerated 
aging in this neural cell population (Stein and Imai 2014). Knockout of Nampt in skeletal 
muscle contributed to an aging phenotype-related loss mass and contractile function 
(Frederick et al. 2016). Adipocyte-specific Nampt knockout mice had severe insulin 
resistance in adipose tissue, as well as liver, and skeletal muscle, and adipose tissue 
dysfunction (Stromsdorfer et al. 2016). In my model of global Nampt knockout, none of 
these tissues were grossly abnormal, save for the loss of most of the adipose tissue stores. 
In contrast, the pancreas seems to be profoundly affected. Remarkably, there doesn’t seem 
to be strong, local, baseline expression of Nampt in the pancreas, therefore it may be 
dependent on distal sources of Nampt-generated NAD+. This would agree with the concept 
that some tissues are “NAD+-frail”; i.e. they aren’t autonomously able to regenerate the 
NAD+ they need to function. This is ascribed namely to the pancreas and brain, as there is 
little evidence of Nampt expression (Revollo et al. 2007), yet there is dependence on NAD+ 
availability (Ramsey et al. 2008, Yoon et al. 2015). It is of particular interest to note, 
however, that the concept of the pancreas being “NAD+-frail” is in relation to the NAD+ 
requirement of the β islet cells of the pancreas for glucose-stimulated insulin secretion 
(Imai 2016). And yet in my model of global Nampt knockout it was the exocrine pancreas 
that experienced a more robust failure.  
6.14 Supplementation of the NAD+ supply pathway 
Evidence is accumulating that a lack of bioavailable NAD+ may underline a number 
of pathologies associated with aging. As such, strategies to prevent or overcome this 
metabolic decline could have therapeutic benefit. During the course of my experiments I 
observed an upregulation in the expression of Nrk1, the enzyme responsible for converting 
NR to NAD+, in the pancreas and liver of Nampt KO mice. This increase was also seen in 
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the aorta and brain of Nampt KO mice during previous work in our lab measuring Nrk1 
expression. NR is a naturally occurring precursor to NAD+ that is easy to obtain and 
deliver. I attempted to circumvent the lethality of Nampt knockout with NR 
supplementation. NR did not ultimately succeed in eliminating the lethal effects of Nampt 
knockout. However, it did strikingly double the lifespan of the Nampt knockout mouse. 
This was particularly impressive given the otherwise rapid decline in mouse health. The 
reason why the beneficial effect of NR supplementation was not sustained is unclear. 
Regardless, the ability of NR to slow and transiently reverse the decline in mouse health, in 
the setting of profound, widespread impairment of NAD+ synthesis, holds promise for 
conditions of less severely impaired NAD+ metabolism.  
6.15 Future directions of Nampt knockout and NAD+ supplementation therapy  
 NR is a molecule found in dietary sources, and such would be a nutrient 
supplement. My findings thus constitute a novel example of a defect in an essential gene 
that can be reversed, at least partially, with a nutritional supplement. Most examples of 
genetic disorders treated by diet involve the omission of a nutrient that might be 
problematic. For example, phenylketonuria is the absence or deficiency in phenylalanine 
hydroxylase, an enzyme involved in metabolizing or converting phenylalanine into 
tyrosine, and patients are managed by following a diet that limits phenylalanine (found in 
foods that contain protein). Future studies to determine which tissues are most able to 
withstand Nampt knockout when supplemented with NR would be an important step to 
then designing therapeutic trials. 
6.16 Summary 
 As described in this thesis, the NAD+-regenerating enzyme Nampt is critical to the 
resistance of hemodynamic and oxidative stress insults that are experienced by SMCs in 
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the aortic media. Depletion of Nampt in SMCs leads to an overwhelming increase in the 
burden of DNA lesions, which may push these cells to a senescent phenotype. Nampt 
depletion is also associated with a decrease of collagen production and assembly, along 
with an increase in proteoglycan deposition, further leading the instability of the aorta. In 
the face of a life-long accumulation of stresses that may serve to shift Nampt expression 
and NAD+ levels to pathologically low levels, strategies of supplementation with 
exogenous NAD+ precursors may help to buffer against the consequences. However, the 
need for a local Nampt-dependent regeneration of NAD+ may never be overcome in certain 
tissues, and disturbed NAD+ metabolism may be the nexus on which the fate of a cell 
hinges.  Collectively, my findings reveal new processes by which SMCs stay healthy and 
functional, with important implications for mitigating the consequences of the 
accumulation of the stresses that push blood vessels, and other organs, to catastrophic 
failure.   
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APPENDIX I - GENE WRITING CONVENTIONS 
 Human Mouse 
DNA  NAMPT Nampt 
cDNA NAMPT Nampt 
Genotypes*  Nampt 
mRNA  NAMPT Nampt 
Protein  NAMPT Nampt 
 
* Gene symbols are italicized when published, as are allele symbols. Transgenes, which are not part of the native 
genome, are not italicized (from JAX) 
 
For reference, see: 
http://www.jci.org/kiosk/publish/genestyle 
http://www.biosciencewriters.com/Guidelines-for-Formatting-Gene-and-Protein-
Names.aspx 
http://www.informatics.jax.org/mgihome/nomen/gene.shtml#gaas 
http://www.genenames.org/about/guidelines#Appendix1 
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